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The bacterial cell wall withstands the turgor pressure and is an essential structure for 
most bacteria. The lipid II cycle is responsible for transporting cell wall building blocks 
across the cytoplasmic membrane by means of the carrier molecule undecaprenyl 
phosphate (UP). One essential step is the recycling of undecaprenyl pyrophosphate 
(UPP) to UP by UPP phosphatases. This step is targeted by bacitracin, an UPP-binding 
anti-microbial peptide (AMP). In the course of this thesis, the effect of deletion and 
depletion of bacitracin resistance modules and UPP phosphatase genes on the cell 
envelope stress response in Bacillus subtilis was evaluated. 
The main resistance determinant against bacitracin, the ABC-transporter BceAB was 
found to be homeostatically regulated “to need” by flux-sensing of its own activity. 
The full effect of the secondary layer of resistance determinants, consisting of the 
UPP phosphatase BcrC and the phage shock protein-like response of the Lia-system, 
is only revealed in the absence of BceAB. For the first time, a resistance phenotype 
for LiaIH toward bacitracin was reported. The genes uppP and bcrC encode UPP 
phosphatases and were found to be synthetic lethal. Depletion of either UPP 
phosphatase in a double mutant background lead to bulging cells in exponential 
growth phase. BcrC is the main UPP phosphatase during growth. In contrast, UppP is 
primarily responsible for normal sporulation.  
The generation of UP in the lipid II cycle is essential and can be impaired by (i) addition 
of the UPP-binding AMP bacitracin, (ii) deletion and depletion of UPP phosphatases 
(BcrC and UppP), or, to a limited degree, (iii) deletion of the undecaprenol kinase 
(UDPK) DgkA. There is a marked difference in the CESR toward these challenges: while 
the addition of bacitracin activates two damage driven promoters, PliaI and PbcrC, a 
lack of UPP phosphatases or DgkA is only detected by the latter. This indicates that 
the blocking of UPP with bacitracin has a different effect on the cell envelope than 
the shortage of UPP phosphatases. Our analysis of the dephosphorylation of UPP in 





Die bakterielle Zellwand ist für die meisten Bakterien überlebensnotwendig, zum 
Beispiel um dem Turgor entgegenzuwirken. Sie besteht aus Zucker-Peptidbausteinen, 
deren Auf- und Abbau komplex reguliert ist. Für die Anlieferung der Bausteine ist der 
Lipid II-Zyklus mit dem Transportmolekül Undecaprenylphosphat (UP) zuständig. 
Nach Einbau des Zellwandbausteins liegt das Transportmolekül als 
Undecaprenylpyrophosphat (UPP) vor und wird von UPP-Phosphatasen zu UP 
dephosphoryliert, um wiederverwendet werden zu können. An diesem essentiellen 
Schritt greift das Peptidantibiotikum Bacitracin an, indem es an UPP bindet und so 
das Recycling verhindert. Eine Blockade des Lipid II-Zyklus führt zu fehlerhafter 
Zellwandsynthese mit entsprechenden morphologischen Phänotypen, sowie zur 
Aktivierung der Zellwandstressantwort. In dieser Arbeit wird die Dephosphorylierung 
von UPP in Bacillus subtilis in zwei Aspekten genetisch untersucht. Zum einen wird 
unter Bacitracinstress beobachtet, wie die nativen Sensoren und 
Resistenzmechanismen in Abhängigkeit voneinander reagieren. Zum anderen 
werden die Auswirkungen eines UPP-Phosphatase-Defizits beleuchtet. 
Der ABC-Transporter BceAB ist die primäre Resistenzdeterminante gegen Bacitracin. 
Seine Anzahl wird durch homöostatische Selbstregulierung an den aktuellen Bedarf 
angepasst, indem die Aktivität der Transporter als Signal für deren Auslastung 
verwendet wird. Die sekundären Resistenzdeterminanten, die UPP-Phosphatase BcrC 
und LiaIH (wobei LiaH Ähnlichkeit zum Phagenschockprotein A aufweist), werden 
schadensabhängig induziert. Ihr volles Potential wird nur in Abwesenheit von BceAB 
sichtbar. Zum ersten Mal wurde gezeigt, dass LiaIH Resistenz gegen Bacitracin 
vermitteln kann, obwohl deren Expression bei Bacitracinstress schon seit über zehn 
Jahren bekannt ist. Außerdem konnte gezeigt werden, dass die Gene bcrC und uppP 
der UPP-Phosphatasen BcrC und UppP ein essentielles Paar bilden. Die Depletion 
dieser Phosphatasen in einer bcrC uppP Doppelmutante führte zu gewölbten Zellen 
in der exponentiellen Wachstumsphase. BcrC stellt die Haupt-UPP-Phosphatase 
während des Wachstums dar, wohingegen UppP für die ordnungsgemäße 
Sporulation benötigt wird. 
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Die (Wieder-)Herstellung von UP ist für den Lipid II Zyklus essentiell und kann auf drei 
Arten gestört werden: (i) Zugabe von Bacitracin, welches UPP bindet und die 
Dephosphorylierung verhindert, (ii) Deletion und Depletion der UPP-Phosphatasen 
BcrC und UppP, oder, in geringem Umfang, (iii) Deletion der Undecaprenol-Kinase 
DgkA. Hierbei zeigt sich ein drastischer Unterschied in der Zellwandstressantwort. 
Während durch Bacitracin zwei schadensabhängige Promotoren aktiviert werden, 
PliaI und PbcrC, ist bei UPP-Phosphatase- oder DgkA-Mangel nur letzterer aktiv. Dies 
deutet darauf hin, dass diese Eingriffe auf die Bildung von UP verschiedene 
molekulare Konsequenzen haben, die unterschiedlich detektiert werden. Unsere 
Untersuchung der UPP-Dephosphorylierung legt einen weiteren Grundstein für das 





“Zwei Seelen wohnen, ach! In meiner Brust, 
Die eine will sich von der andern trennen“ – J. W. v. Goethe, Faust I  
“Two souls, alas, are housed within my breast, 
And each will wrestle for the mastery there” 
My heart, it beats for basic science. My heart, it beats for applied science and 
Synthetic Biology. I was fortunate enough that in the course of my thesis, I did not 
have to choose one of the wishes above the other – I could pleasure both hearts, 
which were linked by the organism of choice: Bacillus subtilis. The order of events did 
not allow me to use the vector toolbox “Bacillus SEVA siblings” for the cell envelope 
stress project, so in this thesis, I will only focus on cell envelope stress and 
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 THE BACTERIAL CELL ENVELOPE 
The cell envelope is an essential complex multilayered structure to separate bacteria 
from the environment and protect their content. Gram-positive bacteria, such as 
Bacillus subtilis, are surrounded by (i) an inner membrane and (ii) a thick cell wall 
(~30 nm). The membrane consists of a phospholipid bilayer where proteins and 
lipoteichoic acids (LTAs) can be anchored. To name just a few functions, the 
membrane serves as a diffusion barrier, allows the formation of a membrane 
potential, and is a platform for protein interaction, e.g. for signaling pathways or 
chemical synthesis which involves multiple enzymes (Hurdle et al., 2011). The cell 
wall contains mainly peptidoglycan (PG) and wall teichoic acids (WTAs), but also LTAs, 
and proteins (Dufresne & Paradis-Bleau, 2015; Silhavy et al., 2010). PG forms a sieve-
structured network of glycan chains composed of N-acetylglucosamine (GlcNAc) and 
N-acetylmuramic acid (MurNAc), cross-linked by short peptide bridges (Vollmer & 
Höltje, 2004). It determines the cell shape, counteracts the cellular turgor pressure, 
and is negatively charged due to the presence of teichoic acids. Both, membrane and 
cell wall compositions, are actively changed by the bacteria according to 
environmental conditions and needs. For example, under phosphate-depleting 
conditions, teichuronic acids instead of teichoic acids are utilized (Bhavsar et al., 
2004; Botella et al., 2014). The essential functions fulfilled by the cell envelope and 
its accessibility make it a perfect target for antibiotics: almost every single step of its 
biosynthesis pathway is targeted by at least one antibiotic (Bugg et al., 2011; 
Schneider & Sahl, 2010), see Figure 1. Since the bacterial cell envelope is distinct from 
eukaryotic cells, the cell wall active antibiotics are suitable candidates for clinical use. 
1.1.1 CELL WALL BIOSYNTHESIS 
The PG biosynthesis can be separated into three stages: (i) intracellular assembly of 
PG precursors, (ii) their shuttling across the membrane (lipid II cycle), and (iii) their 
incorporation into the existing cell wall. Especially the last step needs to be highly 
regulated in a spatio-temporal manner, since the insertion of new building blocks for 
cell elongation requires the hydrolysis of the pre-existing PG in a turgor-strained 
setting; see (Typas et al., 2012) for a recent review. Further structural changes, like 
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the extrusion of flagella and pili or DNA uptake in competent cells, require PG 
modification, as well (Carballido-Lopez et al., 2006).  
1.1.2 LIPID II CYCLE 
The carrier molecule for cell wall components (PG, WTAs, or (in Gram-negative 
bacteria) lipopolysaccharide O-antigen) in most bacteria is undecaprenyl phosphate 
(UP), a linear-chain polyprenyl-phosphate (Manat et al., 2014). The respective 
precursors are attached to the carrier which shuttles them from the inner to the outer 
leaflet of the cytoplasmic membrane. For PG, this process is called lipid II cycle (Figure 
1), in reference to the mature molecule used for cell wall assembly: lipid II (Scheffers 
& Tol, 2015). 
UP is loaded on the cytosolic side of the membrane, flipped to the outside by specific 
flippases and released as undecaprenyl pyrophosphate (UPP) upon polymerization of 
 
Figure 1. The lipid II cycle and a few interfering antibiotics. The first step of the lipid II cycle is 
catalyzed by MraY: the soluble precursor molecule N-acetyl-muramic acid-pentapeptide (MurNAc-
pentapeptide, M) is loaded onto UP, forming lipid I. Subsequently, N-acetyl-glucosamine (GlcNAc, 
G) is added by MurG and lipid II is generated. The flippases MurJ and Amj flip lipid II to the outer 
leaflet of the cytoplasmic membrane (Laddomada et al., 2016; Meeske et al., 2015) where the 
MurNac-GlcNAc-pentapeptide is linked to the cell wall by β-(1Æ4) glycosylation and 
transpeptidation, carried out by Penicillin-binding proteins (PBPs) (Goffin & Ghuysen, 1998; 
Schneider & Sahl, 2010). Thus, UPP is released on the outer leaflet and dephosphorylated by 
designated UPP phosphatases to UP. To be accessible for recycling, UP needs to be flipped back to 
the inner leaflet by a yet unknown mechanism (Manat et al., 2014). Feeding into the lipid II cycle 
are de novo synthesis of UPP via UppS and (probably) phosphorylation of undecaprenol via DgkA. 
Molecules (black) and relevant enzymes in B. subtilis (green) are named in the figure. Modified from 
(Breukink & de Kruijff, 2006).  
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the transported building block (Manat et al., 2014). UPP is dephosphorylated to UP 
by UPP phosphatases and – potentially in this process – flipped back to the inner 
leaflet of the cytoplasmic membrane. De novo assembly of UPP takes place at the 
inner leaflet of the cytoplasmic membrane by the essential UPP synthase UppS: eight 
isoprene units (derived from isoprenyl pyrophosphate) are added to farnesyl 
pyrophosphate (Barreteau et al., 2009). Both, newly synthesized and recycled UPP, 
need to be dephosphorylated to UP by UPP phosphatases to be (re)loaded with new 
building blocks. This process, especially the membrane orientation, is not yet fully 
understood (Manat et al., 2014). The lipid II cycle is a prime target of clinically 
relevant anti-microbial peptides (AMPs), such as tunicamycin, vancomycin, bacitracin 
or mersacidin (Field et al., 2015; Schneider & Sahl, 2010). 
In B. subtilis, UP is responsible for the transport of WTAs and PG (Barreteau et al., 
2009; Bouhss et al., 2008). When the teichoic acid is attached to the PG, UP (instead 
of UPP) is released, in contrast to the lipid II cycle (Anderson et al., 1972; Brown et 
al., 2013).  
 BACTERIAL CELL ENVELOPE STRESS RESPONSE (CESR)  
B. subtilis belongs to the phylum of Firmicutes, which comprises Gram-positive 
bacteria with a low GC-content. It is a model organism for cellular differentiation, 
division and cell shape determination, among others (Jensen et al., 2005; Muchova 
et al., 2013; van Gestel et al., 2015). B. subtilis lives in the soil, one of the most 
competitive environments for bacteria. It is exposed not only to changing 
environmental conditions, like temperature, humidity, nutrients, salinity or pH, but 
also to AMPs, which are produced by competitors to suppress proliferation (Eijsink et 
al., 2002). Their main target is the cell envelope integrity and biosynthesis (Breukink 
& de Kruijff, 2006). In order to survive, cells have to respond immediately and usually 
with differential gene expression. Accordingly, important cues, such as AMPs or cell 
envelope damage, need to be sensed, signals have to be transduced to the cytoplasm 
and the correct protective countermeasures must be taken. This is collectively 




There are three bacterial regulatory principles and representatives of all of them are 
involved in CESR. (i) Extracytoplasmic function sigma factors (ECFs) are activated in 
response to extracellular stress and have evolved diverse mechanisms of signal 
transduction (Mascher, 2013). A cognate, often membrane bound, anti-σ factor is 
responsible for the regulation of σ factor activity. For instance, under non-inducing 
conditions, the anti-σ factor binds and inactivates the σ factor, and releases it upon 
stimulus perception under inducing conditions (Hughes & Mathee, 1998). (ii) One-
component systems (1CS) combine an extracellular input domain with an intracellular 
effector domain in a single protein. The bacitracin-responsive regulator BcrR of 
Enterococcus faecalis (Gauntlett et al., 2008; Gebhard et al., 2009) is so far the only 
known example of a membrane-anchored transcriptional regulator that responds to 
envelope stress. The scarcity of 1CS in the CESR, despite the dominating abundance 
of 1CS in general, is explained by the molecular restrictions of simultaneous 
membrane localization and DNA binding (Ulrich et al., 2005). (iii) This restriction is 
overcome in two-component systems (2CS), in which the input and effector domains 
are located on two separate proteins. One is the membrane-anchored signal sensor, 
a histidine kinase, the other a soluble transcriptional response regulator. The signal 
is communicated via phosphoryl group transfer (Gao et al., 2007). ECFs and 2CSs are 
commonly found amongst the signaling devices mediating the cellular response to 
AMP challenge (Jordan et al., 2008). 
Regarding resistance determinants, there are two general principles at work: (i) 
specific resistance determinants that either transport or sequester AMPs from their 
molecular targets, like ATP binding cassette (ABC)-transporters (Gebhard, 2012) or 
lipoproteins (Aso et al., 2005; Khosa et al., 2016), and (ii) unspecific resistance 
determinants that alter the composition and charge of the cell envelope to 
exacerbate the access of AMPs to their targets (Revilla-Guarinos et al., 2014) or cope 
with the physiological damage that already occurred, e.g. using phage-shock-proteins 
(Psps) (Joly et al., 2010). Especially specific resistance determinants act most 
efficiently if activated before severe damage occurs, so they rely on very sensitive 
sensing of AMPs – at concentrations far below lethality. 
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1.2.1 THE BACITRACIN-INDUCED CESR IN B. SUBTILIS  
In this work, I will focus on the CESR of B. subtilis toward the peptide antibiotic 
bacitracin, and especially how the regulation of resistance determinants 
interdepends. Bacitracin is a cyclic AMP, produced by nonribosomal peptide synthesis 
in some strains of Bacillus licheniformis and B. subtilis (Azevedo et al., 1993; Ishihara 
et al., 2002; Konz et al., 1997), but not the W168 strain used in this study. Bacitracin 
coordinates a divalent cation (optimal is Zn2+), binds UPP tightly and blocks its 
dephosphorylation (Economou et al., 2013; Storm & Strominger, 1973), thereby 
inhibiting an essential step in the preparation or recycling of the carrier molecule to 
transport cell wall building blocks. It is clinically used as broad spectrum antibiotic 
against skin infections (Trookman et al., 2011).  
To enable progression of the lipid II cycle and protect against cell envelope damage, 
there are three known resistance mechanisms against bacitracin in bacteria: (i) 
specific ABC-transporters (Manson et al., 2004; Ohki et al., 2003a; Podlesek et al., 
1995), (ii) (over)expression of (alternative) UPP phosphatases (Bernard et al., 2005; 
Cain et al., 1993; Cao & Helmann, 2002; Ohki et al., 2003b), and (iii) variation of 
exopolysaccharide production (Pollock et al., 1994; Tsuda et al., 2002).  
Upon bacitracin addition, B. subtilis upregulates σB (general stress response) and the 
ECF σM (CESR). Furthermore, several 2CS are activated, which orchestrate the 
upregulation of the following proteins (Mascher et al., 2003; Rietkötter et al., 2008; 
Wolf et al., 2010): (i) the phage-shock-protein A (PspA)-like LiaH, and LiaI, (ii) the ABC-
transporters BceAB and (iii) PsdAB1, (iv) the ZneR-regulon2, (v) YhcYZ and YhdA3, and 
(vi) YdhE4. Systems iii-vi are either not relevant in bacitracin sensing or mediating 
                                                     
1 PsdAB has been shown to be activated by crosstalk of BceS to the response regulator of the Psd-
system PsdR (Rietkötter et al., 2008). 
2 The ZneR-regulon is suspected to be activated by Zn2+, which is present in the biologically active 
bacitracin salt (Mascher et al., 2003). 
3 The yhcYZ-yhdA-operon and ydhE are regulated by LiaFSR (Wolf et al., 2010). YhcYZ are predicted to 
be a sensor kinase and response regulator, but their target is not known (Jordan et al., 2006; Wolf et 
al., 2010). yhdA is part of the same operon and encodes a putative NADPH-dependent azobenzene 
FMN reductase (Deller et al., 2006) 
4 YdhE is a putative macrolide glycosyltransferase, so it could be involved in the inactivation of 
macrolide antibiotics (Liu et al., 2016) 
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resistance (iii, iv), or too little is known about them so far (v, vi), so they are excluded 
from further study on the B. subtilis CESR toward bacitracin.  
We included the following proteins in our study, due to their strong upregulation in 
the presence of bacitracin and/or known involvement in bacitracin resistance: 
- BceAB, an ABC-transporter known to be upregulated in the presence of 
bacitracin and involved in bacitracin resistance (Mascher et al., 2003) 
- LiaIH, two proteins strongly induced in the presence of bacitracin (Mascher et 
al., 2003), but not yet shown to be involved in resistance toward bacitracin 
(Wolf et al., 2010) 
- BcrC, a UPP phosphatase known to be involved in bacitracin resistance 
(Bernard et al., 2003) and regulated by the CESR-related ECF σM (Cao & 
Helmann, 2002). 
The current knowledge on BceAB, LiaIH and BcrC and their regulation will be 
described in the following sections.  
1.2.2 THE ABC-TRANSPORTER BCEAB MEDIATES BACITRACIN-RESISTANCE 
The ABC transporter BceAB (bacitracin efflux) is formed by the cytoplasmic ATPase 
BceA and the permease BceB, which consists of 10 transmembrane helices and a 
large unstructured extracellular loop between helices seven and eight. Its expression 
is regulated by the histidine kinase BceS and the response regulator BceR, which are 
encoded in an operon upstream of bceAB, see Figure 2 (Bernard et al., 2003; Mascher 
et al., 2003; Ohki et al., 2003a). Deletion of bceAB leads to approximately 50-fold 
increased bacitracin sensitivity (Bernard et al., 2003; Mascher et al., 2003). While 
bceRS are constitutively expressed via the weak promoter PbceR, the usually low 
expression of bceAB can be induced >100-fold upon addition of certain AMPs 
(Rietkötter et al., 2008). The permease BceB has a dual role, which depends on the 
ATP-hydrolysing activity of the BceA subunit (Bernard et al., 2007): (i) Transport of 
bacitracin and several other antibiotics interfering with the lipid II cycle, like plectasin, 
actagardin, and mersacidin (Staroń et al., 2011). (ii) Acting as their sensor to control 
its own production (Bernard et al., 2007; Rietkötter et al., 2008). While the coupling 
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of the sensing and resistance mechanism in one specific transporter (in this case 
BceAB) can be advantageous, in most systems both actions are strictly separated as 
sensors and effectors, connected by regulators, as described in 1.2. The dual mode-
of-action of BceAB is rare and was therefore further investigated. 
It was shown that BceAB binds bacitracin in vitro and interacts with BceS in vivo and 
in vitro (Dintner et al., 2014) and some residues potentially involved in signaling 
and/or bacitracin resistance could be identified (Kallenberg et al., 2013). But, the 
exact mechanism of signal transfer is still elusive. 
In Gram-positive bacteria, including important pathogens like Staphylococcus aureus 
and E. faecalis, there are several examples for such Bce-like systems, which are 
named after their best-studied example from B. subtilis (Gebhard et al., 2014; Hiron 
et al., 2011). These transporters mediate resistance against a range of AMPs and are 
regulated by 2CS in which the intermembrane histidine-kinase lacks a recognizable 
 
Figure 2. Schematic representation of the regulation of the BceAB-resistance determinant. 
Configurations are shown in the absence (A) and presence (B) of inducer. Relevant molecules, 
proteins and their corresponding genes are depicted and named. UPP. Undecaprenyl 
pyrophosphate. Bac. Bacitracin. Double-pointing arrows indicate protein-protein interaction 
between BceA and BceB as well as BceB and BceS. A. Low levels of BceABRS are present in the cell. 
BceS and BceR are inactive. B. BceB removes bacitracin from its target UPP (depending on ATP-ase 
activity of BceA) and BceS receives a stimulus from the transporter, which is not yet understood. 
BceS subsequently autophosphorylates and transfers the phosphate residue to the response 
regulator BceR. Consequently, the BceR dimer conformation is changed and BceR activates the 
promoter PbceA to increase the transcription of bceAB. The transcription of bceRS remains at a 
constant low level. Schematic genes and transcripts are not drawn to scale. (Dintner et al., 2014; 
Mascher et al., 2003; Ohki et al., 2003b) 
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ligand-binding domain (Mascher, 2014). Instead, transporter and kinase form a 
sensory complex (Dintner et al., 2014; Kallenberg et al., 2013). The transporter can 
be simultaneously involved in mediating resistance (e.g. in B. subtilis), or one 
transporter is used for sensing and another one for mediating resistance (e.g. in E. 
faecalis) (Gebhard et al., 2014; Rietkötter et al., 2008). For the Bce-system in B. 
subtilis, it was also shown that ATP-hydrolysis by BceA, i.e. active transport by BceB, 
is required for signaling, although the exact stimulus and direction of transport it is 
not yet known (Ouyang et al., 2010; Rietkötter et al., 2008). 
1.2.3 ACTIVATION OF THE PHAGE-SHOCK-PROTEIN-LIKE RESPONSE LIAIH 
The B. subtilis promoter PliaI is controlled by the 2CS LiaRS (for lipid II cycle interfering 
antibiotic response regulator and sensor) and represents a very sensitive indicator of 
cell envelope stress (CES) (Mascher et al., 2004). Surprisingly, the deletion of the 
target genes liaIH lead to no or only very weak resistance phenotypes toward the 
inducers (Wolf et al., 2010). The reason for their induction remained so far elusive.  
The LiaRS 2CS is regulated by the LiaS-inhibitor LiaF and reacts to a broad range of 
cell envelope stressors, including oxidative stress, alkaline shock, or bacitracin 
addition (Jordan et al., 2006; Wolf et al., 2010). LiaRS respond to the disruption of 
active cell wall synthesis and are therefore “damage-sensing” (Wolf et al., 2012). The 
actual stimulus for the Lia system remains to be identified. 
While LiaFSR represent a well-conserved sensor in Firmicutes CESR, neither their 
regulon nor its size is conserved between species, which indicates its adaptation 
toward the lifestyle and regulatory needs (Jordan et al., 2008). In B. subtilis, the 
relevant target of LiaRS is PliaI, which regulates the transcription of the hexacistronic 
operon liaIH-liaGFSR, see Figure 3 (Jordan et al., 2006; Wolf et al., 2010). In the 
absence of CES, PliaG, the weak constitutive promoter upstream of liaG ensures a 
basal expression level of liaGFSR. Upon up-regulating conditions, PliaI activity is 
increased up to ~300-fold, resulting in a major 1.1-kb transcript containing liaIH and 
a 4-kb transcript encompassing the entire locus. LiaG is a predicted membrane 
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protein with a large extracellular domain of unknown function (DUF4097, Pfam5, 
(Finn et al., 2016)). It is only present in close relatives of B. subtilis and its function is 
still elusive (Jordan et al., 2006). LiaF is a membrane protein, which is predicted to 
contain four transmembrane helices (TMHs) and a domain of unknown function 
(DUF2154, Pfam) in its cytoplasmic C-terminus. It was further shown that LiaF serves 
as inhibitor of LiaS if present in excess stoichiometry (approx. 9:2 = LiaF:LiaS), as is 
the case under non-inducing conditions in vivo (Schrecke et al., 2013). The LiaF C-
terminus seems to be important for stimulus perception and/or signaling (Jordan et 
al., 2006).  
Without CES, LiaI proteins can be detected as GFP-fusions in fluorescence microscopy 
(Dominguez-Escobar et al., 2014). These oligomerize and form motile membrane 
patches. LiaH, a PspA/IM30 (inner membrane-associated protein of 30 kDa) protein 
                                                     
5 Protein families database http://pfam.xfam.org/ 
 
Figure 3. Schematic representation of the regulation of the LiaIH-stress response. Configurations 
are shown in the absence (A) and presence (B) of inducing CES. Relevant molecules, proteins and 
there encoding genes are depicted and named. Double-pointing arrows indicate permanent 
interaction between LiaI proteins. A. LiaI forms fast-moving patches at the membrane. LiaF inhibits 
the histidin kinase LiaS. LiaR is therefore inactive. LiaG is a protein of unknown function, seemingly 
neither involved in sensing nor resistance determination. B. Under inducing conditions, e.g. in the 
presence of bacitracin, LiaS is active and phosphorylates the response regulator LiaR, which in turn 
upregulates transcription of PliaI. This results in a high production level of LiaI and LiaH as well as a 
moderate increase of LiaGFSR. The membrane patches of LiaI become static (presumably at 
locations of defect cell wall) and recruit LiaH oligomers to the membrane. Schematic genes and 
transcripts are not drawn to scale. (Dominguez-Escobar et al., 2014; Wolf et al., 2010)  
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family member, is spread dispersedly (Dominguez-Escobar et al., 2014). Under CES 
conditions, LiaIH are strongly produced, the small membrane anchor protein LiaI 
recruits the cytosolic LiaH, and the membrane-associated patches become static 
(Dominguez-Escobar et al., 2014). While the corresponding molecular cue for the 
location of static patches remains elusive, no co-localization with MreB was detected, 
which is important for the localization of the cell wall biosynthesis machine 
(Dominguez-Escobar et al., 2014). LiaH forms rings (potentially nonamers of 
tetramers) similar to the homologous PspA in E. coli (Wolf et al., 2010). The E. coli 
Psp-system supports maintenance of the proton motive force in the presence of 
detergents, mediated by oligomeric PspA (Kleerebezem et al., 1996; Kobayashi et al., 
2007). 
Despite first insights into the role of PspA in E. coli and the strong induction of liaIH 
under bacitracin stress, no link to bacitracin resistance was detected so far (Wolf et 
al., 2010). In fact, only mild contributions to the resistance against some of the 
inducing antibiotics (e.g. daptomycin, fosfomycin, and hydrogen peroxide, but not 
bacitracin, nisin or vancomycin) were demonstrated to date (Hachmann et al., 2009; 
Wolf et al., 2010). 
1.2.4 THE UPP PHOSPHATASE BCRC MEDIATES BACITRACIN RESISTANCE  
The third player in the bacitracin stress response network is the UPP phosphatase 
BcrC. It provides resistance by competing with bacitracin for the target UPP, and 
consequently, a bcrC deletion mutant is about five times more sensitive toward 
bacitracin than the wild type (Bernard et al., 2003; Bernard et al., 2005). bcrC is 
controlled by multiple stress-inducible alternative sigma factors, including σM, σI, σX, 
σV, and potentially also σW (Cao & Helmann, 2002; Guariglia-Oropeza & Helmann, 
2011; Tseng & Shaw, 2008; Zweers et al., 2012). Under CES conditions caused by 
bacitracin, bcrC is under control of σM, which controls approx. 60 genes involved in 
cell wall synthesis, shape determination, DNA damage response and detoxification 
(Bernard et al., 2005; Cao & Helmann, 2002; Eiamphungporn & Helmann, 2008). It 
was shown that the resistance toward bacitracin mainly depends on the additional 
transcription of bcrC mediated by σM in the presence of bacitracin (Cao & Helmann, 
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2002). Consequently, the regulation of σM is important to understand the regulation 
of bcrC. 
The gene encoding σM is co-transcribed in an operon with the genes of the cognate 
anti-σ factors YhdL and YhdK, which tightly control the activity of σM (Figure 4) 
(Horsburgh & Moir, 1999; Jervis et al., 2007). In the absence of membrane stress, 
YhdK, a small membrane protein with three TMHs, was shown to interact with YhdL 
to negatively regulate σM (Yoshimura et al., 2004). It was demonstrated that the 
cytoplasmic N-terminus of YhdL is involved in σM binding, while the single TMH of 
YhdL is required for interaction with YhdK. The extracytoplasmic C-terminus of YhdL 
might function as sensory domain, but the precise molecular cues detected by 
YhdLK/σM remain to be identified and are still a matter of debate (Helmann, 2016; 
Yoshimura et al., 2004).  
 
Figure 4. Regulation of BcrC at CES conditions. A. bcrC is under transcriptional control of five ECFs, 
among them σM, which is active upon bacitracin addition. The corresponding gene σM is controlled 
by the housekeeping sigma factor σA, and σM itself in a positive feedback loop. yhdLK are co-
transcribed with σM and the encoded proteins act as anti-σ-factors, sequestering σM in the absence 
of membrane stress. All depicted genes are transcribed and the corresponding proteins are present 
in cell membranes also in the absence of CES. B. Under CES conditions, σM is released from YhdLK 
to regulate approx. 60 genes. The transcription of σM-yhdLK and bcrC is increased. Schematic genes 
and transcripts are not drawn to scale (Cao & Helmann, 2002; Hahne et al., 2008; Horsburgh & Moir, 
1999; Yoshimura et al., 2004) 
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 THE LINK BETWEEN CESR CAUSED BY BACITRACIN AND UPP 
PHOSPHATASES 
Bacitracin blocks the generation of the essential carrier molecule UP from UPP – UPP 
dephosphorylation – and is known to elicit a CESR. UPP itself is generated by de novo 
synthesis or recycling after incorporation of a cell wall building block into the existing 
PG network. In the first part of this study, I focused on the B. subtilis CESR caused by 
bacitracin and especially the interdependence of the three well-known players 
involved in stress perception and resistance mediation, BceABRS, BcrC/σM and 
LiaIHGFSR. In the second part, I took a different look at this reaction (UPP 
dephosphorylation to UP) by reducing the UPP phosphatase activity, which might 
have a similar effect on B. subtilis like bacitracin addition. 
1.3.1 UP AS A BOTTLENECK IN CELL WALL BIOSYNTHESIS 
UP is the carrier for both PG and WTA building blocks and its availability might 
represent the central bottleneck for the synthesis of lipid II both in vitro and in vivo 
(Breukink & de Kruijff, 2006; Egan et al., 2015). Only ~ 2*105 UP molecules (0.5-1 % 
of all phospholipids) are present per cell (Kramer et al., 2004). The amount of WTA 
and PG synthesis is reduced under UP-limiting conditions; especially if the culturing 
conditions favor the competing pathway (PG if WTA are measured and vice versa), 
which leads to a further decrease of available UP (Anderson et al., 1972). Blocking 
any step of the lipid II cycle will lead to accumulation of intermediates, shortage of 
free carrier molecules and impaired cell wall biosynthesis that depends on UP. The 
availability of lipid carrier is a bottleneck, which is exemplified in Gram-negative 
bacteria that can gain bacitracin resistance by losing pathways for generating 
exopolysaccharides that also use UP as a carrier (Pollock et al., 1994). 
1.3.2 UPP PHOSPHATASES IN B. SUBTILIS  
There are two known (BcrC and UppP) and one putative (YodM) UPP phosphatase 
encoded in the B. subtilis genome. BcrC was originally suspected to be a permease, 
because it is mediating resistance against bacitracin and is in parts similar to the BcrC-
component of the B. licheniformis ABC-transporter BcrABC (Cao & Helmann, 2002; 
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Ohki et al., 2003b). Biochemical analysis however revealed its UPP phosphatase 
activity and therefore its resistance mechanism: BcrC and bacitracin compete for the 
same target UPP (Bernard et al., 2005). The equilibria of UPP dephosphorylation by 
BcrC and UPP binding by bacitracin are shifted toward dephosphorylation with 
increasing concentrations of BcrC. By scrutinizing how the bcrC-promoter is 
regulated, it was also shown that the σM-mediated upregulation of PbcrC in the 
presence of bacitracin is responsible for the higher resistance against bacitracin – not 
its basal activity (Cao & Helmann, 2002).  
The location of UPP dephosphorylation at the inner, outer or both leaflets of the 
cytoplasmic membrane, as well as the translocation of UP from the outer to the inner 
leaflet are still under investigation. Until 2015, it was assumed that 
dephosphorylation of recycled UPP takes place at the outer leaflet of the cytoplasmic 
membrane and dephosphorylation of de novo synthesized UPP at the inner leaflet 
(Manat et al., 2014). This was supported by the finding that there are two known 
families of UPP phosphatases, BacA and PAP2, which are best studied in E. coli.  
The BacA-type is named after the E. coli BacA UPP phosphatase and carries two 
motives (BacA1 and BacA2) that form the catalyzing center (Manat et al., 2015). Using 
TMH predictions and topology studies with the β-lactamase BlaM, BacA is predicted 
to contain 7 TMHs with a cytosolic N-terminus, a periplasmic C-terminus and the 
active center facing the periplasm (Manat et al., 2015). BacA is the “house-keeping” 
UPP phosphatase in E. coli and contributes ~70% to the total UPP phosphatase-
activity (El Ghachi et al., 2004). For the B. subtilis homolog UppP no topology studies 
are available, but it is assumed to be similar, due to their high identity (47%) and 
similarity (63% 6)(Bernard et al., 2005; Inaoka & Ochi, 2012). 
There are three additional UPP phosphatases in E. coli, LpxT, YbjG and PgpB, which 
all belong to the superfamily of plasma membrane-bound (type 2) phosphatidic acid 
phosphatases (PAP2). A crystal structure for PgpB revealed that the cytoplasmic N- 
and C-termini are connected by 6 TMHs and that the catalytic center is localized at 
the periplasmic leaflet of the cytoplasmic membrane (Touze et al., 2008a). 
                                                     
6 Sequence Identity and Similiarity tool, SIAS, http://imed.med.ucm.es/Tools/sias.html 
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Superimposition of the B. subtilis BcrC and YodM protein sequences to the PgpB 
crystal structure is possible and predicts two missing parts in both B. subtilis proteins: 
the first TMH, including part of the periplasmic loop and parts of the C-terminus 
(based on Phyre2 analysis, data not shown; Kelley et al., 2015). Compared to 
UppP/BacA, the sequence is less well conserved (based on SIAS analysis, data not 
shown). It is assumed that the topology is similar enough to postulate a UPP 
phosphatase activity on the outer leaflet of the cytoplasmic membrane.  
In summary, both types of UPP phosphatases are active at the outer leaflet of the 
cytoplasmic membrane, where UPP-recycling takes place. However, de novo 
synthesized UPP is generated at the inner leaflet of membrane, so it remains elusive 
how this fraction of UPP is dephosphorylated. Additionally, the mechanism for 
flipping of UP from the outer to the inner leaflet of the plasma membrane is 
unknown. 
1.3.3 AN ADDITIONAL SOURCE OF THE LIPID CARRIER UP: PHOSPHORYLATION OF 
UNDECAPRENOL 
As described above, the most-studied source of UP originates from UPP 
dephosphorylation. UPP is recycled after releasing the PG building blocks to the cell 
wall, or de novo synthesized via UppS (Guo et al., 2005). In Gram-positive bacteria, 
UP can also be generated by phosphorylating undecaprenol, e.g. by the UDPK DgkA 
in B. subtilis (Higashi et al., 1970; Jerga et al., 2007). Prokaryotic UDPKs and 
diacylglycerol kinases (DAGKs) are membrane proteins that form homotrimers 
(Sandermann & Strominger, 1971; Van Horn & Sanders, 2012). Their catalytic centers 
face the cytoplasm (Abe et al., 2003), in contrast to the UPP phosphatases described 
above. It was discovered that dgkA is expressed during vegetative growth before 
sporulation (Amiteye et al., 2003). In a dgkA mutant the following sporulation 
phenotypes were observed: less bright endospores, a defective spore cortex in some 
spores, and reduced levels of dipicolinic acid, suggesting a supporting role of DgkA 
for efficient sporulation and cortex (spore-specific PG) formation (Amiteye et al., 
2003). The DgkA substrate undecaprenol was only studied in few bacteria to date, 
excluding B. subtilis, and its source remains unclear (Barreteau et al., 2009; Higashi 
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et al., 1970; Siewert & Strominger, 1967). The available data suggests that 
undecaprenol is only present in Gram-positive bacteria (Barreteau et al., 2009). For 
S. aureus, the amounts of undecaprenol (~23%), UP (~19%) and UPP (~58%) were 
measured, demonstrating that undecaprenol substantially contributes to the C55-
isoprenoid pool in this organism (Barreteau et al., 2009). 
Additionally to the previously described UPP dephosphorylation and undecaprenol 
phosphorylation, UP is also generated from recycling the carrier of WTA-shuttling. In 
this pathway, teichoic acids are linked to PG and UP is released as a carrier molecule 
(instead of UPP in case of the lipid II cycle). While the recycling of UP in this case is 
UPP phosphatase-independent, the generation of WTA-precursors itself depends on 
UP and is therefore not self-sustaining (Brown et al., 2013). Consequently, this was 
not part of our study.  
 OPEN QUESTIONS THAT WERE ADDRESSED IN THIS THESIS 
1.4.1 IS BCEAB A FLUX SENSOR? 
The regulation of the bceAB operon depends on the 2CS BceRS and an active BceAB 
transporter, but the type of input remained elusive. Here, a mathematical approach 
was taken to further characterize the signaling input in mutants with fixed levels of 
BceAB that are challenged with increasing amounts of bacitracin.  
See Publication I: 
Fritz G, Dintner S, Treichel N S, Radeck J, Gerland U, Mascher T, Gebhard S (2015) A 
new way of sensing: need-based activation of antibiotic resistance by a flux-sensing 
mechanism. mBio. 6(4):e00975. doi: 10.1128/mBio.00975-15. 
 
1.4.2 INTERDEPENDENCE OF CESR TOWARD BACITRACIN 
Of three known strategies to counteract a bacitracin attack (ABC-transporters, UPP 
phosphatases, and variation of exopolysaccharide production), the first two (ABC-
transporter BceAB, UPP phosphatase BcrC) are known to be employed by B. subtilis. 
These two, and a third player (LiaIH, which was chosen due to its strong activation in 
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the presence of bacitracin) were included in this study. We investigated if LiaIH 
contributes to bacitracin resistance in the absence of BceAB or BcrC. 
There is only little knowledge on how the cell orchestrates the activity of individual 
modules, although a certain degree of interdependence is expected, because of their 
activation by the same stimulus. For example, it was observed that a bcrC bceAB 
double mutant was more sensitive than either of the single mutants (Bernard et al., 
2003). Furthermore, it was shown that their signaling is independent, but this was 
not investigated further (Bernard et al., 2003). Here, a systematic investigation of the 
functional and regulatory interdependence of all three systems that are strongly 
upregulated upon bacitracin addition (BceAB, LiaIH, BcrC) was performed.  
See Publication II: 
Radeck J, Gebhard S, Orchard P, Kirchner M, Bauer S, Mascher T, Fritz G (2016) 
Anatomy of the bacitracin resistance network in Bacillus subtilis. Mol 
Micro.100(4):607-20. doi: 10.1111/mmi.13336. 
 
1.4.3 EFFECT OF UPP PHOSPHATASE REDUCTION ON CESR 
The putative link between CESR and cell wall homeostasis (as exemplified by UP 
turnover) was further investigated in a follow-up study. For both UPP phosphatases 
known to be relevant in vivo, BcrC and UppP (Zhao et al., 2016), we verified the gene 
pair bcrC and uppP to be synthetic lethal7. A comprehensive set of deletion, 
complementation and depletion strains was constructed and studied for 
morphology, sporulation, CESR and bacitracin MIC.  
See Manuscript I: 
Radeck J*, Lautenschläger N*, Mascher T (2017) The essential UPP phosphatase pair 
BcrC and UppP connects cell wall homeostasis with cell envelope stress response in 
Bacillus subtilis. (submitted to Frontiers in Microbiology) 
* contributed equally to this work 
                                                     
7 “Synthetic lethality arises when a combination of deficiencies in the expression of two or more 
genes leads to cell death, whereas a deficiency in only one of these genes does not.” 
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Radeck J, Gebhard S, Orchard P, Kirchner M, Bauer S, Mascher T, Fritz G (2016) 
Anatomy of the bacitracin resistance network in Bacillus subtilis. Mol 
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 RATIONALE OF THIS STUDY 
Bacterial survival in competitive environments is determined by resistance to AMPs, 
such as bacitracin, among others. The resistance mechanisms in B. subtilis against 
bacitracin include the highly-specific ABC-transporter BceAB (Ohki et al., 2003a), the 
UPP phosphatase BcrC (Bernard et al., 2005), and LiaIH (publication II). Although the 
single resistance modules, their regulation and orchestration had already been 
characterized to some extent, their interdependence in the CESR network remained 
unclear. Bacitracin’s mode of action – binding to the lipid carrier UPP and therefore 
blocking the lipid II cycle – is similar to a lack of UPP phosphatases, which catalyze the 
dephosphorylation of UPP to UP. This bottleneck could represent a link between 
homeostatic regulation of cell wall synthesis and the CESR. In this thesis, I aimed at 
characterizing the bacitracin perception by the Bce system, the interdependence of 
modules that perceive and/or relieve CES caused by bacitracin, and the impact of UPP 
phosphatase limitations on B. subtilis.  
 MAIN FINDINGS 
3.2.1 BCEAB IS A FLUX SENSOR 
In Bce-like systems, the ABC-transporter is strictly necessary for sensing, while the 
histidine kinase and response regulator are responsible for signal transfer and 
activation of the target promoter (Dintner et al., 2011; Mascher et al., 2006; Mascher, 
2013). We exploited mathematical modeling to show for the first time that indeed 
the transport activity, or flux, is the stimulus of the B. subtilis Bce-system BceABRS in 
the presence of bacitracin. This new produce-to-demand strategy provides important 
insight in the kind of stimulus perceived by of all Bce-like systems (publication I). 
3.2.2 THE B. SUBTILIS CESR TOWARD BACITRACIN IS ORGANIZED IN TWO LAYERS 
A two-layered, partially redundant CESR network architecture in B. subtilis was 
identified by scrutinizing the bacitracin resistance and promoter activity of a 
comprehensive set of B. subtilis mutants (bceAB, bcrC and liaIH; publication II). We 
further demonstrated that the bacitracin resistance determinants confer resistance 
in a redundant manner. 
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3.2.3 LIAIH CONTRIBUTES TO BACITRACIN RESISTANCE IN B. SUBTILIS 
For the first time, a contribution of LiaIH to the resistance against bacitracin was 
discovered, which was only revealed in the absence of the main resistance 
determinant BceAB. Therefore, we introduced the concept of a primary (drug-
sensing, BceAB) and secondary (damage sensing, BcrC and LiaIH) layer of resistance. 
This finding highlighted the redundancy and interdependence in this CESR network, 
which might be a widespread principle (publication II).  
3.2.4 DEPLETION OF UPP PHOSPHATASES LEADS TO MORPHOLOGICAL DEFECTS 
AND ACTIVATION OF PBCRC 
Publication II also presented data on the activation of CESR at reduced UPP 
phosphatase levels. We investigated this essential part of the lipid II cycle by 
genetically reducing the levels of UPP phosphatases further and identified pleiotropic 
effects on growth, cell morphology, CESR, bacitracin sensitivity and sporulation 
(manuscript I). In depletion mutants, where only one of the UPP phosphatases was 
present at low levels, morphological defects during fast growth were observed. 
Surprisingly, only PbcrC, but not PliaI was induced in these strains, although both 
promoters were activated in presence of bacitracin, which targets the same reaction 
(publication II). Overall, the homeostatically regulated BcrC was more important for 
the prevention of CES and normal growth, whereas UppP was necessary for efficient 
sporulation (manuscript I).  
3.2.5 PHOSPHORYLATION OF UNDECAPRENOL BY DGKA CONTRIBUTES TO THE UP 
POOL 
Furthermore, we could show that DgkA (as part of an UPP-phosphatase independent 
pathway) contributes to the cellular UP pool during late stationary phase as indicated 
by increased PbcrC activity in a dgkA mutant (manuscript I). Taken together, our data 
provides the first insight into the fine-tuning of UP homeostasis that adjusts the lipid 
II cycle (and therefore cell wall biosynthesis) in response to growth rates and 
envelope stress levels. 
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 THE CESR TOWARD BACITRACIN IS ORGANIZED REDUNDANTLY 
B. subtilis combats the AMP bacitracin by using three resistance modules which act 
with principle redundancy (publication II). Upon increasing concentrations of 
bacitracin, three different resistance mechanisms are (increasingly) activated, 
starting with the lowest induction threshold: (i) the ABC-transporter BceAB, (ii) the 
Psp-like LiaIH response, and (iii) the UPP phosphatase BcrC (Rietkötter et al., 2008). 
BceAB represents the primary layer of bacitracin-induced CESR, due to its drug-
sensing and highly effective resistance mechanism. BcrC and LiaIH are both activated 
by secondary effects caused by bacitracin (also referred to as “damage-sensing“ 
(Wolf et al., 2012)) and confer less resistance toward this antibiotic. We elucidated 
that the effect of LiaIH and BcrC is (partially) masked in the presence of BceAB. In 
fact, the activation of the Lia and Bce-system is strongly anticorrelated with the 
amount of BceAB (and BcrC, to a lower extent) present in the cell. For example, in the 
presence of high levels of BceAB, LiaIH is produced in smaller amounts upon the 
addition of bacitracin than in the presence of low levels of BceAB. The levels of LiaIH, 
in contrast, have no influence on the activation of PbcrC and PbceA (publication II and 
Figure 6 of supplemental data).  
The activation (BceAB, LiaIH) or elevated activation (BcrC) of resistance determinants 
upon need is a key feature of “active redundancy“, in contrast to “passive 
redundancy“, in which excess capacity is used steadily to reduce the impact of 
component failures (Pahl et al., 2007). In fact, the principle of redundancy is found in 
different stress contexts, like the oxidative stress responses in Ralstonia 
solanacearum and Salmonella enterica (Flores-Cruz & Allen, 2009; Hebrard et al., 
2009), to name but a few examples (Storz et al., 2011). 
3.3.1 THE ABC TRANSPORTER BCEAB IS A FLUX SENSOR 
Bacteria can monitor their environment by either perceiving the concentration of a 
relevant substance directly, or the downstream effects on cellular physiology 
(Helmann, 2016; Jordan et al., 2008; Staroń et al., 2011). In publication I, we 
demonstrated that sensing of the transport flux is a third option. By this means, the 
cell monitors its current detoxification capacity. To elucidate this novel mechanism 
DISCUSSION 
44 
of sensing, we combined mathematical modeling of the regulatory pathway of BceAB 
with quantitative, time-resolved dose-response promoter dynamics. We found that 
the resistance pump BceAB uses its bacitracin transport activity as input for the 
regulation of transporter abundance. This is an elegant example of negative feedback 
regulation, which allows continuous monitoring of the most relevant parameter for 
survival: the cells current ability to cope with the inhibitory effects caused by the 
drug. In concentration sensing, the transcriptional response correlates with the 
inducer concentration, whereas in flux sensing, the amount of transporters is only 
upregulated if the transport activity is insufficient, even at high antibiotic 
concentrations. This leads to the assumption that flux sensing is a very cost-effective 
strategy for regulation in any physiological context. 
Additionally, the model could predict the bacitracin sensitivity based on the number 
of expressed transporters and shows the expected behavior for flux-sensing 
mechanisms in general. Therefore, it can be used to identify further flux-regulated 
sensors, which seem to be a cost-effective assessment in changing environments. 
This is an efficient way to minimize costs by adjusting the response flexible to demand 
(Kwun & Hong, 2014; Melnyk et al., 2015). 
3.3.1.1 FLUX SENSING MIGHT BE A GENERAL PRINCIPLE FOR BCE-LIKE SYSTEMS 
Over 200 Bce-like systems are distributed in the Firmicutes phylum, in which the 
histidine kinase and permease have coevolved (Dintner et al., 2011). Together with 
experimental evidence of the transporter’s sensory role in all systems studied to date 
(Gebhard et al., 2014; Hiron et al., 2011; Ouyang et al., 2010; Revilla-Guarinos et al., 
2013; Staroń et al., 2011), this tight evolutionary correlation suggests a conserved 
signaling mechanism. The flux sensing activity of BceAB, as shown in publication I, 
might therefore be just one example of a widespread regulatory principle with 
regards to AMP resistance.  
3.3.1.2 MATHEMATICAL MODELING IS AN EFFICIENT TOOL TO CALCULATE “HIDDEN” 
PARAMETERS 
The mathematical modeling approach not only revealed a novel flux-sensing 
mechanism, but also gave access to important system variables. In our case, we 
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calculated that the fraction of bacitracin-bound UPP that leads to growth inhibition 
is ~ 90% (publication I). This insight could be used to predict the bacitracin 
concentrations needed for growth inhibition in strains with fixed levels of BceAB. 
Such “hidden” parameters, which are difficult to quantify experimentally, can be used 
for highly relevant predictions of bacterial physiology and a better understanding of 
cellular processes. For example, Bce-like systems respond to diverse peptide 
antibiotics that interfere with cell wall biosynthesis, like nisin, vancomycin or 
teicoplanin, which are used as food preservatives or in clinical settings (Gebhard & 
Mascher, 2011; Meehl et al., 2007; Pietiäinen et al., 2009). Knowledge derived from 
mathematical modeling of these and further systems can help to develop of new 
treatments against pathogenic bacteria, against which current strategies fail.  
3.3.1.3 INDUCTION AND SPECIFICITY OF BCE-LIKE SYSTEMS 
In B. subtilis, BceAB not only confers resistance to bacitracin, but also to the 
lantibiotics with globular structure actagardin and mersacidin (Mascher et al., 2003; 
Ohki et al., 2003a; Staroń et al., 2011). While bacitracin targets UPP, the latter bind 
to lipid II (Brötz et al., 1998). Surprisingly, structurally similar antibiotics like 
ramoplanin do not induce the Bce-system (Cudic et al., 2002; Staroń et al., 2011). 
Bce-like transporters, in general, can detoxify antibiotics which belong to these 
additional classes: defensins or β-lactams, as summarized in (Gebhard, 2012). In the 
last 15 years, important progress has been made in identifying the structures involved 
in mediating resistance, like the dependence on BceA ATPase activity, and the 
presence of the large extracellular unstructured region of BceB that is important for 
mediating specificity (Gebhard & Mascher, 2011; Hiron et al., 2011; Rietkötter et al., 
2008). Crucial residues for sensing and resistance mediation were further identified 
(Kallenberg et al., 2013) and it was shown that BceB binds bacitracin in vitro (Dintner 
et al., 2014). In publication I, we determined that the transport activity of BceAB is 
the signal for BceRS.  
However, in publication II, we found that PbceA-activity is elevated in a bcrC mutant 
even without the addition of bacitracin. We speculated that this effect could be 
caused by increased levels of UPP or endogenous production of AMPs. For a set of 
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known AMPs produced in B. subtilis that activate PbceA during stationary phase (Höfler 
et al., 2016), we tested this hypothesis: YydF (Butcher et al., 2007), SdpC (sporulation 
delaying protein) and SkfA (sporulation killing factor) (Gonzalez-Pastor et al., 2003). 
Supplemental data (Figure 7) shows that PbceA-activity depended on bcrC, but not on 
the AMPs mentioned above, under the conditions of the study presented in 
publication II. Consequently, another explanation for elevated PbceA activity in a bcrC 
loss mutant is favored: the accumulation of UPP. While the UPP-bacitracin complex 
is the physiological substrate of BceAB, still both individual molecules, UPP and 
bacitracin, might be able to interact with BceAB with lower affinity. The UPP 
accumulation due to the lack of the UPP phosphatase BcrC might therefore cause an 
increased basal activity of PbceA.  
3.3.1.4 DIRECTION OF TRANSPORT OF BCEAB 
The direction (and molecule) of transport and specific residues that interact with the 
target molecule(s) are still elusive. It was speculated that BceAB is (i) an exporter 
(Bernard et al., 2007), or (ii) importer of bacitracin (Dawson et al., 2007; Rietkötter et 
al., 2008), or (iii) an importer of UPP, thereby separating antibiotic and target 
(Kingston et al., 2014), or (iv) that it removes the AMP from its target into the 
extracellular space, similar to LanFEG-type transporters (Dintner et al., 2014; 
Gebhard, 2012). 
While the translocation of UPP could explain how BceAB confers resistance against 
the UPP-binding bacitracin, it cannot describe a resistance mechanism toward 
antibiotics with different targets, like lipid II (Staroń et al., 2011). If the antibiotics are 
removed from their target without translocation through the membrane, resistance 
to different classes of antibiotics that even bind to different target molecules could 
be explained (as outlined in 3.3.1.3). This theory is in accordance with the finding of 




3.3.2 THE LIAIH PHAGE SHOCK-LIKE RESPONSE CONTRIBUTES TO BACITRACIN 
RESISTANCE AND FEEDS BACK ON ITS OWN REGULATION 
PbceA is the most sensitive bacitracin-responsive promoter, followed by PliaI and PbcrC 
(Rietkötter et al., 2008). While BceAB is a specific transporter with high detoxification 
capacity, the role of the strongly produced proteins LiaIH was elusive for the longest 
time (Wolf et al., 2010). In publication II, we could show for the first time that LiaIH 
actually contribute to the bacitracin resistance properties of B. subtilis, but their 
capacity is only revealed in the absence of BceAB. A bceAB liaIH double mutant was 
six times more sensitive to bacitracin than a bceAB mutant, while a liaIH mutant and 
the wild type had the same level of resistance. Finally, a contribution of LiaIH to the 
bacitracin resistance capacities of B. subtilis was shown. Since LiaH is a PspA 
homologue, a comparison to other Psp-like responses might help revealing the 
resistance mechanism provided by LiaIH. 
3.3.2.1 THE PSP RESPONSE HELPS MAINTAINING THE ENERGY STATE OF STRESSED CELLS 
Psp-like proteins are ancient and widely conserved, occur in Gram-positive and -
negative bacteria, as well as in archaea and plant chloroplasts, and are best studied 
in E. coli and Yersinia enterocolitica (Darwin, 2005; Huvet et al., 2011; Joly et al., 
2010). However, little is known about their induction and how they can protect the 
cells. Cells missing the Psp system are still viable, but less tolerant against envelope 
stress, in case of a reduced energy state of the cell (Darwin, 2005; Darwin, 2007; 
Model et al., 1997). For example, ATP- and proton motive force-dependent protein 
secretion are reduced (Kleerebezem & Tommassen, 1993; Kleerebezem et al., 1996) 
and growth is impaired during stationary phase at alkaline pH (Weiner & Model, 
1994) or in the presence of bile salts (Adams et al., 2003). Accumulating data suggests 
that the formation of large protein complexes at the membrane interface is crucial 
for the function of PspA proteins, which (at least in E. coli and Y. enterocolitica) 
prevents proton leakage across the inner membrane (as reviewed in Flores-Kim & 
Darwin, 2016). This indicates that there might be a PspA-mediated resistance 
mechanism that prevents proton leakage caused by various molecules that interfere 
with cell envelope integrity. The Psp systems seem to provide a general, but low-level 
resistance under various conditions. This is in stark contrast to evolutionary “newer” 
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systems, like Bce-like ABC transporters that are almost exclusively found in Firmicutes 
(Dintner et al., 2011). These are drug transporters with a narrow range of specificity 
that confer a high level of resistance against few antibiotics. The specific (drug-acting) 
resistance modules might have evolved “on top” of the ancient, general (damage-
acting) stress response, which could explain their redundancy in conditions, in which 
both systems can provide some resistance. 
Another explanation is based the close relationship between the producers of 
bacitracin and the strains which are resistant against this AMP (in this case, some 
strains of B. licheniformis and B. subtilis (Azevedo et al., 1993; Frøyshov & Laland, 
1974; Ishihara et al., 2002)). The producer of an antibiotic needs to be resistant 
against this compound, so that the genes responsible for bacitracin production and 
bacitracin resistance might have evolved in the same bacteria. Some strains, like B. 
subtilis W168, might have lost the genes responsible for bacitracin production but 
kept the genes responsible for resistance. 
In both cases, the deletion of main, drug-specific resistance determinants might 
reveal further conditions under which the Psp response confers resistance that was 
merely masked. 
3.3.2.2 REGULATION OF THE PSP RESPONSE IN E. COLI COMPARED TO LIAIH IN B. SUBTILIS 
The Psp-like response has been most studied in E. coli and Y. enterocolitica, in which 
it includes the proteins PspABCDEFG (as reviewed in Flores-Kim & Darwin, 2016). In 
these organisms, under non-inducing conditions, PspA interacts with and inhibits the 
transcriptional enhancer PspF. Under inducing conditions, PspA multimerizes, 
becomes membrane located (in part through interaction with PspBC), and PspF 
upregulates transcription of pspABCDE and pspG (Brissette et al., 1990; Flores-Kim & 
Darwin, 2016; Jovanovic et al., 1996). This response is induced by ethanol shock, 
osmotic shock, or secretin proteins that mislocalize in the inner membrane, among 
others (Joly et al., 2010). PspA in its 36-meric form can help to maintain the proton 
motive force by reducing proton loss through the inner membrane (Kobayashi et al., 




We found evidence that the B. subtilis LiaIH also play a partial positive autoregulatory 
role in activating PliaI, although there is no strict dependence involved (publication II). 
It is conceivable that the high levels of LiaIH in the plasma membrane (Dominguez-
Escobar et al., 2014) generate the kind of CES that is detected by the Lia system. This 
could explain, why the regulation of LiaIH is so fine-tuned, but also highly dynamic. 
In E. coli and Y. enterocolitica, an autoregulatory loop of Psp systems exists, as 
described above, in which PspA directly negatively regulates the transcriptional 
activator PspF by forming hetero-oligomers (Joly et al., 2010). However, this 
regulation bears no similarity to B. subtilis, in which the regulation of liaIH is carried 
out through LiaFSR, which are not homologous to PspA or PspF. So even if a similar 
regulatory principle is part of the regulation in both systems, the analogy to PspAF 
can only be on a functional level. All in all, the role of LiaIH in modifying its own 
regulation needs to be further investigated. 
Unfortunately, the molecular cue of the Psp response in general remains elusive. 
There is ongoing discussion about the (unifying) stimulus that seems to be sensed in 
the inner membrane: experimental evidence argues against earlier hypotheses 
(reduced proton motive force or an altered redox state), and membrane-stored 
curvature elastic stress is currently debated (as reviewed in Flores-Kim & Darwin, 
2016). Due to the different regulation of the B. subtilis Lia-system, it is conceivable 
that its stimulus differs from that in the γ-proteobacteria E. coli and Y. enterocolitica. 
Further investigation of the induction, regulation and resistance mechanism of the 
Psp response will hopefully give new insights into this ancient and wide-spread 
system. 
3.3.3 THE (REDUNDANT) UPP PHOSPHATASES RECYCLE UPP AND CONTRIBUTE TO 
BACITRACIN RESISTANCE 
The reaction catalyzed by UPP phosphatases, dephosphorylation of UPP to UP, is 
blocked by bacitracin binding to UPP. By competition for the same target, UPP 
phosphatases can reduce the level of bacitracin toxicity. BcrC levels are increased 
upon bacitracin addition via σM (Cao & Helmann, 2002). BcrC accounts for a 5-fold 
increased resistance toward that antibiotic in the wild type, or 24-fold in a bceAB 
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mutant (publication II). In contrast, UppP only mediates bacitracin resistance in the 
absence or at very low levels of BcrC and it is not upregulated upon bacitracin 
addition (publication II; Cao & Helmann, 2002). At the same time, both UPP 
phosphatases pursue an essential function for the cell, which is exemplified by the 
synthetic lethality of bcrC and uppP and severe morphological defects in depletion 
strains (manuscript I; Zhao et al., 2016)).  
UPP dephosphorylation is usually performed by at least two proteins in a (partially) 
redundant manner in many of the bacteria studied (S. aureus, Streptococcus 
pneumoniae, Mycobacterium smegmatis, E. coli, B. subtilis): each individual gene is 
not essential by itself, but single deletion mutants may exhibit increased bacitracin 
sensitivity or reduced pathogenicity (Chalker et al., 2000; El Ghachi et al., 2004; Röse 
et al., 2004; Zhao et al., 2016). Quite remarkably, in an E. coli K12 bacA deletion 
mutant, UPP phosphatase activity was reduced by 75%, but no growth abnormalities 
were observed under laboratory conditions (El Ghachi et al., 2004). There is 
accumulating data that BcrC (PAP2-type) is the main and UppP (BacA-type) the minor 
UPP phosphatase in B. subtilis during normal growth (manuscript I; Inaoka & Ochi, 
2012; Zhao et al., 2016), while UppP is necessary for sporulation (manuscript I; 
Meeske et al., 2016). But so far, no direct measurement of UPP phosphatase activity 
is available for this organism. Under most conditions, strains with either bcrC or uppP 
deletions exhibit no growth defects (manuscript I; Inaoka & Ochi, 2012; Zhao et al., 
2016), with the exception of a bcrC mutant in liquid LB medium (publication II).  
YodM is the third known UPP phosphatase of B. subtilis, and of only little relevance, 
as judged by the available data. While its native expression levels are not sufficient 
to support growth, Zhao et al. showed that in the presence of strongly enhanced 
transcription and translation of yodM, both uppP and bcrC can be deleted (Zhao et 
al., 2016). This experiment showed that yodM encodes an intact UPP phosphatase. 
During growth under extremely limited UPP phosphatase levels, deletion of yodM 
can reduce the frequency of suppressor mutants (Zhao et al., 2016). Its role during 
CES, however, seems to be very limited. In manuscript I, we showed that there was 
no influence of YodM on bacitracin MIC in strains already lacking either uppP or bcrC, 
even in the absence of the main resistance determinant BceAB. Taken together, 
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YodM seems to have UPP phosphatase activity, but its role is very limited due to low 
expression levels. 
3.3.4 RECYCLING AND DE NOVO SYNTHESIS OF UP: IS A FLIPPASE INVOLVED? 
There are two details of UPP dephosphorylation which are not yet fully understood: 
(i) All known UPP phosphatases are active at the outer leaflet of the cytoplasmic 
membrane (Fan et al., 2014; Manat et al., 2015). It remains elusive, how de novo 
synthesized UPP, which is generated at the inner leaflet of the plasma membrane, is 
dephosphorylated. This raises the question, if there are novel UPP phosphatases yet 
to be found that are active in the cytosol. Alternatively, UPP could be flipped outside 
to be dephosphorylated. (ii) How is UP flipped from the outer to the cytosolic leaflet 
of the membrane? As spontaneous flipping rates are not sufficient to satisfy the high 
rates of PG synthesis, the existence of a flippase is assumed (McCloskey & Troy, 
1980). It is speculated that UP could be shuttled by the same, substrate-specific 
flippases that mediate flipping of glycan-derivatives (Sanyal & Menon, 2010). UPP 
phosphatases might act as flippases themselves, or they might drive associated 
flippases (to be identified) with the energy released by dephosphorylation of UPP 
(Manat et al., 2014). 
These examples illustrate that many fundamental details of the lipid II cycle are still 
unknown. In case of UPP phosphatases, bacitracin resistance and lipid II cycle 
progression are closely interlinked processes in B. subtilis. We therefore shifted our 
focus to the central molecule of the lipid II cycle: UP. 
 UP AS CENTRAL MOLECULE FOR CELL ENVELOPE ASSEMBLY 
UP, the carrier molecule for PG and WTA building blocks, is the central molecule of 
the lipid II cycle. It is generated by UPP dephosphorylation or by phosphorylation of 
undecaprenol. Despite its importance, the total fraction of UP-derivatives is 
estimated to be only about 1% of the phospholipid content in bacterial membranes 
(Hartley & Imperiali, 2012; Jones et al., 1958; Mitchell & Moyle, 1954). In E. coli, this 
corresponds to ~ 2 * 107 lipid molecules and ~ 1.5 * 105 UP+UPP molecules per cell. 
A roughly equivalent number has been determines for a number of Gram-positive 
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and Gram-negative bacteria, e.g. S. aureus, Micrococcus luteus8, Micrococcus flavus 
and Listeria monocytogenes (Barreteau et al., 2009; Kramer et al., 2004; Neidhardt & 
Umbarger, 1996; Storm & Strominger, 1974).  
The amount of PG building blocks in the PG layer (and therefore the minimal amount 
of building blocks that need to be synthesized, shuttled and incorporated during one 
cell division cycle) is ~ 2.5-5 * 106 in E. coli (Mengin-Lecreulx & van Heijenoort, 1985; 
van Heijenoort et al., 1992). Consequently, each carrier molecule is statistically used 
at least 20 times per division cycle, and during exponential growth at least about 5 * 
103 molecules of lipid II are shuttled across the membrane per second (Mengin-
Lecreulx & van Heijenoort, 1985; van Heijenoort et al., 1992). In Gram-positive 
bacteria, this rate is elevated by a factor of ~ 5, depending on the amount of PG per 
cell and the growth rate (Barreteau et al., 2009).  
The lipid II cycle is a set of consecutive chemical reactions, in which the slowest step 
(bottleneck) determines the overall reaction rate. Throughout the growth phases of 
E. coli, lipid II generating enzymes appear to be constitutively active and all cytosolic 
adducts are readily available (Mengin-Lecreulx & van Heijenoort, 1985), so these 
factors seem not to be involved. The levels of lipid I and II are low (~ 7 * 102, and 1-2 
* 103, respectively (van Heijenoort et al., 1992)), compared to those of UP and UPP 
(~1.5 * 105, (Barreteau et al., 2009)). It was shown that the availability of UP is rate-
limiting for in vitro production of lipid II via membrane vesicles (Egan et al., 2015), 
but there is no clear evidence that this is also the case in vivo. Why would the levels 
of lipid I and II be lower than those of UP, if the (missing) availability of UP is rate 
limiting? One explanation could be that the majority of UP molecules is localized at 
the outer leaflet of the plasma membrane (where dephosphorylation of UPP takes 
place), but for the formation of lipid I and lipid II, UP is required at the inner leaflet. 
In this case, the membrane orientation of UP might be critical and worth studying. 
                                                     
8 Outdates species name was used: Micrococcus lysodeikticus 
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3.4.1 UP/UPP-LEVELS INCREASE UPON BACITRACIN ADDITION 
As a small step toward a comprehensive dataset, Barreteau et al. determined the 
fraction of undecaprenol, UP and UPP in the Gram-positive organism S. aureus to be 
approximately 30% (undecaprenol), 20% (UP), and 50% (UPP) (Barreteau et al., 2009). 
Addition of bacitracin lead to a shift (15% (undecaprenol), 15% (UP), and 70% (UPP)), 
and increased levels of UP-derivatives in total (+45% ,Barreteau et al., 2009). These 
measurements showed that UPP indeed accumulated upon bacitracin addition while 
undecaprenol levels simultaneously decreased, which indicates its utilization for the 
generation of UP. It is not clear if UPP de novo synthesis is the sole source of the 
increased amount of carrier molecules. In E. coli no undecaprenol was detected. 
Here, the amount of UP-derivatives increased by 52% upon bacitracin addition, and 
the fraction of UP increased from 22 to 30% (UPP decreased from 78 to 70%). In this 
case, no accumulation of UPP occurred, its fraction rather decreased to a smaller 
degree (Barreteau et al., 2009). This data suggests that both E. coli and S. aureus 
increase their carrier pools upon bacitracin addition. While S. aureus seems to 
mobilize its undecaprenol pool, resulting in UPP accumulation, E. coli might reduce 
the overall activity of the lipid II cycle, which leads to a slight accumulation of UP. An 
investigation of undecaprenol, UP and UPP levels in B. subtilis (wild type and bceAB 
mutant) would elucidate, if undecaprenol is present and if UPP-bacitracin 
accumulates, similar to the Gram-positive organism S. aureus. 
3.4.2 DIFFERENTIAL RESPONSE OF THE LIA-SYSTEM TO BACITRACIN ADDITION AND 
UPP PHOSPHATASE DEPLETION 
Figure 5 illustrates the flow of undecaprenol, UP and UPP in B. subtilis W168. In this 
organism, mobilization of undecaprenol to UP is possible via DgkA (manuscript I), 
UPP is dephosphorylated to UP by BcrC and UppP, and BceAB can release UPP from 
its complex with bacitracin (publication I). Unfortunately, no quantitative data is 
available for any of the intermediates in this organism. Wolf et al. found that the 
strong activation of the liaI-promoter in the presence of lipid II cycle targeting 
antibiotics (e.g. bacitracin, mersacidin, vancomycin, nisin, daptomycin) was absent in 
murE-depleted, cell wall deficient L-forms of B. subtilis (Wolf et al., 2012). This 
suggested that instead of the antibiotics themselves (“drug-sensing”), downstream 
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effects on the lipid II cycle are the inducer for the Lia-system (“damage-sensing”). 
Along these lines, we tested if the depletion of UPP phosphatases leads to the 
activation of PliaI, but this was not the case (manuscript I). This result was 
independently obtained in UPP phosphatase knock-down mutants, using a 
CRISPR/dCas9-mediated approach (Zhao et al., 2016).  
Since downstream effects of bacitracin addition (which binds to UPP and blocks its 
dephosphorylation) lead to PliaI-activation, but depletion of UPP phosphatases does 
not (although the same reaction is affected), it can be assumed that the two 
alterations result in distinct types of cell envelope damage. In case of bacitracin 
addition, it was estimated that about 90% of all UP-derivatives are locked in the UPP-
bac state at lethal concentrations of bacitracin (publication I). Here, the pools of UPP 
(without bacitracin), UP, lipid I, lipid II, and presumably undecaprenol are all reduced. 
Depleted UPP phosphatase activity, in contrast, primarily leads to increased levels of 
UPP, which might influence the activity of PBPs and lead to the accumulation of 
upstream precursors. While PliaI is only activated upon addition of bacitracin, PbcrC is 
activated additionally by UPP phosphatase depletion, presumably via σM (Cao & 
 
Figure 5. Schematic representation of the generation and use of UP in B. subtilis. Und, 
undecaprenol; UP, undecaprenyl phosphate; UPP, undecaprenyl pyrophosphate; UPP-bac, complex 
between UPP and bacitracin. UP is generated by phosphorylation of undecaprenol via DgkA, or 
dephosphorylation of UPP via BcrC or UppP. UP is utilized for the synthesis of lipid II and WTA. After 
the attachment of PG or WTA-building blocks to the cell wall, the carrier is released as UPP or UP, 
respectively. UPP is also generated by de novo synthesis, where UppS catalyzes the final step. 
Bacitracin binds to UPP, thereby blocking its dephosphorylation. The ABC-transporter BceAB 
efficiently removes bacitracin from its target. Some of these steps occur at different leaflets of the 
plasa membrane, which is not depicted, because it is not yet fully understood. See Figure 1 for more 
details. Modified from (Brown et al., 2013). 
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Helmann, 2002; Zhao et al., 2016). This indicates that the molecular triggers of both 
“damage-sensing” systems are different.  
We demonstrated that the depletion of UPP phosphatases has different effects on 
the lipid II cycle than the addition of bacitracin. Such comparisons can help to 
elucidate the molecular triggers of CESR systems. In this case, the CESR of two groups 
should be compared: (i) mutants in which enzymes are depleted that are involved in 
the lipid II cycle, and (ii) cells that were treated lipid II cycle-targeting antibiotics. 
Consequently, differences in the activation spectrum of both groups can be analyzed. 
Especially if combined with studies that measure the amount of carrier in various 
stages, as detailed in 3.4.1, new experimental-driven insights can be gained on the 
molecular cues of “damage-sensing” CESR systems.  
3.4.3 PROMISCUOUS ACTIVITY OF SOME UPP PHOSPHATASES 
Those steps of the lipid II cycle that take place at the inner leaflet of the plasma 
membrane are performed by single essential proteins, like de novo synthesis of UPP 
by UppS, or formation of lipid I and lipid II by MraY and MurG, respectively (Figure 1). 
The reactions that are localized at the outer leaflet, crosslinking of PG building blocks 
to the cell wall by PBPs and dephosphorylation of UPP by UPP phosphatases, are 
performed redundantly. In case of UPP phosphatases, two protein families are 
involved, as outlined in section 3.3.3. What could possibly be the reason(s) for this 
partial redundancy?9 One answer might be that enzymes which are active at the 
outer leaflet of the cytoplasmic membrane are easier to target by antibiotics – a 
weakness that can be overcome by redundancy. Or, the redundant enzymes 
specialize in different physiological roles, as we have shown for B. subtilis (manuscript 
I), in which UPP phosphatases are involved during different growth stages 
(sporulation) or environmental conditions (bacitracin addition). Another example is 
the performance of additional (promiscuous) functions by the same protein, as 
described by Manat et al. for three PAP2-type UPP phosphatases (Manat et al., 2014): 
(i) E. coli PgpB is additionally involved in the dephosphorylation of 
                                                     
9 Genetic redundancy, in general, allows the evolution of new proteins while the essential function is 
still fulfilled (Nowak et al., 1997). 
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phosphatidylglycerol phosphate to the essential lipid phosphatidylglycerol – a task 
that is also performed redundantly by PgpA, PgpB, and PgpC (Funk et al., 1992; Lu et 
al., 2011). (ii) YeiU=LpxT from E. coli, Salmonella typhimurium and S. enterica were 
found to catalyze the specific transfer of one phosphate group from UPP to 
lipopolysaccharides, thereby linking UP metabolism to the pathway of remodeling 
the lipid A group of lipopolysaccharides (Kato et al., 2012; Touze et al., 2008b). These 
are part of the outer membrane in Gram-negative bacteria and their modification is 
critical for resistance to some antibiotics or evasion of host immune defenses 
(Needham & Trent, 2013). (iii) PbrB of Cupriavidus metallidurans participates in lead 
resistance by precipitating lead (Pb2+) in the periplasm with inorganic phosphate 
groups released from UPP dephosphorylation (Hynninen et al., 2009). These 
examples demonstrate the diversity of functions exhibited by UPP phosphatases, 
which could explain their redundancy (Manat et al., 2014). Future investigations need 
to reveal, if such systems are also present in B. subtilis and other Gram-positive 
bacteria.  
3.4.4 THE UNDECAPRENOL KINASE DGKA CONTRIBUTES TO THE UP POOL DURING 
SPORULATION 
In B. subtilis, dgkA encodes an UDPK that phosphorylates undecaprenol to UP 
(Higashi et al., 1970; Jerga et al., 2007) and is necessary for efficient sporulation 
(Amiteye et al., 2003). In a dgkA mutant, fewer phase-bright endospores were 
generated and the cortex was drastically reduced in some spores (Amiteye et al., 
2003), which suggests a deficiency in cell wall biosynthesis, probably due to a lack of 
the lipid carrier UP. Additionally, we could demonstrate that the CESR was increased 
during the stationary phase, as indicated by the upregulation of the CES-responsive 
bcrC-promoter under low UPP phosphatase conditions (manuscript I). We therefore 
propose that a lack of UP carrier is the input signal for σM-dependent activation of 
PbcrC. In this case, the activation of PbcrC in a ΔdgkA mutant suggests a lack of UP, 
similar to that caused by a lack of UPP phosphatases or bacitracin addition. This 
implies a contribution to the UP pool, by DgkA-mediated phosphorylation of 
undecaprenol to UP. The identification of spores that lack PG structures (similar, but 
less prominent than the sporulation phenotype observed for a uppP mutant (Meeske 
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et al., 2016)) supports this theory (Amiteye et al., 2003). The bacitracin sensitivity, 
which is severely increased in UPP phosphatase depletion mutants, was not altered 
if dgkA was additionally deleted (manuscript I), indicating that the contribution of 
DgkA might be limited to sporulation. In summary, this data is a first indicator that 
DgkA indeed contributes to the pool of UP in B. subtilis, especially during sporulation.  
The contribution of undecaprenol to the UP pool is of paramount importance to 
understand the flow of carrier molecules in the lipid II cycle. Unfortunately, no data 
is available for B. subtilis. Therefore, data from Gram-positive relatives will be 
discussed below, to shed a light on the current status of knowledge on undecaprenol 
and the corresponding kinase DgkA. 
Bacterial UDPKs are closely related to bacterial DAGKs, to the extent that the 
corresponding genes are sometimes both named dgkA. Bacterial DAGKs are 
structurally different from “eukaryotic” diacylglycerol kinases and their prokaryotic 
homologues (encoded by dgkB) (Van Horn & Sanders, 2012). In B. subtilis, DgkB 
performs DAGK-activity and DgkA UDPK-activity (Jerga et al., 2007; Sandermann & 
Strominger, 1971). UDPK-activity is required for bacitracin resistance, growth at low 
pH, biofilm and smooth surface dental caries formation in Streptococcus mutans (Lis 
& Kuramitsu, 2003; Shibata et al., 2009; Yamashita et al., 1993; Yoshida & Kuramitsu, 
2002), and for efficient sporulation in B. subtilis (Amiteye et al., 2003). But despite its 
physiological relevance, little is mechanistic knowledge exists about this process so 
far. 
While UP and UPP10 are present in all bacteria with a cell wall (Manat et al., 2014), 
undecaprenol, the substrate of UDPKs, was only found in Gram-positive bacteria to 
date (S. aureus, E. faecalis11, Lactobacillus plantarum, L. monocytogenes), but not in 
Gram-negative bacteria (E. coli)12 (Barreteau et al., 2009; Bohnenberger & 
Sandermann, 1976; Gough et al., 1970; Higashi et al., 1970; Umbreit et al., 1972). In 
                                                     
10 or rare derivatives with shorter prenyl chains 
11 Outdated species name was used: Streptococcus faecalis 
12Bohnenberger. & Sandermann (1976) cite a personal communication from H. Kleinig that 
undecaprenol was found in Myxococcus fulvus, a Gram-negative bacterium, but no publication was 
found to support this. 
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these studies, the level of undecaprenol (if present) was higher or similar to that of 
UP (Barreteau et al., 2009; Umbreit et al., 1972). For B. subtilis, no data is available.  
Little is known about the origin of undecaprenol. The de novo generation of UPP does 
not involve undecaprenol as an intermediate step. It is therefore either generated by 
an unknown pathway, or by dephosphorylation of UP. The presence of UP 
phosphatase activity has been reported for membranes of S. aureus , but not B. 
subtilis, M. luteus13 , E. faecalis14, or E. coli (Willoughby et al., 1972). This data needs 
to be interpreted with a grain of salt: ficaprenol phosphate, which was used in the 
phosphorylation assay, shows a different conformation than UP, so it might be an 
unsuitable substrate for UP phosphatases. At least in E. faecalis, in which 
undecaprenol was detected (Umbreit et al., 1972), the presence of a UP phosphatase 
activity is expected, if this is the source of undecaprenol.  
Taken together, more data is needed to shed light on the source of undecaprenol and 
its regulation, which might be linked to the lipid II cycle and therefore cell wall 
biosynthesis. Toward this end, the amounts of undecaprenol, UP and UPP could be 
measured to test the hypothesis if undecaprenol is present in Gram-positive, but not 
in Gram-negative bacteria. Furthermore, the presence of UP phosphatase activity 
needs to be verified for S. aureus and further bacteria that contain undecaprenol to 
elucidate if this pathway is responsible of the generation of undecaprenol. 
 CONCLUSION AND OUTLOOK 
In this thesis, we demonstrated that in the presence of bacitracin, BceAB of B. subtilis 
regulates its own expression by a flux-sensing mechanism. The CESR of B. subtilis 
towards bacitracin is organized in two layers, which are partially redundant. We 
showed that the expression of the secondary layer of resistance (consisting of BcrC 
and LiaIH) depends on the expression levels of the primary resistance layer (the ABC-
transporter BceAB). Furthermore, we revealed that the contribution of LiaIH to the 
cell’s resistance toward bacitracin is masked by the activity of BceAB in the wild type. 
                                                     
13 Outdated species name was used: M. lysodeikticus 
14 Outdated species name was used: S. faecalis 
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The activation of PbcrC in a bcrC mutant lead us to investigate the reaction of UPP 
dephosphorylation in the lipid II cycle from a different angle: UPP phosphatase 
depletion instead of bacitracin addition. Here, we found that bcrC and uppP are a 
synthetic lethal gene pair and that the main contributions of their gene products are 
at different growth stages. The observation of elevated CESR in a dgkA mutant is a 
hint that undecaprenol phosphorylation (in addition to UPP dephosphorylation) 
contributes to the UP pool in B. subtilis, especially during sporulation. Nevertheless, 
several unsolved questions remain to be addressed in the course of future 
investigations. They will be briefly discussed below. 
3.5.1 WHAT ARE THE MOLECULAR CUES OF THE SYSTEMS INDUCED BY BACITRACIN? 
For the Bce-system, we have elucidated that the transporter senses its own activity 
when removing bacitracin from its target UPP (publication I). LiaIH expression is 
regulated by LiaFSR and BcrC expression by σM. Both are supposed to respond to 
some aspect of cell envelope damage, triggered by the extracellular presence of 
bacitracin. Remarkeably, the depletion of UPP phosphatases, which targets the same 
reaction (UPP dephosphorylation) only activated σM, but not LiaFSR, (manuscript I; 
Zhao et al., 2016). This observation indicates that the molecular stimuli of both 
systems differ. σM activation might be related to decreased levels of UP or increased 
levels of UPP, although not all inducing conditions can be explained with that model 
(Helmann, 2016; Meeske et al., 2015). As a first step to challenge this hypothesis, the 
measurement of UP and UPP levels or availability need to be determined in B. subtilis. 
Since LiaFSR activation by bacitracin depends on active cell wall synthesis (Wolf et al., 
2012), the involvement of the lipid II cycle in the generation of the molecular stimulus 
is conceivable. PliaI was not activated by UPP phosphatase depletion, so the 
accumulation of UPP alone does not seem to represent the molecular stimulus. The 
investigation of the stoichiometry of lipid II cycle intermediates in B. subtilis under 
different Lia- inducing and -non-inducing conditions might reveal if the lipid II cycle is 
involved at all, and maybe even what the trigger might be. 
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3.5.2 HOW DOES LIAIH MEDIATE RESISTANCE?  
In publication II, we demonstrated for the first time that, LiaIH mediate resistance 
against bacitracin in B. subtilis. Studies from E. coli suggest that PspA-proteins 
prevent proton leakage across the membrane (Kobayashi et al., 2007). LiaH, a PspA 
homolog, forms static, membrane associated foci upon bacitracin addition that are 
recruited by LiaI, similar to PspA and PspBC in E. coli (Dominguez-Escobar et al., 2014). 
It has been postulated recently that the protection of the membrane integrity is 
achieved by dissociation of the large (LiaH or PspA) protein complexes, which results 
in the coverage of a stressed membrane area by mono- or oligomers (Thurotte et al., 
2017). However, it is not yet clear, which damages are caused by bacitracin addition 
– or other inducing conditions – and how they are prevented by LiaIH.  
While the molecular mechanism is almost impossible to be studied directly, further 
data might be generated using a genetic approach. In publication II, we revealed that 
the contribution of LiaIH to bacitracin resistance only becomes detectable in the 
absence of the primary resistance determinant BceAB. If specialized resistance 
determinants for certain inducing conditions are known, the potential of LiaIH might 
be demonstrated in the respective deletion mutants. 
3.5.3 HOW IS THE GENERATION AND UTILIZATION OF UP REGULATED? 
UP is generated by UPP dephosphorylation or undecaprenol phosphorylation in B. 
subtilis. To unravel the influence of these reactions on the lipid II cycle, it is important 
to know the contribution of each reaction in different growth stages or stress 
conditions. For example, undecaprenol phosphorylation seems to be important 
especially during B. subtilis sporulation (manuscript I; Amiteye et al., 2003).  
In this study, we focused on UP as a carrier of PG building blocks in the lipid II cycle. 
But it is also used for other cell envelope-related structures, such as WTAs or – in 
Gram-negative bacteria – exopolysaccharides. A comprehensive understanding of 
the use and flow of the lipid carrier (in different organisms), similar to metabolic 
models, will be a great tool for basic science. Especially research in B. subtilis will be 
useful, because it is one of the main model organisms for cell wall biosynthesis. Such 
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a model might even be able to predict the effect of stress conditions or the addition 
of a combination of antibiotics (Ahmed et al., 2014). A comprehensive knowledge 
about the metabolism and cell wall synthesis is the key to predict the impact of these 
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5 OVERVIEW OF FIGURES 
Figure 1. The lipid II cycle and a few interfering antibiotics. The first step of the lipid II cycle is catalyzed by MraY: 
the soluble precursor molecule N-acetyl-muramic acid-pentapeptide (MurNAc-pentapeptide, M) is loaded onto 
UP, forming lipid I. Subsequently, N-acetyl-glucosamine (GlcNAc, G) is added by MurG and lipid II is generated. 
The flippases MurJ and Amj flip lipid II to the outer leaflet of the cytoplasmic membrane (Laddomada et al., 2016; 
Meeske et al., 2015) where the MurNac-GlcNAc-pentapeptide is linked to the cell wall by β-(1Æ4) glycosylation 
and transpeptidation, carried out by Penicillin-binding proteins (PBPs) (Goffin & Ghuysen, 1998; Schneider & Sahl, 
2010). Thus, UPP is released on the outer leaflet and dephosphorylated by designated UPP phosphatases to UP. 
To be accessible for recycling, UP needs to be flipped back to the inner leaflet by a yet unknown mechanism 
(Manat et al., 2014). Feeding into the lipid II cycle are de novo synthesis of UPP via UppS and (probably) 
phosphorylation of undecaprenol via DgkA. Molecules (black) and relevant enzymes in B. subtilis (green) are 
named in the figure. Modified from (Breukink & de Kruijff, 2006). ....................................................................... 22 
Figure 2. Schematic representation of the regulation of the BceAB-resistance determinant. Configurations are 
shown in the absence (A) and presence (B) of inducer. Relevant molecules, proteins and their corresponding genes 
are depicted and named. UPP. Undecaprenyl pyrophosphate. Bac. Bacitracin. Double-pointing arrows indicate 
protein-protein interaction between BceA and BceB as well as BceB and BceS. A. Low levels of BceABRS are 
present in the cell. BceS and BceR are inactive. B. BceB removes bacitracin from its target UPP (depending on ATP-
ase activity of BceA) and BceS receives a stimulus from the transporter, which is not yet understood. BceS 
subsequently autophosphorylates and transfers the phosphate residue to the response regulator BceR. 
Consequently, the BceR dimer conformation is changed and BceR activates the promoter PbceA to increase the 
transcription of bceAB. The transcription of bceRS remains at a constant low level. Schematic genes and 
transcripts are not drawn to scale. (Dintner et al., 2014; Mascher et al., 2003; Ohki et al., 2003b) ..................... 27 
Figure 3. Schematic representation of the regulation of the LiaIH-stress response. Configurations are shown in 
the absence (A) and presence (B) of inducing CES. Relevant molecules, proteins and there encoding genes are 
depicted and named. Double-pointing arrows indicate permanent interaction between LiaI proteins. A. LiaI forms 
fast-moving patches at the membrane. LiaF inhibits the histidin kinase LiaS. LiaR is therefore inactive. LiaG is a 
protein of unknown function, seemingly neither involved in sensing nor resistance determination. B. Under 
inducing conditions, e.g. in the presence of bacitracin, LiaS is active and phosphorylates the response regulator 
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the corresponding proteins are present in cell membranes also in the absence of CES. B. Under CES conditions, 
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ABSTRACT Sensing of and responding to environmental changes are of vital importance for microbial cells. Consequently, bac-
teria have evolved a plethora of signaling systems that usually sense biochemical cues either via direct ligand binding, thereby
acting as “concentration sensors,” or by responding to downstream effects on bacterial physiology, such as structural damage to
the cell. Here, we describe a novel, alternative signaling mechanism that effectively implements a “flux sensor” to regulate antibi-
otic resistance. It relies on a sensory complex consisting of a histidine kinase and an ABC transporter, in which the transporter
fulfills the dual role of both the sensor of the antibiotic and the mediator of resistance against it. Combining systems biological
modeling with in vivo experimentation, we show that these systems in fact respond to changes in activity of individual resistance
transporters rather than to changes in the antibiotic concentration. Our model shows that the cell thereby adjusts the rate of de
novo transporter synthesis to precisely the level needed for protection. Such a flux-sensing mechanismmay serve as a cost-
efficient produce-to-demand strategy, controlling a widely conserved class of antibiotic resistance systems.
IMPORTANCE Bacteria have to be able to accurately perceive their environment to allow adaptation to changing conditions. This
is usually accomplished by sensing the concentrations of beneficial or harmful substances or by measuring the effect of the pre-
vailing conditions on the cell. Here we show the existence of a new way of sensing the environment, where the bacteria monitor
the activity of an antibiotic resistance transporter. Such a “flux-sensing” mechanism allows the cell to detect its current capacity
to deal with the antibiotic challenge and thus precisely respond to the need for more transporters. We propose that this is a cost-
efficient way of regulating antibiotic resistance on demand.
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Sensing of and responding to environmental changes are ofvital importance formicrobial cells, as they facilitate their fine-
tuned adaptation to prevailing conditions. The range of parame-
ters a single cell can monitor is immense, including conditions as
diverse as nutrient supply, oxygen levels, temperature, pH, cell
densities, and presence of toxic compounds. It is therefore hardly
surprising that bacteria have developed a plethora of sensory and
regulatory strategies to accomplish this feat. In the specific context
of antibiotic resistance, bacteria have to be able to accurately de-
termine the severity of the attack in order to decide on an adequate
response. The precision of this response is key to both survival of
antimicrobial action and minimizing the metabolic cost of resis-
tance (1, 2).
One common feature of controlling a cellular response is to
monitor the ambient concentration of a specific substance. In the
case of antibiotic resistance, this can be achieved, e.g., via direct
binding to a sensory protein, such as the vancomycin-responsive
histidine kinase (HK) VanSsc of Streptomyces coelicolor (3). An
alternative approach is to monitor the cellular damage caused by
the antibiotic, as is the case, e.g., for the LiaRS cell envelope
damage-sensing system of Bacillus subtilis (4). Such an indirect
sensing strategy allows the cell to integrate into its response its
current physiological state, which can significantly influence the
potency of a given concentration of antibiotic. For instance, fast-
growing cells are usually much more susceptible to antibiotic ac-
tion than slow-growing cells. While a damage-sensing strategy
undoubtedly provides a more context-dependent response, it re-
quires the accumulation of a certain degree of cellular damage.
Here, we present evidence for a third, previously undescribed reg-
ulatory strategy, allowing the bacterium to directly monitor its
current capacity to deal with the antibiotic threat by measuring
the activity of a drug efflux pump (referred to as “flux sensing”).
We recently showed that a unique type ofATP-binding cassette
(ABC) transporters is actively involved in a signaling pathway
controlling its own production (5–7). These transporters mediate
resistance against a wide range of antimicrobial peptides in many
Gram-positive species, including important pathogens, such as
Staphylococcus aureus and Enterococcus faecalis (8). Their expres-
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sion is regulated by two-component systems whose HKs lack dis-
cernible ligand-binding domains and instead form a sensory com-
plex with the transporter (9, 10). The signaling process is best
understood in Bacillus subtilis, where the two-component system
BceRS and its associated ABC-transporter BceAB together sense
and counteract the deleterious effects of bacitracin and several
other antimicrobial peptides interfering with the lipid II cycle of
cell wall biosynthesis, by triggering a 500-fold increase in the ex-
pression of the bceAB transporter operon (5, 9, 11) (Fig. 1a).
To characterize the regulatory role of the transporter, here we
took a systems approach, combiningmathematicalmodelingwith
experiments probing the time-resolved, dose-dependent response
of the Bce system to its substrate bacitracin. We show that signal-
ing within the Bce system operates by a flux-sensing mechanism,
monitoring the activity of individual transporters. Our model al-
lowed us to derive a unique response signature for a flux sensor,
which was experimentally validated. Moreover, the model was
able to predict the antibiotic sensitivity of cells depending on
transporter expression, leading us to propose that flux sensing
serves as a novel produce-to-demand strategy to control antibiotic
resistance in changing environments.
RESULTS
ABC transporter production rapidly adapts to a wide range of
bacitracin inputs.To obtain detailed quantitative information on
the regulatory dynamics of the Bce system, we first studied the
relationship between the external antibiotic concentration and the
transcriptional response of the target promoter PbceA. To this end,
exponentially growing SGB073 cells (wild-type B. subtilis carrying
a chromosomally integrated PbceA-luxABCDE reporter) were ex-
posed to sublethal concentrations of bacitracin. At virtually all
bacitracin concentrations tested, luciferase activity initially rose
rapidly upon antibiotic addition, before leveling off to reach a
plateau 20 to 30min after induction (Fig. 2A). A plot of the plateau
level against antibiotic concentration revealed that the system’s
response quickly adapted to a wide dynamic range of antibiotic
FIG 1 Schematic of conceivable sensory scenarios employed by the BceRS-BceAB system. In an external sensing scenario (a), the ABC transporter BceABmight
act as a scaffold that keeps the histidine kinase BceS in an active conformation, which would allow BceS to perceive the extracellular concentration of bacitracin
(red symbols). Since up-regulation of BceAB is not expected to change the extracellular concentration of bacitracin, the rate of gene expression should be
independent of the BceAB level in this scenario (no feedback). In an internal sensing scenario (b), BceAB might be required to translocate bacitracin into the
cytoplasm where BceS could sense its abundance. Here, up-regulation of BceAB should lead to an increased rate of bacitracin influx, which would in turn lead
to further up-regulation of BceAB expression (positive feedback). In a flux-sensing scenario (c), BceAB itself is the true sensor, which directly signals its transport
activity to BceS. In such a scenario, up-regulation of BceAB would reduce the load experienced by each individual transporter and thereby reduce signaling via
BceS (negative feedback). (d) Schematic depiction of the expected impact of different levels of the BceAB transporter (low, red curves; high, green curves) on
dose-dependent PbceA activity.
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input (0.1 to 100 !g/ml bacitracin) (Fig. 2B). Such gradual, ho-
meostatic control of target gene expression is often found in reg-
ulatory systems that exploit negative-feedbackmechanisms, while
positive-feedback regulation frequently enables switch-like or
even hysteretic responses (12). The presence of a negative feed-
back mechanism was also suggested by our observation that the
PbceA promoter activity reached its steady-state value within a
short time (20 to 30 min) (Fig. 2A) relative to the cell doubling
time of ~70 min (see Fig. S1 in the supplemental material), as
negative-feedback control is known to reduce the response time of
genetic circuits (13).
To elucidate the source of this apparent feedback effect, we
considered three plausible roles of the transporter in the regula-
tory pathway. (i) In the simplest scenario, the transporter acts as a
mere ligand-binding component in a sensory complex with the
HK, as is the case in regulation of sugar phosphate uptake by the
Uhp system in Escherichia coli (14, 15). The input signal for such a
system is the ambient concentration of the cognate substrate
(Fig. 1a). This signal will not change if the number of transporters
inserted in the membrane increases, since the amount of HK, and
hence the number of sensory complexes, remains constant. Thus,
there will be no feedback on regulation. (ii) Alternatively, the
transporter might be required to translocate the substrate to a
cytoplasmic recognition site (Fig. 1b). Such a strategy is realized,
e.g., in the regulation of arabinose utilization by E. coli (16), where
the level of intracellular substrate serves as the input signal. While
the polarity of BceAB-mediated transport is not known, it has
been suggested that BceAB may act as an importer of bacitracin,
releasing it into the cytoplasm for degradation (5, 8). Here, the
strength of the stimulus should increase during the induction pro-
cess, because the amount of bacitracin transported into the cell
will rise with the supply of transporters, thus creating a positive
feedback on the response. (iii) The third conceivable scenario is
that the HK activity is determined by the rate of flux through
individual transporters (Fig. 1c). BceAB has also been proposed to
act as a “hydrophobic vacuum cleaner” (17), conferring resistance
by clearing the target from the inhibitory grip of the antibiotic
(Fig. 1c) (7, 18). In such a scenario, increasing BceAB copy num-
bers should alleviate the load experienced by individual transport-
ers (Fig. 1c), resulting in a negative feedback of BceAB on its own
expression. Thus, qualitatively, a flux-sensing scenario best re-
flects the observed dynamics of PbceA activation.
The behavior of the wild-type system is compatible with a
mathematical model for relative flux sensing. To test if the pro-
posed flux-sensing mechanism can quantitatively explain the reg-
ulatory dynamics in the Bce system, we developed amathematical
model, incorporating signal transduction via such a mechanism.
Bacitracin is known to bind to its membrane-associated target
molecule undecaprenol-pyrophosphate (UPP), thus blocking the
dephosphorylation and recycling of UPP in the lipid II cycle of cell
wall biosynthesis (19). If we suppose that the ABC transporter
BceAB catalyzes the release of bacitracin from UPP with
Michaelis-Menten enzyme kinetics, the time-dependent concen-
tration of the bacitracin-bound form of UPP, UPP-bac, can be




# koff !UPP-bac" # vmaxJbac!BceAB" (1)
Here, [bac] is the externally applied bacitracin concentration,
kon and koff are the spontaneous on and off rates for the binding of
bacitracin to UPP, UPPtot is the total UPP level in the cell, Jbac!
[UPP-bac]/(Km " [UPP-bac]) is the relative bacitracin load per
BceAB transporter, and vmax and Km are the maximal transport
rate and Michaelis-Menten constant of BceAB, respectively (see
Tables S1 and S2 in the supplemental material).
To implement the proposed flux-sensing mechanism in our
model, we took into account that the expression of the two-
component system operon bceRS is constitutive (see Fig. S2 in the
supplemental material) and also that the interaction between the
histidine kinase BceS and the BceAB transporter is bacitracin in-
dependent (9). Moreover, we verified that the overproduction of
BceS did not significantly affect the MIC of a strain with constitu-
tive BceAB expression (see Fig. S3 in the supplemental material),
indicating that the transport activity of BceAB is not affected by
the formation of the sensory complex with BceS in vivo. Thus, as
long as BceABmolecules outnumber BceSmolecules, so that BceS
is the limiting component in complex formation, there should be
a constant number of functional BceS-BceAB sensory complexes
in the cell, while the number of free BceAB transporters should
change with increasing total transporter levels. Under inducing
conditions this is a safe assumption, because we can readily detect
the presence of BceAB, but not of BceS, usingWestern blotting or



















































FIG 2 Gene expression driven by the PbceA promoter rapidly adapts to a wide
range of antibiotic concentrations. (A) Exponentially growing cells of strain
SGB073 were exposed to sublethal concentrations of bacitracin at 0 min, and
luciferase activity from a PbceA-luxABCDE reporter construct was monitored
over time. Data are means and standard deviations for at least three indepen-
dent biological replicates (lower error bars are not depicted if negative values
were reached). Lines show the dynamics predicted by the quantitative mathe-
matical model described in the main text. (B) Experimental dose-response
curve of the PbceA promoter at a fixed time (42.5 min) after induction (sym-
bols) and the fit to the mathematical model (lines). For details, see the text.
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fluorescent protein fusions (our unpublished observations). Un-
der noninducing conditions, both proteins are below our current
detection limit and therefore not accessible to quantification.
Based on the relative promoter strengths of PbceR (see Fig. S2 in the
supplemental material) and PbceA (Fig. 2A), it could well be that
uninduced cells possess more kinases than transporters. Never-
theless, within our mathematical model we assume that the num-
ber of sensory complexes does not change over time and thus that
BceS always monitors the activity of a fixed number of transport-
ers. While this assumption might be inaccurate in the early phase
of induction, BceAB levels are expected to quickly exceed those of
BceS such that the model should well reflect the experimental
conditions shortly after induction.
Based on these considerations, we assume within our model
that BceS signals the load of individual transporters to the re-
sponse regulator BceR, such that the level of the active (phosphor-
ylated) form of BceR is proportional to the bacitracin load per
transporter, Jbac. Following a thermodynamic model for tran-
scriptional regulation (20), activation of gene expression from the
PbceApromoter by phosphorylated BceR can then be formulated in
terms of Jbac, such that the dynamic equations for bceAB mRNA




1% #Jbac ⁄ '$n # (!m" (2)
d
dt!BceAB" " )!m" # *!BceAB" (3)
Here,$ is the basal transcription rate,& is the ratio of maximal
to basal promoter activity, ( is the mRNA degradation rate, and '
is ameasure of the relative flux at which PbceA is activated. TheHill
exponent (n) in turn reflects all forms of cooperativity in stimulus
perception and signal transduction, as well as in BceR-DNA bind-
ing and recruitment of RNA polymerase. Finally, ) is the transla-
tion rate and * is the protein dilution rate due to cell doubling. The
dynamic equations for luciferase reporter expression were formu-
lated analogously to equations 2 and 3 and are given in Materials
and Methods.
We then asked whether the data in Fig. 2 were in quantitative
agreement with our mathematical model. To this end, all known
and measured model parameters were fixed to their physiological
values (see Table S1 in the supplemental material), the remaining
ones were confined to physiological intervals (see Table S2 in the
supplemental material), and then the model was fitted to the ex-
perimental dose-response in Fig. 2B (see Materials and Methods
for details of the fitting procedure). Overall, we found that the
dynamic behavior of the model closely resembled the rapid adap-
tation kinetics observed in the experimental time series (Fig. 2A).
Likewise, the model adequately captured the gradual increase of
the experimental dose-response characteristics over a wide range
of input levels (Fig. 2B). These findings provided the first quanti-
tative indication that the Bce system does in fact implement a
flux-sensing mechanism that monitors the bacitracin load per
BceAB transporter. The agreement between theory and experi-
ment in the early phase (0 to 15 min) after induction further
demonstrates that the model assumption of a constant number of
sensory complexes per cell was reasonable: if BceAB were initially
less abundant than BceS, the number of sensory complexes should
increase upon induction of BceAB production, which should re-
sult in a positive feedback on signaling. Such a positive feedback
should cause a lag in the response while the number of sensory
complexes is still very low, followed by a rapid increase in signal-
ing as more andmore complexes are formed. Such an effect is not
visible in our data (Fig. 2A), showing that thewindow inwhich the
number of sensory complexes is not constant is short and cannot
be resolved by the luciferase reporter.
Predicting the signature of a relative flux sensor. One key
feature of the proposed flux sensor model is that up-regulation of
BceAB leads to a reduction of the bacitracin load per transporter,
which ultimately down-regulates transcription of bceAB. Hence, if
the model was correct, disabling this negative autoregulation of
BceAB should abolish the graded response to bacitracin. Conse-
quently, constitutively supplying the cell with a fixed number of
transporter molecules should provide an alternativemeans of dis-
tinguishing between the three different signaling scenarios de-
tailed above. For a relative flux-sensing mechanism, in cells with
few transporters, the load per transporter should be saturated at
low bacitracin concentrations, leading to a highly sensitive re-
sponse (Fig. 1d, right). Conversely, cells with many transporters
should respond more sluggishly (Fig. 1d, right), because more
bacitracin is required to produce a high load per transporter. For
an intracellular sensing mechanism, the opposite behavior is ex-
pected: cells with a high level of BceAB should respond more sen-
sitively than those with few transporters, as the total amount of
bacitracin translocated increases with the number of transporters
present (Fig. 1d, center). Last, for an extracellular-concentration-
sensing mechanism, the dose-response behavior should not be
affected by alterations in the level of the transporter (Fig. 1d, left).
In fact, this last situation was recently reported for the DctA/DcuS
sensor complex of E. coli (21), in which the transporter DctA
merely acts as an activity switch for the HK DcuS.
When we modified our mathematical model to accommodate
constitutive production of the transporter, the predicted dose-
response behavior was altered in two respects. First, the elimina-
tion of autoregulation of the level of BceAB results in a more
switch-like response of the PbceA promoter to increasing bacitracin
concentrations (Fig. 3a). This sharp response is due to the fact that
the fit to the data for the wild type in Fig. 2 yielded a Hill exponent
(n) of 7.5# 0.2, suggesting that signal transduction and regulation
of PbceA exhibit a high degree of cooperativity. Second, when the
copy number of the transporter is changed, the model predicts a
shift in the dose-response curves consistent with the signature of a
flux sensor: in cells that constitutively express low levels of BceAB,
the promoter is triggered by low bacitracin concentrations
(Fig. 3a), while much higher concentrations of the antibiotic are
required to activate PbceA in cells that synthesize large amounts of
BceAB (Fig. 3a).
In order to test these predictions experimentally, we con-
structed a strain (SGB218) in which the endogenous bceAB locus
had been deleted, and replaced by a chromosomally integrated
construct driven by the xylose-inducible promoter PxylA. In addi-
tion, this strain carries the PbceA-luxABCDE reporter used above.
We previously quantified the dose-response characteristics of
PxylA (22). It showed a basal transcription level ~30-fold higher
than that driven by PbceA and could be activated up to~100-fold by
increasing the xylose concentration in the medium (Fig. 3b).
Based on these data, we selected five xylose concentrations (0%,
0.005%, 0.01%, 0.03%, and 0.2%) that resulted in markedly dif-
ferent PxylA activities. Incorporation of these promoter activities
into our mathematical model led to distinct BceAB protein levels
Fritz et al.
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for each xylose concentration and thus also to the parameter-free
predictions for the shifts in the activation threshold of PbceA dis-
cussed above (Fig. 3a).
Figure 3c shows the bacitracin-dependent PbceA activity of
SGB218 cells grown in the presence of the selected xylose concen-
trations. Strikingly, we found that both the theoretically predicted
abrupt onset of activation and the shift in induction threshold
with increasing xylose concentration were quantitatively reflected
in our experimental results. The latter becomes manifest, for in-
stance, when EC10 values (the bacitracin concentration at which
the dose-response reached 10% of its maximum) are plotted as a
function of xylose concentration. Theoretically, the EC10 is ex-
pected to be proportional to the concentration of BceAB in the cell
and, accordingly, to reflect the level of PxylA promoter activity
(Fig. 3b). Indeed, the experimental EC10 values all fell along this
curve (Fig. 3b), suggesting (i) that PxylA activity is in fact propor-
tional to BceAB protein levels and (ii) that the number of BceAB
transporters per cell determines howmuch bacitracin the cell will
tolerate before signaling is activated. To inspect the shape of the
dose-response curves in Fig. 3c more closely, we rescaled all x axes
to the EC10 values. When this was done, all dose-response curves
collapsed onto a single master curve (Fig. 3d). Remarkably, the
experimental data points showed an even steeper increase than
predicted by our model (Fig. 3d), highlighting the strong cooper-
ativity involved in signal perception, transduction, and gene reg-
ulation at PbceA. Considering that sensory perception and signal-
ing by the Bce system involve a multiprotein complex (9), it is not
difficult to envisage such strongly cooperative effects arising.
Moreover, it was previously shown that many promoters of
bceAB-like operons contain binding sites for two dimers of the
response regulator (23). Indeed, PbceA also possesses two BceR
binding sites, spaced 13 bp apart and located directly upstream of
the $10/$35 promoter elements. We recently showed that both
binding sites are required for bacitracin-dependent induction of
PbceA (C. Fang and T. Mascher, unpublished data). Since each
binding site consists of a repeat sequence, each site will likely be



















































































































FIG3 Signature of a relative flux sensor. (a) Theoretical prediction of PbceA-luxABCDE dose-response curves for various levels of constitutive BceAB transporter
production (colored curves), compared to the wild type with autoregulated bceAB expression (black curve). The expression levels of bceAB in the legend are
percentages of the maximal PbceA expression level in the wild type. These expression levels were derived from the experimental dose-response curve of the PxylA
promoter in panel b, which drives expression of bceAB in the experimental system in panel c. (b) Xylose-dependent dose-response curve of a PxylA-luxABCDE
reporter strain (black symbols) published previously (22) and fitted by a Hill function (black curve). In addition, the EC10 values , i.e., concentrations at
which the dose-response curves in panel c reach 10% of their maximal activity, are shown as a function of xylose concentration (red symbols). (c)
Experimental PbceA-luxABCDE dose-response curves in strain SGB218, in which the endogenous chromosomal bceAB locus has been deleted and
transporter expression is constitutively driven from a chromosomally integrated xylose-dependent PxylA-bceAB construct (colored symbols). The wild-
type dose-response curve (black symbols) was derived from strain SGB073. (d) Data from panels a and c with the x axis rescaled by the respective EC10
values. For details, see the text.
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occupied by a dimer of BceR, indicating that a total of four BceR
molecules are required for promoter induction, which could fur-
ther enhance cooperativity in signaling.
Themodel successfullypredicts inhibitory concentrationsof
bacitracin. Bacitracin acts by binding to the lipid carrier UPP and
preventing its dephosphorylation (19). Due to its essentiality for
cell growth, a certain minimal fraction of free lipid carrier is
needed to maintain cell wall biosynthesis at a given growth rate,
and blocking a larger fraction of UPP is thus lethal. Intuitively,
expression of the BceAB transporter is expected to release UPP
from the inhibitory grip of bacitracin and thereby keep a signifi-
cant fraction of UPP bacitracin free. Hence, BceAB expression
should directly affect the bacitracin-bound UPP levels in the cell
and, with that, the cellular sensitivity to inhibition by bacitracin.
To analyze the physiological implications of the flux-sensing
mechanism, we first calculated the fraction of bacitracin-bound
UPP in the cell using our mathematical model. For the wild-type
strain employing bacitracin-dependent feedback regulation of
bceAB expression, the fraction of bacitracin-bound UPP first in-
creases rapidly with the applied concentration of the antibiotic
(Fig. 4a). As soon as BceS detects a significant bacitracin flux via
the BceAB transporter (at ca. 0.3 !g/ml bacitracin), transporter
production is up-regulated and the rate of accumulation of
bacitracin-bound UPP is slowed. Based on the bacitracin concen-
tration needed to inhibit the growth of the wild type (ca. 200 !g/
ml), we calculated the lethal fraction of bacitracin-bound UPP to
be 90% (Fig. 4a). In the absence of BceAB transporters, ourmodel
predicted that the fraction of bacitracin-bound UPP increases
rapidly with the applied bacitracin concentration and reaches the
lethal 90% threshold at 2!g/ml bacitracin (Fig. 4a). This is slightly
below the experimentally determined MIC of 8 to 16 !g/ml for a
strain with bceAB deleted. However, the difference is not surpris-
ing given that the model does not take into account residual bac-
itracin resistance caused, e.g., by the UPP phosphatase BcrC and
other members of the +M, +X, and +W regulons involved in the
response ofB. subtilis to cell envelope stress (24–26). In contrast to
the homeostatic control seen in the wild type, for the strain with
constitutive bceAB expression, the model predicted the binding
curve to be of the same shape as in the absence of BceAB.However,
the curves were shifted to ever-higher bacitracin concentrations
the more transporter was present in the cell (Fig. 4a). Hence, the
model also predicted that the higher the level of BceAB, the greater
the antibiotic concentration required for killing (Fig. 4a).
To confront these predictions with experimental data, we as-
sayed the reporter strains for growth inhibition by bacitracin. For
this, growth rates were determined after addition of a range of
bacitracin concentrations to exponentially growing cultures pro-
ducing different levels of transporter. For each culture, increasing
the added concentration of bacitracin first led to a significant de-
crease in growth rate (Fig. 4b) and eventually to complete cessa-
tion of growth or cell lysis, with higher concentrations being re-
quired to inhibit cells expressing bceAB at higher levels. Prediction
of the lethal threshold concentration by the model approximately
reproduced the observed relationship between growth inhibition
and bceAB expression (dashed line in Fig. 4b). The steeper decline
of the theoretical curve compared to the experimental data at low
levels of BceAB can again be explained by the presence of alterna-
tive resistance determinants in B. subtilis, as discussed above.
When we adjusted the model to the background resistance of a
bceAB deletion-containing strain (here, 15 !g/ml), it accurately
described the correlation between BceAB expression levels and
inhibitory bacitracin concentration (solid line in Fig. 4b).
Our model does not distinguish between the cellular concen-
tration of UPP-bacitracin complexes (i.e., the assumed transport
substrate) and the true transport flux as input parameters, because
binding kinetics and transport activity are mathematically equiv-
alent in theMichaelis-Menten equation employed. This consider-
ation becomes important in light of the possibility that BceAB
might serve as a sensor without actually translocating any of its
substrate. However, if BceAB were transport deficient, the con-
centration of UPP-associated bacitracin should always be propor-
tional to the extracellular antibiotic concentration, regardless of
the number of functional transporters in the cell. This is entirely
inconsistent with the shifts in dose-response curves observed in
































































FIG 4 Inhibition of cell wall biosynthesis by blocking UPP recycling. (a)
Change in the fraction of bacitracin-bound UPP as a function of external
bacitracin, predicted by a model with feedback regulation (black curve) and a
model with the indicated levels of constitutive bceAB expression (colored
curves). In addition to the bceAB expression levels used in Fig. 3, the red curve
shows the percentage of bacitracin-bound UPP in the absence of the BceAB
transporter. Assuming that cell wall biosynthesis can be maintained as long as
the percentage of blocked UPP carrier molecules remains below a given limit
(dashed grey line), the intersection with the solid lines leads to a prediction of
how the bacitracin MIC should scale with increasing BceAB expression level
(dashed grey line in panel b). (b) Growth inhibition of strain SGB218 with
constitutive transporter expression from a xylose-dependent PxylA-bceAB con-
struct (colored symbols). Cultures with a low bceAB expression level (0% xy-
lose) are more susceptible to bacitracin than cultures with a high bceAB ex-
pression level (0.2% xylose). The model quantitatively captures the scaling of
this growth inhibition line (solid grey line), when background resistance
mechanisms, which are reflected in an additive offset for low bceAB expression
level, are taken into account.
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the good fit between observed growth inhibition by bacitracin and
predicted lethal threshold at different transporter expression lev-
els (Fig. 4) showed that the transporter indeed had an impact on
the fraction of bacitracin-bound UPP and thus must be able to
translocate its substrate.
Taken together, our theoretical and experimental data clearly
indicate that a combination of relative flux sensing and concom-
itant negative feedback provides efficient homeostatic control
over the level of bacitracin-bound UPP, allowing it to be main-
tained below the lethal concentration threshold over a range of
antibiotic concentrations covering at least two orders of magni-
tude.
DISCUSSION
Bacteria can perceive their environment either directly, by moni-
toring the concentration of a relevant substance, or indirectly, by
monitoring the effects on cellular physiology caused by a particu-
lar condition. We show here that sensing of transport flux of an-
timicrobial substances through a resistance pump presents a third
and novel sensing strategy, by which the cell can directly monitor
and respond to its current detoxification capacity. Through quan-
titative, time-resolved analysis of the dose-response dynamics,
combined with mathematical modeling of the regulatory path-
way, we obtained evidence that the Bce system of B. subtilis imple-
ments such a flux sensor, where the parameter monitored by the
signaling system is the activity of individual BceAB transporters.
This elegantmechanismpermits continual assessment of themost
critical parameter of antibiotic resistance, i.e., the cell’s current
capacity to deal with the inhibitory effects of the applied drug.
From a systems perspective, this parameter is far more relevant to
the cell than the present concentration of the antibiotic: as long as
the cell’s transport capacity is sufficient to detoxify the drug, there
is no need for a further response even at high antibiotic concen-
trations. We therefore propose that flux sensing is a very cost-
efficient regulatory strategy to control antibiotic resistance. To
our knowledge, this is the first report of such a regulatory mech-
anism in any physiological context.
Over 200 Bce-like systems can currently be found in protein
databases, and their components were shown to have coevolved
(23). Combinedwith experimental confirmation of the transport-
er’s sensory role in all systems studied to date (8, 11, 27–29), this
tight evolutionary correlation suggests conservation of the signal-
ing mechanism. Flux sensing may therefore be a widespread reg-
ulatory principle in antimicrobial peptide resistance. Because this
mechanism relies on the intricate process of communicating
transport flux between proteins, it should, conceivably, be easy to
disrupt and thus might constitute a prime drug target to counter-
act resistance in pathogenic bacteria possessing Bce-like systems,
such as S. aureus, E. faecalis, Listeria monocytogenes, and Clostrid-
ium difficile (8, 23, 27, 30).
Our modeling approach not only has provided evidence for a
flux-sensing mechanism but also has given access to important
system variables that are difficult to quantify experimentally,most
notably the fraction of bacitracin-bound UPP. Analysis of such
“hidden” parameters can lead to highly relevant predictions for
bacterial physiology, such as our calculation of the dependence
between the bacitracin concentration required to inhibit growth
and the expression level of the resistance determinant. Ultimately,
such an approach may have important implications for the treat-
ment of infectious disease caused by drug-resistant bacteria. Im-
portantly, Bce-like systems have been shown to respond to a large
variety of peptide antibiotics that interfere with different stages of
cell wall synthesis, including lantibiotics such as nisin, but also the
clinically relevant glycopeptides vancomycin and teicoplanin (6,
31, 32).
In summary, we report the first observation of transport flux
sensing as an elegant way of implementing adaptation via negative
feedback regulation.Wepropose that this represents a highly cost-
efficient mode of gene regulation, finely adjusted to the current
physiological needs of the cell. In the case of antibiotic resistance
mediated by Bce-like systems, this need is an increased demand
for detoxification. Future exploration of further systems employ-
ing transporters to control a signaling pathway will show if this
mechanism can also be found in other physiological contexts.
MATERIALS AND METHODS
Bacterial strains and growth conditions.All strains used in this study are
listed in Table S3 in the supplemental material. Strains were routinely
propagated in Luria-Bertani (LB) medium. For all functional assays,
B. subtilis was grown in chemically defined CSE medium (33), in which
the carbon source was modified to provide constant growth rates over an
extended period of time [3.3 g/liter (NH4)2SO4, 29 mMKH2PO4, 70 mM
K2HPO4, 1% III= salts (100% III= salts is 0.232 g/liter MnSO4·4H2O,
12.3 g/liter MgSO4·7H2O), 50 mg/liter tryptophan, 22 mg/liter ammo-
nium ferric citrate, 0.8% (wt/vol) potassium glutamate, 0.6% (wt/vol)
sodium succinate, 2.5% (wt/vol) fructose]. Selective medium for B. sub-
tilis contained kanamycin (10 mg/liter), chloramphenicol (5 mg/liter) or
erythromycin (1 mg/liter) in combination with lincomycin (25 mg/liter)
for macrolide-lincosamide-streptogramin B resistance (MLSr). Selective
medium for E. coli contained ampicillin (100 mg/liter). Solid medium
additionally contained 1.5% (wt/vol) agar.
Construction of plasmids and strains.All cloning was performed ac-
cording to BioBrick standard RFC10 (http://hdl.handle.net/1721.1/
45138) or RFC25 (http://hdl.handle.net/1721.1/45140). Plasmids, strains,
and primer sequences are listed in Table S3 in the supplemental material.
The bceAB operon of B. subtilis was adapted to the BioBrick standard by
addition of prefix and suffix sequences according to a modified RFC25
standard (22) using PCR (primers TM2577 and TM2578). All internal
PstI sites were changed fromCTGCAG to CTCCAG and EcoRI sites from
GAATTC to GAGTTC by PCR overlap extensionmutagenesis (34). Point
mutations were chosen so to avoid any change in the encoded protein
sequence. Cloning of the resulting fragment into the EcoRI and SpeI sites
of pSB1A3 resulted in pNTSB103. The PxylA region of pXTwas adapted for
BioBrick cloning by the addition of RFC10 prefix and suffix sequences via
PCR (primers iGEM134 and iGEM135) and cloning into the EcoRI and
SpeI sites of pSB1A3, to generate pNTSB104. Subsequently, the bceAB
operon was placed under the transcriptional control of PxylA by BioBrick
assembly of the pNTSB103 and pNTSB104 inserts into the vector pBS2E
(22), resulting in pNT2E01. To quantify target promoter activities, wild-
type B. subtilis W168 was transformed with a transcriptional PbceA-
luxABCDE reporter construct, pSDlux101 (35), producing strain
SGB073. Introduction of the same reporter together with pNT2E01 into
the bceAB::Kan deletion strain TMB035 produced strain SGB218.
Luciferase assays. Luciferase activities were assayed using a Synergy2
multimodemicroplate reader from BioTek (Winooski, VT) controlled by
the software Gen5. Aliquots of culture (100 !l) were added to 96-well
plates (black walls, clear bottoms; Greiner Bio-One, Frickenhausen, Ger-
many), which were incubated at 37°C with medium-intensity agitation.
Cell growth was monitored by measuring optical density at 600 nm
(OD600). For each individual sample, the OD600 and relative lumines-
cence units (RLU) (endpoint reads; 1-s integration time; sensitivity, 200)
were background corrected by subtracting the respective valuesmeasured
for wells containing 100 !l of CSE medium. RLU/OD600 values were
calculated for individual measurements. Means and standard deviations
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of RLU/OD600 values were determined from at least three biological rep-
licates.
To synchronize cultures, 10 ml of CSE medium in a 125-ml flask was
inoculated with 0.2ml of an overnight culture and incubated at 37°C with
agitation (200 rpm) to an OD600 of 0.2 to 0.5. Cultures were then diluted
in freshCSEmedium to anOD600 of 0.05 and transferred to 96-well plates.
OD600 and luminescence were monitored every 10 min, and at an OD600
of ~0.1 (corresponding to an OD600 of ~0.4 in cuvettes with a 1-cm light
path length), 5 !l of Zn2" bacitracin was added to give the final concen-
trations indicated in the figure legends. Incubation was continued, and
OD600 and luminescence were monitored every 5 min for 1 h. For con-
trolled expression of bceAB in strain SGB218, xylose was added to all
growth media at the final concentrations indicated in the figure legends.
Bacitracin sensitivity assays. The MIC of bacitracin for B. subtilis
grown in CSE medium was determined by a broth dilution technique.
Cultures were grown to stationary phase in CSEmedium and then diluted
(1:500) into fresh CSE medium containing different concentrations of
Zn2" bacitracin. Following 20 to 24 h of incubation at 37°Cwith agitation,
the MIC was scored as the lowest concentration at which no growth was
observed. Inhibition of growing cultures (Fig. 4b) was determined as fol-
lows. Cells of strain SGB218 were cultured with the indicated xylose con-
centrations and challenged with the final concentrations of Zn2" bacitra-
cin indicated in the figure legends as described for the luciferase assays
above. Average growth rates (,) were estimated from an exponential fit to
the growth curve (OD600) from 0 h (bacitracin addition) to 1 h for each
experimental condition. Growth inhibition was calculated as 1 $ (,/
,max), where ,max is the maximal growth rate at a given xylose concentra-
tion.
Mathematicalmodel andparameter estimation.Theminimalmodel
for the dynamics of the bceAB operon in the wild-type strain SGB073 is
described by equations 1 to 3. In constructing this model we made the
simplifying assumption that themaximal amount ofUPP in a cell, UPPtot,
is given by the sum of all intermediate forms of the lipid carrier molecule
present in the cell (see Table S1 in the supplemental material for param-
eter values). Binding of bacitracin to UPP then leads to the accumulation
of the bacitracin-bound form of UPP, UPP-bac, to the maximal amount
(UPPtot). Tomodel the constitutive expression of bceAB in strain SGB218,
the flux-dependent transcription rate in equation 2 was replaced by a
temporally constant transcription rate, which is determined solely by the
concentration of externally supplied xylose:
d
dt
!m"" $xyl# (!m" (4)
The xylose-dependent rate of bceAB transcription driven by PxylA was
modeled as $xyl ! $ % f(xyl)/g(bac!0), where $ is the rate of PbceA-
controlled transcription in the absence of bacitracin and f(xyl) and g(bac)
are the experimental dose-response curves for PxylA (Fig. 3b) and PbceA
(Fig. 2B), respectively. In addition, expression of the luxABCDE reporter
genes in all strains is under the control of an ectopically integrated PbceA
promoter, which is assumed to follow the same transcriptional kinetics as





1% #Jbac ⁄ '$n
# (lux!mlux" (5)
Here,mlux is the luxABCDEmRNA, (lux is the associated degradation
rate, and all other parameters are the same as in equation 2. Assuming that
one of the proteins in the lux operon is rate limiting for light production,
its dynamics is modeled by
d
dt
!Lux"" )!mlux"# *lux!Lux" (6)
where ) is the translation rate and *lux is the corresponding protein
half-life. In addition, a multiplicative scaling factor, +, was introduced to
relate the Lux protein level to the experimentally measured luminescence
output.
To fit themodel to our experimental data, the parameters were fixed to
physiological values whenever possible (see Table S1 in the supplemental
material) and constrained to physiologically reasonable intervals in all
other cases (see Table S2 in the supplemental material). Then, a trust
region-reflective Newton method (MatLab; The MathWorks, Inc.) was
used to minimize the value of -2 between the dose-response curve in
Fig. 2B and the model. To account for the presence of local optima and to
quantify the uncertainty in the estimated parameters, 100 independent fits
were performed with randomly chosen initial parameter sets (see Fig. S4
and S5 in the supplementalmaterial for correlation graphs between-2 and
estimated parameters). Confidence intervals for the fitted parameters (see
Table S2) were obtained as previously described (36). The prediction of
the dose-response curves for strain SGB218 was based on the parameter
set from strain SGB073, but calculated using equation 4 instead of equa-
tion 2.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.00975-15/-/DCSupplemental.
Figure S1, EPS file, 0.5 MB.
Figure S2, EPS file, 0.1 MB.
Figure S3, TIF file, 2.3 MB.
Figure S4, EPS file, 0.8 MB.
Figure S5, EPS file, 2 MB.
Table S1, DOCX file, 0.1 MB.
Table S2, DOCX file, 0.1 MB.
Table S3, DOCX file, 0.02 MB.
ACKNOWLEDGMENTS
Work in the labs ofU.G., T.M., andG.F. was funded through theDeutsche
Forschungsgemeinschaft (DFG) in the context of the Priority Program
SPP 1617 “Phenotypic Heterogeneity and Sociobiology of Bacterial Pop-
ulations” (GE1098/6-1 toU.G.,MA2837/3-1 to T.M., and a start-up grant
to G.F.).Work in S.G.’s lab was funded by aDFG research grant (GE2164/
3-1).
We thank Ina Lackerbauer for technical assistance in strain construc-
tion and Ulrike Mäder for determination of the bceAB mRNA half-life.
We are also grateful to LaurenceHurst for valuable suggestions during the
writing process and to Jim Caunt for critical reading of the manuscript.
G.F. performed all mathematical modeling; S.D., N.S.T., and J.R. per-
formed the experiments; S.G. coordinated experimental work; T.M.,
U.G., G.F., and S.G. designed the study; G.F. and S.G. wrote the manu-
script; all authors approved the manuscript.
REFERENCES
1. Kwun MJ, Hong H-J. 2014. The activity of glycopeptide antibiotics
against resistant bacteria correlates with their ability to induce the resis-
tance system. Antimicrob Agents Chemother 58:6306–6310. http://
dx.doi.org/10.1128/AAC.03668-14.
2. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it
possible to reverse resistance? Nat Rev Microbiol 8:260–271. http://
dx.doi.org/10.1038/nrmicro2319.
3. Koteva K, Hong HJ, Wang XD, Nazi I, Hughes D, Naldrett MJ, Buttner
MJ. 2010. A vancomycin photoprobe identifies the histidine kinase
VanSsc as a vancomycin receptor. Nat Chem Biol 6:327–329.
4. Wolf D, Domínguez-Cuevas P, Daniel RA, Mascher T. 2012. Cell enve-
lope stress response in cell wall-deficient L-forms of Bacillus subtilis. An-
timicrob Agents Chemother 56:5907–5915. http://dx.doi.org/10.1128/
AAC.00770-12.
5. Rietkötter E, Hoyer D, Mascher T. 2008. Bacitracin sensing in Bacillus
subtilis. Mol Microbiol 68:768–785. http://dx.doi.org/10.1111/j.1365
-2958.2008.06194.x.
6. Gebhard S, Mascher T. 2011. Antimicrobial peptide sensing and detoxi-
fication modules: unravelling the regulatory circuitry of Staphylococcus
aureus. Mol Microbiol 81:581–587. http://dx.doi.org/10.1111/j.1365
-2958.2011.07747.x.
7. Gebhard S. 2012. ABC transporters of antimicrobial peptides in Firmic-
Fritz et al.











Publication I: Flux-sensing for antibiotic resistance
86
utes bacteria—phylogeny, function and regulation. Mol Microbiol 86:
1295–1317. http://dx.doi.org/10.1111/mmi.12078.
8. Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T. 2011. Bacitracin
and nisin resistance in Staphylococcus aureus: a novel pathway involving
the BraS/BraR two-component system (SA2417/SA2418) and both the
BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol 81:
602–622. http://dx.doi.org/10.1111/j.1365-2958.2011.07735.x.
9. Dintner S, Heermann R, Fang C, Jung K, Gebhard S. 2014. A sensory
complex consisting of an ATP-binding cassette transporter and a two-
component regulatory system controls bacitracin resistance in Bacillus
subtilis. J Biol Chem 289:27899 –27910. http://dx.doi.org/10.1074/
jbc.M114.596221.
10. Mascher T. 2014. Bacterial (intramembrane-sensing) histidine kinases:
signal transfer rather than stimulus perception. Trends Microbiol 22:
559–565. http://dx.doi.org/10.1016/j.tim.2014.05.006.
11. Staron´ A, Finkeisen DE, Mascher T. 2011. Peptide antibiotic sensing and
detoxificationmodules of Bacillus subtilis. Antimicrob Agents Chemother
55:515–525. http://dx.doi.org/10.1128/AAC.00352-10.
12. Hasty J, McMillen D, Isaacs F, Collins JJ. 2001. Computational studies of
gene regulatory networks: in numero molecular biology. Nat Rev Genet
2:268–279. http://dx.doi.org/10.1038/35066056.
13. Rosenfeld N, Elowitz MB, Alon U. 2002. Negative autoregulation speeds
the response times of transcription networks. J Mol Biol 323:785–793.
http://dx.doi.org/10.1016/S0022-2836(02)00994-4.
14. Island MD, Kadner RJ. 1993. Interplay between the membrane-
associated UhpB and UhpC regulatory proteins. J Bacteriol 175:
5028–5034.
15. Schwöppe C, Winkler HH, Neuhaus HE. 2003. Connection of transport
and sensing by UhpC, the sensor for external glucose-6-phosphate in
Escherichia coli. Eur J Biochem 270:1450–1457. http://dx.doi.org/10.1046/
j.1432-1033.2003.03507.x.
16. Schleif R. 2000. Regulation of the L-arabinose operon of Escherichia coli.
Trends Genet 16:559 –565. http://dx.doi.org/10.1016/S0168
-9525(00)02153-3.
17. Chang G. 2003. Multidrug resistance ABC transporters. FEBS Lett 555:
102–105. http://dx.doi.org/10.1016/S0014-5793(03)01085-8.
18. Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K,
Ogasawara N. 2003. The BceRS two-component regulatory system in-
duces expression of the bacitracin transporter, BceAB, in Bacillus subtilis.
Mol Microbiol 49:1135–1144. http://dx.doi.org/10.1046/j.1365
-2958.2003.03653.x.
19. Storm DR, Strominger JL. 1973. Complex formation between bacitracin
peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide
interactions. J Biol Chem 248:3940–3945.
20. Bintu L, Buchler NE, Garcia HG, Gerland U, Hwa T, Kondev J, Phillips
R. 2005. Transcriptional regulation by the numbers: models. Curr Opin
Genet Dev 15:116–124. http://dx.doi.org/10.1016/j.gde.2005.02.007.
21. Steinmetz PA, Wörner S, Unden G. 2014. Differentiation of DctA and
DcuS function in the DctA/DcuS sensor complex of Escherichia coli: func-
tion of DctA as an activity switch and of DcuS as the C4-dicarboxylate
sensor. Mol Microbiol 94:218 –229. http://dx.doi.org/10.1111/
mmi.12759.
22. Radeck J, Kraft K, Bartels J, Cikovic T, Dürr F, Emenegger J, Kelterborn
S, Sauer C, Fritz G, Gebhard S, Mascher T. 2013. The Bacillus BioBrick
box: generation and evaluation of essential genetic building blocks for
standardized work with Bacillus subtilis. J Biol Eng 7:29. http://dx.doi.org/
10.1186/1754-1611-7-29.
23. Dintner S, Staron´ A, Berchtold E, Petri T, Mascher T, Gebhard S. 2011.
Coevolution of ABC transporters and two-component regulatory systems
as resistance modules against antimicrobial peptides in Firmicutes bacte-
ria. J Bacteriol 193:3851–3862. http://dx.doi.org/10.1128/JB.05175-11.
24. Cao M, Helmann JD. 2002. Regulation of the Bacillus subtilis bcrC baci-
tracin resistance gene by two extracytoplasmic function + factors. J Bac-
teriol 184:6123– 6129. http://dx.doi.org/10.1128/JB.184.22.6123
-6129.2002.
25. Cao M, Helmann JD. 2004. The Bacillus subtilis extracytoplasmic-
function +X factor regulates modification of the cell envelope and resis-
tance to cationic antimicrobial peptides. J Bacteriol 186:1136–1146.
http://dx.doi.org/10.1128/JB.186.4.1136-1146.2004.
26. Eiamphungporn W, Helmann JD. 2008. The Bacillus subtilis +M regulon
and its contribution to cell envelope stress responses. Mol Microbiol 67:
830–848. http://dx.doi.org/10.1111/j.1365-2958.2007.06090.x.
27. Gebhard S, Fang C, Shaaly A, Leslie DJ, Weimar MR, Kalamorz F,
Carne A, Cook GM. 2014. Identification and characterization of a baci-
tracin resistance network in Enterococcus faecalis. AntimicrobAgents Che-
mother 58:1425–1433. http://dx.doi.org/10.1128/AAC.02111-13.
28. Revilla-Guarinos A, Gebhard S, Alcántara C, Staron A, Mascher T,
Zúñiga M. 2013. Characterization of a regulatory network of peptide an-
tibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ
Microbiol 79:3160–3170. http://dx.doi.org/10.1128/AEM.00178-13.
29. Ouyang J, Tian X-L, Versey J, Wishart A, Li Y-H. 2010. The BceABRS
four-component system regulates the bacitracin-induced cell envelope
stress response in Streptococcus mutans. Antimicrob Agents Chemother
54:3895–3906. http://dx.doi.org/10.1128/AAC.01802-09.
30. Collins B, Curtis N, Cotter PD, Hill C, Ross RP. 2010. The ABC
transporter AnrAB contributes to the innate resistance of Listeria mono-
cytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimi-
crob Agents Chemother 54:4416 – 4423. http://dx.doi.org/10.1128/
AAC.00503-10.
31. Meehl M, Herbert S, Götz F, Cheung A. 2007. Interaction of the GraRS
two-component system with the VraFG ABC transporter to support
vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob
Agents Chemother 51:2679–2689. http://dx.doi.org/10.1128/AAC.00209
-07.
32. Pietiäinen M, François P, Hyyryläinen H-L, Tangomo M, Sass V, Sahl
H-G, Schrenzel J, Kontinen VP. 2009. Transcriptome analysis of the
responses of Staphylococcus aureus to antimicrobial peptides and charac-
terization of the roles of vraDE and vraSR in antimicrobial resistance.
BMC Genomics 10:429. http://dx.doi.org/10.1186/1471-2164-10-429.
33. Stülke J, Hanschke R, Hecker M. 1993. Temporal activation of beta-
glucanase synthesis in Bacillus subtilis is mediated by the GTP pool. J Gen
Microbiol 139:2041–2045. http://dx.doi.org/10.1099/00221287-139-9
-2041.
34. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed
mutagenesis by overlap extension using the polymerase chain reaction.
Gene 77:51–59. http://dx.doi.org/10.1016/0378-1119(89)90358-2.
35. Kallenberg F, Dintner S, Schmitz R, Gebhard S. 2013. Identification of
regions important for resistance and signalling within the antimicrobial
peptide transporter BceAB of Bacillus subtilis. J Bacteriol 195:3287–3297.
http://dx.doi.org/10.1128/JB.00419-13.
36. Wall ME, Markowitz DA, Rosner JL, Martin RG. 2009. Model of tran-
scriptional activation by MarA in Escherichia coli. PLoS Comput Biol
5:e1000614. http://dx.doi.org/10.1371/journal.pcbi.1000614.
Flux-Sensing for Antibiotic Resistance











Publication I: Flux-sensing for antibiotic resistance
87
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Parameter Notation Value Source 
Binding constant for bacitracin 
– UPP interaction 
Kd,BAC-UPP 1 µM In vitro equilibrium dissociation constant for 
bacitracin A – C55-isoprenyl-pyrophosphate 
interaction (Storm & Strominger, 1973) 
Dissociation rate for bacitracin – 
UPP interaction 
kd,BAC-UPP 0.75 min-1 Estimated from Fig. 2B in (Economou et al., 
2013) 
Association rate for bacitracin – 
UPP interaction 
ka,BAC-UPP 0.75 PM-1 min-1 Adjusted to match Kd,BAC-UPP 
Total number of UPP molecules 
per cell 
UPPtot 104 molecules/cell We made the simplifying assumption that the 
maximal amount of UPP,  UPPtot  , is given by the 
total sum over all intermediate forms of the lipid 
carrier molecule; Pool levels of uridine 
nucleotides range from 104-105 molecules per 
cell (Mengin-Lecreulx et al., 1982) 
Fold-change of PbceAB promoter Z 5000 Suggested by data in Fig. 2B in the main text; 
within physiological range of 1-104 (see e.g. (Lutz 
& Bujard, 1997) for promoters with high dynamic 
range) 
bceAB mRNA degradation rate ObceAB 0.462 min-1 Corresponds to a bceAB mRNA half-life of 1.5 
min (this study; data not shown) 
luxABCDE mRNA degradation 
rate 
Olux 0.138 min-1 Corresponds to a lux mRNA half-life of 5 min; 
upper limit for mRNA half-life inferred in (Radeck 
et al., 2013) 
BceAB protein decay rate G  0.01 min-1 Corresponds to a cell doubling time of 70 min 
(this study) 
LuxABCDE protein decay rate G  0.023 min-1 Corresponds to a protein half-life of 30 min 
Translation rate Q 10 proteins/mRNA/min  
Scaling factor between protein 
level and luminescence 
V 83 RLU/OD/protein Arbitrary choice 
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Table S2. Estimated model parameters. 
aLB, UB: lower and upper boundary, respectively, for constrained optimization of parameters 
  
Parameter Notation LBa UBa Estimated Value Comment 
Maximal bacitracin 
transport rate via BceAB 
vmax 1 104 (1.0±0.8) x 104 
molecules/protein/min 
Unknown parameter with wide 
range 
Michaelis-Menten constant 
for bacitracin transport via 
BceAB 
Km 10-3 10 (2.9±2.4) mM Unknown parameter with wide 
range 
Basal transcription rate of 
PbceAB promoter 
D 10-3 1 (4.2±0.1) x 10-3 
mRNA/min 
Physiological range (see e.g. (Fritz 
et al., 2014)) 
PbceAB activation threshold N 10-4 1 (0.3±4.1) x 10-3 Relative bacitracin flux per 
transporter at which PbceAB 
promoter is activated 
Hill coefficient n 1 10 7.5±0.2 Effective parameter with wide 
range 
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Table S3. Plasmids, strains and primers used in this study  
Name Descriptiona Sourceb 
Plasmids   
pAH328 Vector for transcriptional promoter fusions to luxABCDE 
(luciferase); integrates in B. subtilis sacA; Ampr, Cmr 
(Schmalisch et al., 
2010) 
pBS2E Empty vector; integrates in B. subtilis lacA; Ampr, Mlsr (Radeck et al., 2013) 
pBS1C Empty vector; integrates in B. subtilis amyE; Ampr, Cmr (Radeck et al., 2013) 
pSB1A3 Empty E. coli vector, MCS features rfp cassette; Ampr RSBP 
pNTSB103 pSB1A3 harboring B. subtilis bceAB adapted to the BioBrick 
RFC25 cloning standard 
This study 
pNTSB101 pSB1A3 harboring bceS adapted to the BioBrick RFC25 cloning 
standard, using same strategy as for pNTSB103 
This study 
pNTSB104 pSB1A3 harboring PxylA from pXT (Derré et al., 2000) adapted to 
the BioBrick RFC10 cloning standard  
This study 
pNT2E01 pBS2E harboring PxylA-bceAB assembled according to the BioBrick 
RFC10 cloning standard 
This study 
pSDlux101 pAH328 harboring a transcriptional PbceA-luxABCDE fusion (Kallenberg et al., 
2013) 
pNT2E07 pBS2E harboring PxylA-bceS assembled according to the BioBrick 
RFC10 cloning standard 
This study 
pJR1C02 pBS1C harboring PbceR-bceAB assembled according to the 
BioBrick RFC10 cloning standard 
This study 
E. coli strains   
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F′::Tn10 
proAB lacIq Δ(lacZ)M15]  
Stratagene 
B. subtilis strains  
W168 Wild-type, trpC2 Laboratory stock 
SGB073 W168 sacA::pSDlux101 This study 
SGB218 W168 bceAB::kan sacA::pSDlux101 lacA::pNT2E01 This study 
TMB035 W168 bceAB::kan; Kanr (Rietkötter et al., 
2008) 
TMB1461 W168 ∆bceRSAB  This study 
TMB3095 W168 ∆bceRSAB amyE::pJR1C02 lacA::pNT2E07 This study 
TMB3097 W168 ∆bceRSAB amyE::pJR1C02  This study 








iGEM135 GATCACTAGTATTCGATAAGCTTGGGATCCC This study 
aAmpr, ampicillin resistance; Cmr, chloramphenicol resistance; Kanr, kanamycin resistance; Mlsr, 
erythromycin-induced resistance to macrolide, lincosamide and streptogramin B antibiotics (MLS). 
Restriction sites in primer sequences are underlined; start codons are in bold; stop codons in italics; 
the optimal Shine-Dalgarno sequence in bold italics. 
bRSBP, Registry of Standard Biological parts (http://partsregistry.org) 
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Summary
Protection against antimicrobial peptides (AMPs)
often involves the parallel production of multiple,
well-characterized resistance determinants. So far,
little is known about how these resistance modules
interact and how they jointly protect the cell. Here,
we studied the interdependence between different
layers of the envelope stress response of Bacillus
subtilis when challenged with the lipid II cycle-
inhibiting AMP bacitracin. The underlying regulatory
network orchestrates the production of the ABC
transporter BceAB, the UPP phosphatase BcrC and
the phage-shock proteins LiaIH. Our systems-level
analysis reveals a clear hierarchy, allowing us to dis-
criminate between primary (BceAB) and secondary
(BcrC and LiaIH) layers of bacitracin resistance.
Deleting the primary layer provokes an enhanced
induction of the secondary layer to partially compen-
sate for this loss. This study reveals a direct role of
LiaIH in bacitracin resistance, provides novel
insights into the feedback regulation of the Lia sys-
tem, and demonstrates a pivotal role of BcrC in main-
taining cell wall homeostasis. The compensatory
regulation within the bacitracin network can also
explain how gene expression noise propagates
between resistance layers. We suggest that this
active redundancy in the bacitracin resistance net-
work of B. subtilis is a general principle to be found
in many bacterial antibiotic resistance networks.
Introduction
In their natural environment many microbes are in fierce
competition for a limited supply of resources. This fre-
quently involves the production of antimicrobial peptides
(AMPs) that suppress the proliferation of competitors
(Eijsink et al., 2002). In this biochemical warfare, the cell
envelope serves as a prime target, and many AMPs
interfere with its biosynthesis and integrity (Breukink and
de Kruijff, 2006). To defend against antimicrobial attacks
by rival species, it is thus of vital importance for cells to
accurately sense these cues and to swiftly mount pro-
tective countermeasures, collectively referred to as cell
envelope stress response (CESR) (Jordan et al., 2008;
Schrecke et al., 2012). In many bacteria the defense
against AMPs involves the simultaneous expression of a
number of resistance systems that protect cells at vari-
ous levels. Those include on the one hand specific
resistance determinants, such as ABC transporters
(Gebhard, 2012) and immunity lipoproteins (Stein et al.,
2003; Aso et al., 2005) that transport and/or sequester
AMPs from their molecular targets. On the other hand,
bacteria induce the production of more nonspecific
resistance determinants that alter the charge and com-
position of the cell envelope to reduce access of AMPs
to their sites of action (Revilla-Guarinos et al., 2014)
and allow cells to cope with deleterious effects on down-
stream cell physiology (Joly et al., 2010). While many of
the AMP resistance modules have been individually
characterized in great detail, our present knowledge
about how these modules interact, and how they jointly
contribute to the overall AMP resistance of a cell, is still
limited. Thus, as for many other bacterial stress
responses, the daunting task is to decipher how the cell
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orchestrates the activity of individual resistance modules
into a complex and multi-layered CESR network.
In the present work we approached this question by
focusing on the resistance mechanisms of Bacillus sub-
tilis against the peptide antibiotic bacitracin, which is
produced by some strains of Bacillus licheniformis and
B. subtilis (Azevedo et al., 1993; Ishihara et al., 2002)
and is clinically used as broad spectrum antibiotic
against Gram-positive bacteria causing skin infections.
Bacitracin acts by inhibiting the lipid II cycle of cell wall
biosynthesis, which is essential for the translocation of
peptidoglycan precursors from the cytosol to the extra-
cytoplasmic space (Fig. 1A). The tight complex forma-
tion between bacitracin and the diphosphate lipid carrier
undecaprenyl pyrophosphate (UPP) prevents dephos-
phorylation of UPP to undecaprenyl phosphate (UP) and
thereby efficiently blocks recycling of the lipid carrier
(Storm and Strominger, 1973; Economou et al., 2013).
To perpetuate progression of the lipid II cycle under
bacitracin attack and to protect against cell envelope
damage, B. subtilis up-regulates the expression of three
major resistance modules (Mascher et al., 2003;
Rietk€otter et al., 2008): The ABC transporter BceAB
(Ohki et al., 2003; Mascher et al., 2003), the UPP phos-
phatase BcrC (Cao and Helmann, 2002; Ohki et al.,
2003; Bernard et al., 2005) and the phage shock protein
(Psp)-like LiaI and LiaH proteins (Mascher et al., 2004;
Jordan et al., 2006) (Fig. 1A and B). Recent evidence
suggests that BceAB confers resistance by clearing
UPP from the inhibitory grip of bacitracin (Fritz et al.,
2015), but it remains elusive whether bacitracin is trans-
ported into the cytoplasm for degradation or whether it
is released into the extracytoplasmic space, as sug-
gested previously (Ohki et al., 2003; Rietk€otter et al.,
2008). Simultaneously, the phosphatase BcrC catalyzes
the dephosphorylation of UPP to UP (Fig. 1A) and
thereby promotes the progression of the Lipid II cycle.
Finally, under cell-envelope perturbing conditions the
liaIH operon is induced, and the small membrane
anchor protein LiaI recruits the cytosolic PspA/IM30 pro-
tein family member LiaH into static, membrane-
associated patches (Dom"ınguez-Escobar et al., 2014).
While the homologous Psp system encoded by the
pspABCDE operon of Escherichia coli has been linked
to maintenance of the proton motive force under
envelope-perturbing conditions (Kleerebezem et al.,
1996; Kobayashi et al., 2007), the physiological role of
the Lia system in B. subtilis remained elusive: despite
its more than !100-fold induction under bacitracin
stress, no increase in bacitracin sensitivity was detected
in a liaIH deletion strain (Wolf et al., 2010). While this
might suggest that there is no contribution of the Lia
system to bacitracin resistance, we reasoned that the
presence of the two other bacitracin resistance layers,
BceAB and BcrC, could potentially compensate for the
lack of LiaIH. However, to date it is not known whether
these systems act in fact redundantly, or whether they
contribute independently or even cooperatively to baci-
tracin resistance.
To gain deeper insight into how these modules inter-
act and form an efficient bacitracin stress response net-
work, we here systematically studied their functional and
regulatory interactions in a comprehensive set of
mutants deficient in the three resistance determinants.
Our analysis reveals a hierarchy among resistance mod-
ules, which we find reflected in marked anti-correlations
between the expression of primary (drug-sensing) and
secondary (mostly damage-sensing) layers of bacitracin
resistance. This means that the increased expression of
the primary resistance layer reduced the expression of
the secondary layer and vice versa. Strikingly, these
anti-correlations can also explain how gene expression
noise propagates between the different resistance mod-
ules at the single cell level, as revealed by flow cytome-
try analyses. Moreover, our study underpins the
importance of the UPP phosphatase BcrC for cell wall
homeostasis in the absence of bacitracin stress and
provides novel clues about the physiological stimuli trig-
gering the induction of the modules in the bacitracin
resistance network.
Results
Contributions of CESR modules to antibiotic resistance
First, we studied whether the three CESR modules pro-
tect the cell in a redundant, independent or even in a
cooperative manner. To this end we constructed mutants
deficient in one, two or in all three resistance determi-
nants and determined their sensitivity towards bacitracin
using the E-testV
R
agar gradient diffusion method
(Fig. 2A). Compared to the minimal inhibitory concentra-
tion (MIC) of bacitracin for wild type cells (256 mg ml21),
mutants deficient in only one of the resistance modules
displayed a clear hierarchy in their sensitivity towards
bacitracin: While the MIC of the DliaIH mutant was iden-
tical to that of the wild type, the DbcrC mutant displayed
a 5-fold and the DbceAB mutant an 85-fold increase in
bacitracin susceptibility, suggesting that BceAB acts as
the primary resistance determinant under these growth
conditions. Interestingly, in a mutant background devoid
of bceAB, the additional deletion of either of the other
two resistance modules had a significantly stronger
impact on the MIC than observed in the single mutants.
Here, the DbceAB DliaIH double mutant had a 6-fold
lower MIC than the DbceAB mutant, thereby revealing
the first phenotype of LiaIH in the bacitracin stress
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Fig. 1. Schematic overview of bacitracin resistance determinants and their regulation in B. subtilis.
A. In the absence of bacitracin, the membrane-associated steps of cell wall biosynthesis in B. subtilis involve the cytosolic attachment of
peptidoglycan precursors to the lipid carrier undecaprenyl-phosphate (UP) via MraY and MurG, followed by transport of the resulting lipid II
molecule to the extracytoplasmic leaflet of the cytoplasmic membrane via at least two redundant flippases MraY and Amj. After incorporating
peptidoglycan precursors into the cell wall by penicillin binding proteins (PBPs), the remaining phosphorylated form of the lipid carrier,
undecaprenyl-pyrophosphate (UPP), is converted to UP via the phosphatase BcrC, before it can enter the next transport cycle. Bacitracin
blocks this essential lipid II cycle by tightly binding to UPP and thereby preventing the recycling of the lipid carrier. Bacitracin resistance is
conferred by the increased production of the ABC-transporter BceAB, which removes bacitracin from UPP by a so far unknown transport
mechanism, and the increased production of BcrC, which allows the lipid II cycle to progress in the presence of bacitracin.
B. The third player in the bacitracin stress response network is the phage-shock protein-like Lia response. Upon bacitracin challenge, the
small membrane anchor LiaI recruits the cytosolic PspA/IM30 protein family member LiaH into membrane-associated patches of unknown
physiological function. Potentially, these structures stabilize the membrane underneath damaged areas of the cell wall.
C. Regulation scheme of the bacitracin stress response network in B. subtilis. Expression of bceAB is activated via a flux-sensing mechanism,
monitoring the detoxification flux of the ABC transporter BceAB via complex formation between BceAB and the histidine kinase BceS (Dintner
et al., 2014; Fritz et al., 2015), which in turn activates transcription via phosphorylation of the response regulator BceR. Expression of bcrC is
regulated by the ECF r-factors rM and rX and their cognate anti r-factors, which together are considered to be sensors for cell wall integrity
(Inoue et al., 2013; Lee and Helmann, 2013). Likewise, expression of liaIH is regulated by the LiaFSR three-component system (Jordan et al.,
2006; Mascher, 2006; Schrecke et al., 2013), which has also been shown to be a sensor of cell envelope damage (Wolf et al., 2012).
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response. Hence, we suggest that the previously
reported lack of a DliaIH phenotype upon bacitracin
stress (Rietk€otter et al., 2008) might be explained by a
redundant organization of the bacitracin stress response
network, in which resistance conferred by BceAB masks
the weaker contribution of the LiaIH module. Moreover,
the DbceAB DbcrC double mutant was 24-fold more
sensitive than the DbceAB reference strain, suggesting
that BceAB also partially masks the contribution of
BcrC. Please note that we did not observe a similar
“masking effect” between the secondary resistance
modules, as the MIC of a DbcrC mutant (48 mg ml21)
was identical to that of a DbcrC DliaIH mutant (Fig. 2A).
Only when compared to a DbceAB DbcrC double
mutant, we found that a DbceAB DbcrC DliaIH triple
mutant showed an !3-fold increased bacitracin sensitiv-
ity (Fig. 2A). In summary, these results show that the
secondary resistance modules do in fact protect the cell
against bacitracin, but also reveal that the contributions
of the secondary resistance modules are masked by the
much stronger resistance conferred by the Bce system.
Next, we asked whether the increased bacitracin sus-
ceptibility of the mutants above was in fact due to the lack
of the respective resistance modules, or whether those
mutants exhibited a general growth defect that might
result in increased bacitracin susceptibility. For instance, it
is known that the BcrC phosphatase is also involved in
Lipid II cycle progression under normal growth conditions
(Bernard et al., 2005), but the extent to which the cyto-
solic UPP phosphatase UppP (formerly YubB) could com-
pensate for the deletion of BcrC was controversial (Cao
and Helmann, 2002; Bernard et al., 2005). To quantita-
tively test the fitness of the different mutants, we meas-
ured their doubling times in LB medium at 378C in a
microplate reader (Fig. 2B). In the absence of bacitracin,
the wild type and DliaIH mutant grew at similar doubling
times of td523.062.2 min, and td5 24.76 2.1 min,
respectively, while the DbceAB mutant grew slightly faster
(td520.060.3 min) and the DbcrC mutant significantly
slower (td528.761.7 min) than wild type (P value of
unpaired Student’s t-test5 0.024). Moreover, we observed
that under these conditions of rapid growth, the DbcrC
mutant was about as sensitive as the DbceAB mutant,
which displayed killing at 10 mg ml21 bacitracin and higher
(Fig. 2B). This suggests that at high growth rates the
deletion of bcrC can only be partially compensated for by
the activity of the second UPP phosphatase UppP, imply-
ing that UPP dephosphorylation might become the bottle-
neck for cell wall biosynthesis and hence for cell growth.
Thus, we conclude that the increased bacitracin sensitivity
of the DbcrC mutant can—at least partially—be attributed
to a general growth defect incurred by reduced rates of
UPP dephosphorylation.
Regulatory interactions between the CESR modules
The redundant contributions of the CESR modules to
bacitracin resistance described above provoked the
question of the extent to which deletion of one resist-
ance module would affect the expression of the other
resistance modules. To study these regulatory interac-
tions, we fused the target promoter of each module to
the luxABCDE cassette derived from Photorhabdus
luminescens (Schmalisch et al., 2010; Radeck et al.,
2013) and integrated the resulting reporter plasmids into
the chromosome of wild type and mutants deficient in
one of the three resistance modules (Supporting Infor-
mation Table S1). Subsequently, exponentially growing
cultures (OD600"0.1) were challenged with different
bacitracin concentrations and the dose-dependent luci-
ferase activity (one hour post-addition) was recorded as
a proxy for promoter activity (Fig. 3).
Quantitative behavior of the unperturbed CESR network
In the wild type strain (Fig. 3, black data), PbceA
(Fig. 3A) displayed low activity (104 RLU/OD) in
the absence of bacitracin and responded already
at low bacitracin concentrations of #0.01 mg ml21. This
response gradually increased with rising bacitracin lev-
els and reached its maximum about 300-fold over
background at 30 mg ml21 bacitracin. Recently, we
showed that this gradual response over a high input-
dynamic range is the result of negative feedback regu-
lation in the Bce system, in which a flux-sensing mech-
anism homeostatically adjusts the rate of de novo
transporter synthesis to the level needed for cell pro-
tection (Fritz et al., 2015). In contrast to PbceA, PbcrC
(Fig. 3B) already had a high basal activity (7 3 105
RLU/OD) and only responded at much higher bacitra-
cin concentrations (1 mg ml21) with a maximum 3-fold
induction over background at 30 mg ml21. The strong
PbcrC activity in the absence of antibiotic treatment is
consistent with the notion that BcrC is an important
player in lipid II cycle progression under exponential
growth conditions, as noted above. Similar to PbceA,
PliaI (Fig. 3C) displayed a low basal activity and a
strong (400-fold) induction at high bacitracin levels, but
its input-dynamic range was much narrower (0.1 to
10 mg ml21 bacitracin) than seen for PbceA (0.01 to
30 mg ml21 bacitracin). Hence, production of the pri-
mary resistance determinant BceAB is induced already
at lower antibiotic concentrations than expression of
the secondary resistance modules. This suggests that
the primary layer might “buffer” against cell envelope
stress at low bacitracin levels, while the demand for
further protective measures only occurs at higher anti-
biotic concentrations.
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BceAB is the pacemaker of the CESR network
If this buffering hypothesis was accurate, the second-
ary layer should become more sensitive and also more
active in the absence of the primary resistance.
Indeed, we found that in a DbceAB mutant the PbcrC
and PliaIH promoters were activated already at lower
bacitracin concentrations and displayed a steeper
dose-response behavior than in the wild type (Fig. 3B
and C, blue data). Note that the activity of PbceA itself
remained at a basal level in the DbceAB mutant
(Fig. 3A), again highlighting that the transport activity
of BceAB is strictly required for activation of the PbceA
promoter (Rietk€otter et al., 2008; Fritz et al., 2015). To
further corroborate the buffering hypothesis, we next
tested the effect of different constitutive BceAB levels
on the expression of the secondary resistance layer.
To this end, we complemented the DbceAB mutant
with a xylose-inducible copy of bceAB. Strikingly, com-
pared to the highly sensitive PliaI response in the
DbceAB mutant (Fig. 4A (ii); red data), constitutive
expression of bceAB at low levels was already suffi-
cient to shift the induction threshold of the PliaI pro-
moter to 3-fold higher bacitracin levels [Fig. 4A (ii);
orange data]. A high constitutive expression level of
bceAB resulted in a further 10-fold increase of the PliaI
induction threshold [Fig. 4A (ii); light green data], which
could be even further increased by overexpression of
bceAB in the wild type [Fig. 4A (ii); dark green data].
Importantly, varying the bceAB expression level caused
similar shifts in the induction threshold of the PbcrC pro-
moter (Supporting Information Fig. S1). Hence these
data show that whenever the production level of
BceAB is high, the expression of the two secondary
resistance modules is low and vice versa. These clear-
cut anti-correlations suggest that the ABC transporter
actively prevents cell envelope stress and thereby
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Fig. 2. Contributions of CESR modules to bacitracin resistance.
A. MIC of indicated B. subtilis strains as determined by the E-testV
R
agar gradient diffusion method on M€uller-Hinton medium. Strains tested
were W168, TMB35 (DbceAB), TMB297 (DbcrC), TMB1151 (DliaIH), TMB713 (DbceAB DbcrC), TMB2127 (DbceAB DliaIH), TMB2128 (DbcrC
DliaIH) and TMB1829 (DbceAB DbcrC DliaIH). Pictures are representative for three biological replicates with a maximal sample deviation of
one concentration step; arrows indicate the fold-change of sensitivity.
B. Doubling times of exponentially growing cells one hour after treatment with indicated bacitracin concentration. Graphs show data for single
mutant strains containing the lux-reporter, see caption of Fig. 3. Standard deviation was obtained from at least nine biological replicates.
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reduces the demand for expression of the secondary
layers of the CESR network.
Note that the variation of the bceAB expression levels
also triggered shifts in the response of the PbceA pro-
moter itself [Fig. 4A (i)]. Previously, we showed that
this behavior can be rationalized by a flux-sensing
mechanism, in which a sensory complex between the
ABC transporter BceAB and the histidine kinase BceS
detects the rate of bacitracin flux by individual trans-
porters, which in turn activates the PbceA promoter via
the response regulator BceR (Fritz et al., 2015).
Accordingly, in cells with low BceAB levels the load per
transporter saturates already at low bacitracin levels
and triggers full induction of PbceA [Fig. 4A (i); orange
curve]. Conversely, in cells with higher BceAB levels
the load per transporter saturates at significantly higher
bacitracin levels, which in turn leads to proportional
shifts of the PbceA dose-response characteristic to the
right [Fig. 4A (i); green curves] (Fritz et al., 2015).
BcrC has pleiotropic effects on CESR modules
The deletion of bcrC triggered a 2- to 3-fold increased activ-
ity of its own promoter, PbcrC, compared to the wild type
(Fig. 3B, green data)—even in the absence of bacitracin
stress. Given that the deletion of bcrC slowed down growth
by impairing cell wall biosynthesis (Fig. 2B), the elevated
PbcrC activity seemed reasonable, because this promoter
belongs to the regulon of the alternative sigma factor rM
(Cao and Helmann, 2002). rM itself responds to a broad
spectrum of cell envelope-perturbing agents (Eiamphung-
porn and Helmann, 2008) and was therefore considered to
be a sensor for cell wall integrity (Inoue et al., 2013; Lee and
Helmann, 2013). Likewise, the PliaI promoter activity was
elevated 3-fold in the DbcrC mutant (Fig. 3C), consistent
with the role of the Lia system as a general sensor of cell
envelope stress (Wolf et al., 2012). However, it was surpris-
ing that the PbceA promoter was also up-regulated 10-fold in
the DbcrC mutant (Fig. 3A), since previous reports were
consistent with a model in which the Bce system responds
to the detoxification flux of the drug and not to downstream
damage on cell physiology (cf. Fig. 1C). This curious effect
is discussed in more detail below.
To further substantiate that the observed phenotypes
specifically arose from the deletion of bcrC, we comple-
mented the DbcrC mutant with a xylose-inducible copy of
bcrC. This complementation indeed returned the elevated
activities of PbceA and PliaI back to wild-type levels (Fig.
4B; light green data). Interestingly, the overexpression of
bcrC in a wild type background lead to a further decrease
of both the PliaI and PbceA activities (Fig. 4B; dark green
data), suggesting that an elevated rate of UPP dephos-
phorylation reduced the cellular susceptibility to bacitracin.
Fig. 3. Dose-dependent activation of resistance modules in
perturbed and unperturbed CESR networks. Target promoter
activities of (A) Pbce-lux, (B) PbcrC-lux and (C) PliaI-lux in strains
carrying indicated deletions of CESR modules, as given by specific
luciferase activity (RLU/OD600) one hour after addition of indicated
amounts of bacitracin. Measurements were performed during
exponential growth phase in LB medium at 378C in a microtiter
plate reader. Data are shown for strains TMB1619, TMB1620,
TMB1617 (W168); TMB1623, TMB1624, TMB1621 (DbceAB);
TMB1627, TMB1628, TMB1625 (DbcrC) and TMB1661, TMB1662,
TMB1659 (DliaIH) containing PbceA-lux, PbcrC-lux or PliaI-lux,
respectively, see Supporting Information Table S1. Data points and
error bars indicate means and standard deviations derived from at
least three biological replicates.
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Taken together, these data show that the level of BcrC
sets the rate of UPP dephosphorylation, which in turn
determines how many UPP target molecules the cell dis-
plays for binding by bacitracin. Accordingly, low levels of
BcrC lead to the accumulation of UPP and make cells vul-
nerable to bacitracin attack, whereas high BcrC levels
keep UPP levels low and make cells more resistant. This
pattern is reflected both in the responses of the Lia and
BcrC systems, which measure bacitracin-dependent dam-
age of the cell envelope, as well as in the response of the
Bce system, which presumably senses the UPP-bound
form of bacitracin (see Discussion for more details).
LiaIH plays a positive autoregulatory role
In contrast to the marked effects the deletions of bceAB and
bcrC had on the expression of all resistance modules, the
deletion of liaIH (Fig. 3, orange data) did not significantly
influence the regulation of PbceA and PbcrC (Fig. 3A and B).
However, the DliaIH mutant displayed up to 7-fold reduced
activity of its own promoter (Fig. 3C). This is the first report
showing that the expression of the lia operon is not only
regulated via the LiaFSR three-component system
(Schrecke et al., 2013), but that also the target proteins
LiaIH play a positive autoregulatory role required for the full
Lia response. In fact, when scrutinizing the temporal dynam-
ics of promoter activities, it became evident that the DliaIH
mutant displayed only a transient PliaI induction that reached
a peak between 10 and 20 min after bacitracin addition and
declined afterwards, whereas the wild type displayed pro-
longed PliaI activity with a peak at !40 min after bacitracin
addition (Supporting Information Fig. S2).
In line with these observations, in a liaIH complementa-
tion strain variations of the LiaIH production level did not
Fig. 4. Regulatory crosstalk between primary and secondary resistance modules. Target promoter activities of PbceA-lux and PliaI-lux in
strains expressing different levels of (A) BceAB, (B) BcrC and (C) LiaIH, as given by specific luciferase activity (RLU/OD600) one hour after
addition of indicated amounts of bacitracin. Measurements were performed as described in Fig. 3. Colors code for different expression levels
of resistance module X (X5bceAB, bcrC or liaIH), as driven by the xylose-inducible promoter PxylA: (red) No expression, via deletion of
module X; (orange) Low constitutive expression, via complementation of the deletion mutant with PxylA-X in the absence of xylose; (light
green) High constitutive expression, via complementation of the deletion mutant with PxylA-X in the presence of 0.2% xylose; (dark green)
Overexpression in W168 wild type background, via expression of PxylA-X in the presence of 0.2% xylose. The corresponding strains are A.
TMB1619, TMB1623, TMB2590, TMB2594 (PbceA-lux) and TMB1617, TMB1621, TMB2589, TMB2593 (PliaI-lux) (B) TMB1619, TMB1627,
TMB2592, TMB2430 (PbceA-lux) and TMB1617, TMB1625, TMB2591, TMB2429 (PliaI-lux) (C) TMB1619, TMB1661, TMB2693, TMB2691
(PbceA-lux) and TMB1617, TMB1659, TMB2692, TMB2690 (PliaI-lux), as listed in Supporting Information Table S1. Error bars indicate the
standard deviation between at least three biological replicates.
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affect the dose-response behavior of the PbceA promoter,
but had significant effects on PliaI activity itself (Fig. 4C).
In the absence of bacitracin, the constitutive expression
of liaIH triggered a 20-fold increased PliaI activity com-
pared to the wild type [Fig. 4C (ii); light green data]. At
bacitracin concentrations higher than 0.3 mg ml21, how-
ever, PliaI displayed a weaker activity than in wild type.
These data show on the one hand that LiaIH has a posi-
tive regulatory effect on the PliaI promoter even in the
absence of externally added antibiotics. On the other
hand they show that the inability to up-regulate liaIH lead
to reduced PliaI activity, suggesting that a positive feed-
back via LiaIH might be needed for the full activation of
the Lia system in wild type. To rule out that the marker-
less deletion of liaIH had polar effects on the expression
of the signaling system LiaFSR, we complemented the
DliaIH mutant with a copy of liaIH under the control of its
native promoter (PliaI), and found that wild type behavior
of PliaI induction could be restored (data not shown).
Moreover, the overproduction of LiaIH in a wild type back-
ground [Fig. 4C (ii); dark green data] lead to an elevated
PliaI activity in the absence of bacitracin, while at high
bacitracin levels the Lia system was as active as in the
wild type. Taken together, these results show that LiaIH
has no influence on the primary resistance BceAB, but is
instead involved in fully activating and perpetuating its
own expression by a so far unknown mechanism. In the
future, it remains to be clarified whether LiaIH is involved
in the perception of cell envelope stress, or whether LiaIH
generates some degree of envelope stress itself.
Single cell induction of CESR modules
The compensatory regulation between the different
CESR modules observed at the bulk-level (see above),
raises the question of how the bacterial population
implements this response at the individual cell level. Do
all cells within the population behave uniformly, or is
there significant phenotypic heterogeneity within the
population? Given that the excess expression of resist-
ance determinants is often associated with a fitness
cost (Andersson and Hughes, 2010), it is in fact intri-
guing to ask whether bacteria evolved to minimize
“noise” in resistance gene expression (adjusting resist-
ance as close as possible to its optimal level), or
whether they actively use heterogeneous gene expres-
sion as a means to diversify resistance levels within the
population – a strategy that can be beneficial in fluctuat-
ing environments (Fraser and Kaern, 2009).
To scrutinize the expression behavior of the three
CESR modules at the single cell level, we fused their
promoters to a plasmid-borne copy of gfp and intro-
duced them into wild type B. subtilis W168. We then
challenged exponentially growing cells with various lev-
els of bacitracin and quantified GFP fluorescence by
flow cytometry one hour after bacitracin addition
(Fig. 5). In the absence of bacitracin the fluorescence
distributions of the PbceA-gfp (Fig. 5A) and the PliaI-gfp
(Fig. 5C) reporters were identical to the autofluores-
cence distribution of B. subtilis W168 (data not shown),
while the PbcrC-gfp reporter activity was !5-fold higher
than background (Fig. 5B), consistent with the high
basal activity of the PbcrC promoter quantified with the
luciferase reporter above (cf. Fig. 3). This suggests that
the gfp reporter is less sensitive than the luciferase
reporter, such that promoter activities below !105 RLU/
OD in Fig. 3 are hidden by the autofluorescence of
B. subtilis. However, apart from this difference in
reporter sensitivity, the mean fluorescence values for all
promoter-gfp fusions were consistent with the results
obtained for the promoter-lux fusions in Fig. 3.
Next, we compared gene expression noise in the
response of the three resistance modules. As mentioned
before, in the absence of bacitracin the fluorescence
distributions of PbceA-gfp (Fig. 5A) and PliaI-gfp (Fig. 5C)
reporters were identical to the broad autofluorescence
distribution of B. subtilis. In contrast, PbcrC-gfp reporter
displayed a narrow fluorescence distribution, and also
showed low noise levels at all bacitracin levels tested. In
the presence of bacitracin the response of the PbceA-gfp
reporter became almost as homogeneous as the PbcrC-gfp
reporter. Only the PliaI-gfp reporter was expressed broadly
heterogeneously across the population when challenged
with intermediate concentrations (1–3 mg ml21) of bacitracin
(Fig. 5C), as reported before (Kesel et al., 2013). Indeed,
when quantifying gene expression noise by the coefficient of
variation h, we found that at similar mean GFP expression
levels the PliaI promoter was significantly noisier than the
other promoters (Supporting Information Fig. S3A). This
broadly heterogeneous production of LiaIH argues for signif-
icant cell-to-cell variability in the downstream damage per-
ceived by the Lia system in the presence of bacitracin. In
contrast, the low noise levels in the expression of bceAB
and bcrC suggest that their expression is subject to a more
stringent control, which might be the result of negative feed-
back regulation within these systems (see Discussion).
To test whether the noisy Lia response is influenced
by the expression of the other two resistance modules,
we introduced the PliaI-gfp reporter plasmid into DbceAB
and DbcrC mutants and determined their single cell
response towards bacitracin as above. Strikingly, the Lia
response displayed notably less cell-to-cell variability in
the DbceAB mutant than in the wild type (Fig. 5D). Also,
when comparing their coefficients of variation at similar
mean expression levels (Supporting Information Fig.
S3B), we found that PliaI is less noisy in the DbceAB
mutant than in the wild type, thereby showing that the
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reduced noise level is not only caused by the stronger
and more sensitive PliaI response in this mutant. This
suggests that in the unperturbed (wild type) CESR net-
work, the broadly heterogeneous Lia response is directly
triggered by heterogeneity in bceAB expression: At the
time of antibiotic treatment there exists a narrow, yet
stochastic distribution of BceAB protein levels across
the population, such that cells with higher levels of
BceAB have sufficient ability to cope with bacitracin,
whereas cells with lower levels of BceAB experience
more cell envelope damage, which in turn triggers
higher LiaIH production levels. Consequently, in the
absence of BceAB this model predicts that all cells in
the population would experience a similar envelope
stress level, consistent with the homogeneous Lia
response in the DbceAB mutant.
In contrast, our data showed that in a DbcrC mutant
noise in the Lia response was markedly increased
(Fig. 5D). We suggest that the increased noise in the
expression of bceAB in this mutant (Supporting Informa-
tion Fig. S4) leads to a significant heterogeneity in the
downstream damage perceived by the Lia system. How-
ever, we cannot exclude that population heterogeneity in
other lipid II cycle-associated players factors into the
noise properties of PliaI in this highly impaired mutant
strain. For instance, stochastic expression of uppP,
encoding the second, BacA-like UPP phosphatase in B.
subtilis (Cao and Helmann, 2002; Bernard et al., 2005;
Inaoka and Ochi, 2012), could result in largely variable
rates of cell wall biogenesis, which would in turn lead to
phenotypic heterogeneity in the susceptibility towards
cell wall antibiotics.
Fig. 5. Noise in the response of
bacitracin resistance modules.
Single cell bacitracin response of
wild type strains carrying (A) PbceA-
gfp, (B) PbcrC-gfp, and (C) PliaIH-gfp
reporter plasmids (strains TMB2174,
TMB2173 and TMB1176, see
Supporting Information Table S1), as
well as in (D) DbceAB and (E) DbcrC
mutant backgrounds carrying a PliaI-
gfp reporter plasmid (strains
TMB2056 and TMB2057, see
Supporting Information Table S1).
Fluorescence distributions were
quantified using flow cytometry, one
hour after treatment of exponentially
growing cells (378C, LB medium) with
bacitracin.
Fluorescence distributions (colored)
were obtained under bacitracin
treatment indicated on the right,
while transparent overlays (gray) are
reference distributions obtained in
the absence of bacitracin treatment.
In every case one representative
dataset of at least two independent
biological replicates is shown.
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Discussion
After the discovery of the bacitracin stimulon in Bacillus
subtilis (Mascher et al., 2003) and the quantitative charac-
terization of its individual modules (Rietk€otter et al., 2008),
we here present the first description of the full anatomy of
the bacitracin resistance network in B. subtilis. Using a
systems-level approach we showed that a clear hierarchy
exists between resistance modules, allowing us to discrim-
inate between primary (BceAB) and secondary layers
(BcrC and LiaIH) of bacitracin resistance. Strikingly, in
mutants devoid of the primary resistance layer, the sec-
ondary layer was more strongly induced, revealing a high
level of redundancy between resistance modules. Accord-
ingly, our data now show for the first time that in the
absence of the primary bacitracin resistance module, the
deletion of liaIH displays a clear-cut phenotype with a
6-fold reduction of bacitracin resistance. Hence, we argue
that the high level of resistance conferred by BceAB
masks the weaker contribution from the Lia system. This
explains previous reports that noted surprisingly weak
phenotypes of a liaIH deletion alone, despite the strong
Lia expression under a variety of cell envelope-perturbing
conditions, including lipid II cycle-interfering antibiotics as
well as oxidative stress reagents (Jordan et al., 2006;
Rietk€otter et al., 2008; Suntharalingam et al., 2009; Wolf
et al., 2010). So far, one of the strongest phenotypes was
found during treatment with the membrane pore-forming
lipopeptide daptomycin, where a liaIH deletion caused a
3-fold reduction of resistance (Hachmann et al., 2009;
Wecke et al., 2009). Notably, B. subtilis features no pri-
mary resistance mechanism against daptomycin, again
highlighting that the contribution of the Lia system to anti-
biotic resistance is strongest if other resistance layers are
lacking. Based on these observations, and in conjunction
with the wide distribution of the PspA/IM30 protein family
(of which LiaH is a member) across various bacterial phyla
and even in archaea and eukaryotes (Joly et al., 2010),
we speculate that the Lia system constitutes an ancient
resistance module that provides a low level of resistance
against a broad range of cell envelope-perturbing agents.
In contrast, the Bce-like resistance modules confer high
levels of protection against a rather narrow range of anti-
microbial peptides (Gebhard, 2012) and are almost exclu-
sively found in Firmicutes bacteria (Joseph et al., 2002;
Mascher, 2006; Dintner et al., 2011), suggesting that
these specialized resistance layers were acquired later
during evolution.
The results presented here also shed new light on the
role of the UPP phosphatase BcrC in lipid II cycle home-
ostasis under antimicrobial peptide attack. First, we
showed that the deletion of bcrC lead to a significant
decrease in growth rate - even in the absence of
antibiotic treatment. It appears likely that the second
BacA-like UPP phosphatase, UppP, partially compen-
sates for the loss of BcrC, but that its activity is insuffi-
cient to maintain adequate cell wall synthesis under the
rapid growth conditions in LB media. The precise extent
to which the uppP promoter is up-regulated in such a
mutant, and how it responds to lipid II cycle-inhibiting
antimicrobial peptides, remains to be elucidated. Sec-
ond, our data revealed that bcrC deletion had pleiotropic
effects on the expression of all resistance modules and,
most notably, triggered their up-regulation also in the
absence of externally added bacitracin. In these highly per-
turbed cells, the induction of the Lia system was consistent
with its role as a general sensor of cell envelope stress (Wolf
et al., 2010). Likewise, the up-regulation of the rM- and rX-
dependent PbcrC promoter was not unexpected, because
these alternative r factors were also shown to be sensors
for cell wall integrity (Inoue et al., 2013; Lee and Helmann,
2013). However, it was surprising to find the PbceA promoter
affected in the bcrC mutant, because all previous reports
were consistent with a model in which the Bce system
responds to the detoxification flux of the drug and not to
downstream damage on cell physiology (Wolf et al., 2012;
Fritz et al., 2015).
One possible explanation for the elevated PbceA activ-
ity might be that the lack of the phosphatase BcrC
causes the accumulation of UPP in the membrane, and
thereby provides a surplus of targets for bacitracin. In
turn, increased levels of UPP-bacitracin complexes
would increase the detoxification flux per BceAB trans-
porter, which then serves as the signal for PbceA activa-
tion. While this model can explain the increased PbceA
activity in the presence of bacitracin, it is less intuitive
why there was also a !10-fold activation in the absence
of bacitracin (cf. Fig. 3A). One possibility is that the
accumulation of UPP itself somehow triggers BceAB
activity. Interestingly, Kingston and colleagues sug-
gested that BceAB may recognize UPP directly and flip
it to the inner face of the membrane, where it may be
protected from bacitracin and dephosphorylated by a
cytosolically acting UppP (Kingston et al., 2014).
Although it is known that BceB directly binds free baci-
tracin in vitro with high affinity (Dintner et al., 2014), it is
conceivable that the physiological substrate of the trans-
porter is the UPP-bacitracin complex in the cell, as sug-
gested previously (Fritz et al., 2015). In this case, the
transporter may also be able to interact with both com-
ponents of the complex separately, i.e., free bacitracin
and free UPP, especially when increased amounts of
these are present. The increased basal activity of PbceA
in the bcrC mutant may then be due to accumulation of
UPP. A third alternative explanation might be that one or
more of the endogeneously produced antimicrobial pep-
tides activate the Bce system under these conditions.
For instance, we recently showed that the endogeneous
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production of the sporulation delay protein C (SdpC)
and the sporulation killing factor A (SkfA) in early sta-
tionary phase up-regulate production of BceAB and the
paralogous PsdAB transporter in B. subtilis more than
100-fold (H€ofler et al., 2016).
Taken together, the work from us and earlier work support
the following, multi-layered model of the bacitracin resist-
ance network in B. subtilis: In the presence of bacitracin
(Bac) the accumulation of UPP-bacitracin (UPP-Bac) com-
plexes blocks the lipid II cycle of cell wall biosynthesis and,
as a consequence, leads to cell envelope damage. UPP-
Bac is recognized by the ABC transporter BceAB, which
releases UPP from the inhibitory grip of bacitracin by a so
far unknown transport mechanism and thereby shifts the
binding equilibrium towards the free form of UPP. Expres-
sion of bceAB is controlled by a flux-sensing mechanism
(Fig. 1C), which homeostatically adjusts the BceAB level
such that the transport activity of individual ABC transport-
ers does not exceed a critical threshold (Fritz et al., 2015).
At the same time such homeostatic, negative feedback sys-
tems are known to reduce gene expression noise (Alon,
2007), fully consistent with the homogeneous response of
the Bce system observed at the single cell level. Simultane-
ously to the action of BceAB, BcrC reduces the concentra-
tion of the bacitracin-target UPP by dephosphorylation to
UP, thereby further promoting progression of the lipid II
cycle. Under bacitracin stress, transcription of bcrC is con-
trolled by the alternative ECF r factor rM, which is regulated
by the membrane-bound anti-r factors YhdK/L (Fig. 1C).
Previous data showed that either the depletion of UP and/or
the depletion of lipid II could be the cues for anti-r factors
YhdK/L (Inoue et al., 2013; Lee and Helmann, 2013;
Meeske et al., 2015). This suggests that the end product of
the reaction catalyzed by BcrC (UPP ! UP) could nega-
tively regulate the expression of bcrC, which would in turn
close a negative feedback loop that asserts homeostatic UP
level control in the cell. This model is also consistent with all
our data, most importantly the elevated PbcrC activity in the
bcrC mutant (which we expect to display low UP levels), as
well as the low noise level of the PbcrC promoter, which is
again characteristic of negative feedback systems. Within
our model, the Lia system constitutes the last line of defense
that directly responds to and combats cell envelope dam-
age, thereby explaining why the expression of the Lia sys-
tem did not affect the expression of the other resistance
modules in our data.
More generally, we propose that the redundant organi-
zation of the bacitracin resistance network of B. subtilis
described here is a universal principle of many stress
response networks within the microbial world, as demon-
strated for instance in the oxidative stress responses of
Salmonella enterica (H"ebrard et al., 2009) and Ralstonia
solanacearum (Flores-Cruz and Allen, 2009) or in the reg-
ulation of drug efflux systems in various bacterial species
(Grkovic et al., 2002). Here the induction of individual
stress response modules typically relieves stress per-
ceived by other modules, which can be interpreted as a
coupling between stress response modules via a global
negative feedback mechanism. Failure of one of the
“nodes” in such a network then triggers compensatory up-
regulation of other nodes, which then jointly protect the
cell. Interestingly, in the engineering disciplines this con-
cept is known as “active redundancy,” during which the
performance of individual devices is automatically moni-
tored and dynamically reconfigured to eliminate perfor-
mance declines of the system (Pahl and Beitz, 1996). In
contrast, “passive redundancy” uses excess capacity to
reduce the impact of component failures (Pahl and Beitz,
1996), which would be akin to the constitutive expression
of all resistance determinants. In biological stress
response networks, we propose that the use of active
redundancy serves as an optimal regulation strategy to
maximize cellular protection while preventing the direct or
indirect costs of excess resistance gene expression.
Experimental procedures
Bacterial strains and growth conditions
Bacillus subtilis and Escherichia coli were routinely grown in
Luria-Bertani (LB) medium at 378C with agitation (200 rpm).
Transformations of B. subtilis were carried out as described
previously (Harwood and Cutting, 1990). All strains used in
this study are derivatives of the wild-type strain W168 and
are listed in Supporting Information Table S1. Kanamycin
(10 mg ml21), chloramphenicol (5 mg ml21), spectinomycin
(100 mg ml21), tetracycline (10 mg ml21) and erythromycin
(1 mg ml21) plus lincomycin (25 mg ml21) for macrolide-
lincosamide-streptogramin B (“MLS”) resistance were used
for the selection of the B. subtilis mutants used in this
study. Solid media contained 1.5% (w/v) agar. For comple-
mentation studies, full induction of the promoter PxylA
was achieved by adding xylose to a final concentration of
0.2% (w/v).
DNA manipulation
Plasmids were generated by using standard cloning techni-
ques (Sambrook, Russell 2001) with enzymes and buffers
from New England Biolabs (NEB; Ipswich, MA, USA)
according to the respective protocols. PCR-DNA amplifica-




polymerase. Primers used in this study are listed in Sup-
porting Information Table S2 and plasmid descriptions as
well as details on their construction are given in Supporting
Information Table S3. All plasmids were verified by
sequencing of the insert. The integration of plasmids or
DNA fragments into the genome, or the presence of a repli-
cative vector, was confirmed by colony PCR. Integration
into the thrC-locus was checked by threonine-auxotrophy in
minimal medium.
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Determination of minimal inhibitory concentration
Bacitracin resistance of B. subtilis strains was deter-
mined using EtestV
R
strips on bacterial lawn (bioM"erieux,
Marcy l’Etoile, France), providing a concentration range
from 256 to 0.016 mg ml21 bacitracin. Briefly, 3 ml of
M€uller-Hinton (MH) medium (2.1% (w/v) M€uller-Hinton
broth) were inoculated 1:100 from fresh overnight culture
and cells were grown at 378C with agitation to
OD6005 0.6–0.8. Subsequently, 30 ml of the cell suspen-
sion were added to 3 ml molten MH soft agar (608C,
0.75% (w/v) agar), mixed and distributed on MH agar
plates. After 20 min of solidification, one EtestV
R
strip was
applied per agar plate. Results were documented after
24 h of incubation at 378C.
Luciferase assays
Luciferase activities of B. subtilis strains harboring pBS3Clux-
derivates were assayed using a SynergyTM NEOALPHAB
multi-mode microplate reader from BioTekV
R
(Winooski, VT,
USA). The reader was controlled using the software Gen5TM
(version 2.06). Cells were inoculated 1:1000 from fresh over-
night cultures and grown to OD60050.1–0.5. Subsequently,
cultures were diluted to OD6005 0.01 and split into 100 ml per
well in 96-well plates (black walls, clear bottom; Greiner Bio-
One, Frickenhausen, Germany). Cultures were incubated at
378C with linear agitation (intensity, 567 cpm) and the optical
density at 600 nm (OD600) as well as luminescence was
monitored every 5 min. After one hour, freshly diluted Zn21-
bacitracin was added to the indicated final concentrations and
incubation and monitoring was resumed for 2 h. Specific lumi-
nescence activity is given by the raw luminescence output
(relative luminescence units, RLU) normalized by cell density
(RLU/OD).
Flow cytometry assays
Single-cell fluorescence of B. subtilis strains carrying GFP-
reporter plasmids was measured using a BD AccuriTM C6
flow cytometer (BD Biosciences, Becton, Dickinson and
Company, New Jersey, USA). Cells were inoculated 1:1000
from overnight cultures and grown at 378C to OD600!0.1.
Subsequently the culture was split into test tubes, stained
with FMV
R
4-64 (Life Technologies GmbH, USA) to a final
concentration of 2 ng ml21 and incubated at 378C with agi-
tation. After 30 min cells were induced with indicated final
concentrations of Zn21-bacitracin and 1 hour after further
incubation, culture samples were assayed by flow cytome-
try. It was controlled by the BD AccuriTM C6 software using
the following settings: sample threshold5 11,000 on FSC-
H, core size5 5mm, flow rate5 10 ml min21. Noise in the
resulting fluorescence distributions (cf. Supporting Informa-
tion Fig. S3) was quantified by the coefficient of variation h,
defined as the ratio of the standard deviation r to the
mean l. In doing so, we used the geometric mean and var-
iance, because those measures are known to yield more
accurate statistics for log-normal distributed values than the
arithmetic mean and standard deviation.
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Figure S1. Regulatory crosstalk between BceAB and BcrC resistance module. Target 
promoter activities of PbcrC-lux in strains producing different levels of BceAB, as given by specific 
luciferase activity (RLU/OD600) one hour after addition of indicated amounts of bacitracin. 
Measurements were performed as described in Fig. 3 of the main text. Colors indicate different 
expression levels of bceAB, as obtained from strains TMB1620, TMB1624, TMB2745 and 
TMB2744 listed in Table S1.  
 




Figure S2. Expression dynamics of resistance modules in all mutant backgrounds. 
Dynamics of growth and target promoter activities of Pbce-lux, PbcrC-lux and PliaI-lux in strains 
carrying indicated deletions of CESR modules, as given by specific luciferase activity 
(RLU/OD600) after addition of indicated amounts of bacitracin at t = 0 min. Measurements were 
performed during exponential growth phase in LB medium at 37°C in a microtiter plate reader. 
Data points and error bars indicate mean and standard deviation from at least three biological 
replicates. Data was obtained with strains TMB1619, TMB1620, TMB1617 (W168); TMB1623, 
TMB1624, TMB1621 (ΔbceAB); TMB1627, TMB1628, TMB1625 (ΔbcrC) and TMB1661, 
TMB1662, TMB1659 (ΔliaIH) containing PbceA-lux , PbcrC-lux or PliaI-lux, respectively, listed in 











Figure S3. Quantification of gene expression noise in the three resistance modules. 
Scatterplot of gene expression noise η versus mean fluorescence values µ, as obtained from the 
fluorescence distributions in Fig. 5 of the main paper (each data point corresponds to the values 
of η and µ obtained for one fluorescence distribution). Here, gene expression noise was 
quantified by the coefficient of variation η, defined as the ratio of the standard deviation divided 
by the mean value of a fluorescence distribution. To exclude that differences in gene expression 
noise between different fluorescent distributions are the mere result of changes in the mean 
fluorescence level, we compare the values of η at identical mean fluorescence level, i.e., vertical 
lines in the graphs above. (A) Noise in PbceA-gfp, PbcrC-gfp and PliaI-gfp reporter gene expression 
in a wild type (B. subtilis W168) strain background. (B) Noise in PliaI-gfp reporter gene 
expression in W168, ΔbceAB and ΔbcrC strain background. 




Figure S4. Influence of bcrC deletion on noise in PbceA and PbcrC promoter activity. 
Comparison of single cell bacitracin response in strains wild type and ΔbcrC deletion 
background for (A) PbceA-gfp and (B) PbcrC-gfp reporter plasmids (strains TMB2174, TMB2178, 
TMB2173 and TMB2177). Fluorescence distributions were quantified using flow cytometry, one 
hour after treatment of exponentially growing cells (37°C, LB medium) with bacitracin. 
Fluorescence distributions (colored) were obtained under bacitracin treatment indicated on the 
right, while transparent overlays (gray) are reference distributions obtained in the absence of 
bacitracin treatment. In every case one representative dataset of at least two independent 
biological replicates is shown. 
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Table S1. Bacterial strains used in this study  
a kan, kanamycin resistance; tet, tetracycline resistance. 
Name Descriptiona Source 
E. coli strains 
XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F′::Tn10 
proAB lacIq Δ(lacZ)M15] 
Stratagene 
DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 
λ– thi-1 gyrA96 relA1 
Laboratory stock  
NEB5α 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
NEB 
B. subtilis strains 
W168 Wild-type, trpC2 Laboratory stock 
For determination of minimal inhibitory concentration 
TMB35 W168 bceAB::kan  (Rietkötter et al., 2008) 
TMB297 W168 bcrC::tet (Rietkötter et al., 2008) 
TMB713 W168 bcrC::tet bceAB::kan This study 
TMB1151 W168 ΔliaIH clean deletion (Toymentseva et al., 2012) 
TMB1829 W168 ΔliaIH bceAB::kan bcrC::tet This study 
TMB2127 W168 ΔliaIH bceAB::kan This study 
TMB2128 W168 ΔliaIH bcrC::tet This study 
For luminescence analysis 
TMB1617 W168 sacA::pCHlux101 (PliaI-lux) This study 
TMB1621 W168 bceAB::kan sacA::pCHlux101 (PliaI-lux) This study 
TMB1625 W168 bcrC::tet sacA::pCHlux101 (PliaI-lux) This study 
TMB1659 W168 ∆liaIH sacA::pCHlux101 (PliaI-lux) This study 
TMB2429 W168 lacA::pJNE2E01 (PxylA-bcrC) sacA::pCHlux101 (PliaI-lux) This study 
TMB2440 W168 ∆liaIH lacA::pJR2EF01 (PliaI-liaIH) sacA::pCHlux101 (PliaI-lux) This study 
TMB2589 W168 bceAB::kan lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux101 (PliaI-lux) This study 
TMB2591 W168  bcrC::tet lacA::pJNE2E01 (PxylA-bcrC) sacA::pCHlux101 (PliaI-lux) This study 
TMB2593 W168 lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux101 (PliaI-lux) This study 
TMB2690 W168 lacA::pJR2EF02 (PxylA-liaIH) sacA::pCHlux101 (PliaI-lux) This study 
TMB2692 W168 ∆liaIH lacA::pJR2EF02 (PxylA-liaIH) sacA::pCHlux101 (PliaI-lux) This study 
TMB1619 W168 sacA::pCHlux103 (PbceA-lux) (Höfler et al., 2016) 
TMB1623 W168 bceAB::kan sacA::pCHlux103 (PbceA-lux) This study 
TMB1627 W168 bcrC::tet sacA::pCHlux103 (PbceA-lux) This study 
TMB1661 W168 ∆liaIH sacA::pCHlux103 (PbceA-lux) This study 
TMB2430 W168 lacA::pJNE2E01 (PxylA-bcrC) sacA::pCHlux103 (PbceA-lux) This study 
TMB2590 W168 bceAB::kan lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux103 (PbceA-lux) This study 
TMB2592 W168 bcrC::tet lacA::pJNE2E01 (PxylA-bcrC) sacA::pCHlux103 (PbceA-lux) This study 
TMB2594 W168 lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux103 (PbceA-lux) This study 
TMB2691 W168 lacA::pJR2EF02 (PxylA-liaIH) sacA::pCHlux103 (PbceA-lux) This study 
TMB2693 W168 ∆liaIH lacA::pJR2EF02 (PxylA-liaIH) sacA::pCHlux103 (PbceA-lux) This study 
TMB1620 W168 sacA::pCHlux104 (PbcrC-lux) (Höfler et al., 2016) 
TMB1624 W168 bceAB::kan sacA::pCHlux104 (PbcrC-lux) This study 
TMB1628 W168 bcrC::tet sacA::pCHlux104 (PbcrC-lux) This study 
TMB1662 W168 ∆liaIH sacA::pCHlux104 (PbcrC-lux) This study 
TMB2744 W168 lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux104 (PbcrC-lux) This study 
TMB2745 W168 bceAB::kan lacA::pNT2E01 (PxylA-bceAB) sacA::pCHlux104 (PbcrC-lux) This study 
For flow cytometry analysis 
TMB1176 W168 pAT3803 (PliaI-gfp) (Toymentseva et al., 2012) 
TMB2056 W168 bceAB::kan pAT3803 (PliaI-gfp) This study 
TMB2057 W168 bcrC::tet pAT3803 (PliaI-gfp) This study 
TMB2173 W168 pJR3801 (PbcrC-gfp) This study 
TMB2177 W168 bcrC::tet pJR3801 (PbcrC-gfp) This study 
TMB2174 W168 pJR3802 (PbceA-gfp) This study 
TMB2178 W168 bcrC::tet pJR3802 (PbceA-gfp) This study 
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Table S2. Primers used in this study 
















a Recognition sites for endonuclease restriction enzymes are in bold, resulting overhangs for BsaI are in italics. The annealing part is 
underlined. 
  




Table S3. Vectors and plasmids used in this study  
Name Description 
Resistance 
in E. coli /  
B. subtilisa 
Primers and Enzymes used for cloningb Source 
Vectors 
pAH328 
sacA'…'sacA, luxABCDE, cat, bla 
 
Ampr / cmr  (Schmalisch et 
al., 2010) 
pGP380 
ori1030, erm, bla, Strep-Tag, 
PdegQ36 (Construction of N-term. 
Strep-tag in B. subtilis (SPINE)) 
Ampr / MLSr  (Herzberg et 
al., 2007) 
 
pBS2E lacA'…'lacA, erm, bla 
Ampr / MLSr  (Radeck et al., 
2013) 
pBS4S thrC'…'thrC, spc, bla 
Ampr / spcr  (Radeck et al., 
2013) 
pSG1151 
gfpmut1, cat, bla, ori-ColE1, ori-f1 
 
Ampr / cmr Template for gfp-amplification (Feucht and 
Lewis, 2001) 
Plasmids 
pCHlux101 pAH328-derivative, sacA::PliaI-lux, 
cat, bla 









Ampr / cmr  (Höfler et al., 
2016) 
pAT3803  
pGP380-derivative, PliaI-gfp, erm, 
bla 
Ampr / MLSr  (Toymentseva 
et al., 2012) 
pJR3801 
pGP380-derivative, PbcrC-gfp, erm, 
bla 
Ampr / MLSr PbcrC: TM3172/ TM3173; BsaI(EcoRI), XbaI. 
gfp: TM1993/ TM1994; XbaI+SalI. 
This study 
pJR3802 
pGP380-derivative, PbceA-gfp, erm, 
bla 
Ampr / MLSr PbceA: TM3170/ TM3171; EcoRI, XbaI. 









Ampr / MLSr PxylA:TM2968/ TM2969; EcoRI+SpeI. 




bceAB, erm , bla 





Ampr / MLSr PxylA:TM2968/ TM2969; EcoRI+SpeI. 
bcrC: TM2731/ TM2732; XbaI+PstI. 
This study 
bAmpr, ampicillin resistance; cmr, chloramphenicol resistance; MLSr, erythromycin-induced resistance to macrolide, lincosamide and 
streptogramin B antibiotics; spcr, spectinomycin resistance. 
b Genomic DNA of B. subtilis W168 was used as template for PCR, except for amplification of gfpmut1 where pSG1151 served as 
template. The vector was opened using the upstream restriction site of the promoter and the downstream restriction site of the gene, 
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Introduction: the cell envelope, its enemies 
and guardians
The envelope is an essential structure of any bacterial cell: 
it separates the cell from its environment and protects its 
content, serves as a molecular sieve, a diffusion barrier, a 
communication interface and counteracts the high internal 
osmotic pressure, thereby keeping the cell intact (Dufresne 
and Paradis-Bleau 2015; Silhavy et al. 2010). Because of 
its essential role, it is not surprising that the cell envelope, 
and in particular its biosynthesis, represents a primary tar-
get for antibiotic action—both for interspecies competition 
within the natural habitat and in clinical therapy. In fact, lit-
erally every step in the biosynthetic pathway leading from 
intracellular sugar and amino acid intermediates to the 
extracellular peptidoglycan is targeted by at least one anti-
biotic (Bugg et al. 2011; Schneider and Sahl 2010).
Cell wall biosynthesis encompasses three stages, rang-
ing from the intracellular assembly of the building block, the 
membrane-anchored cyclic process of shuttling them to the 
outside (the lipid II cycle), and finally their incorporation in 
the growing peptidoglycan network. Of these stages, the lipid 
II cycle has gained particular attention in recent years, result-
ing in the development of a number of promising antimicro-
bial peptides (AMPs), such as lantibiotics or the lipo(depsi)
peptides, daptomycin and friulimicin, that interfere with its 
individual steps (Schneider and Sahl 2010). In addition to 
these ‘new kids on the block’, a number of ‘old goodies’ of 
clinical relevance, such as tunicamycin, moenomycin, vanco-
mycin or bacitracin, also interfere with the lipid II cycle.
Abstract The cell envelope stress response (CESR) 
encompasses all regulatory events that enable a cell to 
protect the integrity of its envelope, an essential structure 
of any bacterial cell. The underlying signaling network is 
particularly well understood in the Gram-positive model 
organism Bacillus subtilis. It consists of a number of two-
component systems (2CS) and extracytoplasmic function 
σ factors that together regulate the production of both spe-
cific resistance determinants and general mechanisms to 
protect the envelope against antimicrobial peptides target-
ing the biogenesis of the cell wall. Here, we summarize the 
current picture of the B. subtilis CESR network, from the 
initial identification of the corresponding signaling devices 
to unraveling their interdependence and the underlying 
regulatory hierarchy within the network. In the course of 
detailed mechanistic studies, a number of novel signal-
ing features could be described for the 2CSs involved in 
mediating CESR. This includes a novel class of so-called 
intramembrane-sensing histidine kinases (IM-HKs), 
which—instead of acting as stress sensors themselves—are 
activated via interprotein signal transfer. Some of these IM-
HKs are involved in sensing the flux of antibiotic resistance 
transporters, a unique mechanism of responding to extra-
cellular antibiotic challenge.
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The lipid II cycle starts on the cytoplasmic side of the 
membrane by hooking the soluble precursor molecule 
N-acetyl-muramic acid-pentapeptide onto the lipid carrier 
molecule undecaprenyl phosphate (UP), generating lipid I. 
Onto this first membrane-associated intermediate, N-acetyl-
glucosamine is added, resulting in the formation of lipid II, 
which is then transferred to the extracytoplasmic side of the 
membrane by the action of flippases. Once on the outside, 
the disaccharide pentapeptide, which represents the bricks 
of the murein sacculus, is then incorporated in the growing 
peptidoglycan network, resulting in the release of undeca-
prenyl pyrophosphate (UPP). In order to be recharged, this 
lipid carrier needs to be dephosphorylated by UPP phos-
phatases and flipped back to the cytoplasmic side of the 
membrane, before the cycle can be re-initiated once again 
(Dufresne and Paradis-Bleau 2015; Silhavy et al. 2010).
To survive threats to their envelope, cells have evolved 
countermeasures to respond to antimicrobial challenge 
and thereby protect the integrity of the envelope. These 
responses are collectively referred to as cell envelope stress 
responses (CESR) (Jordan et al. 2008). So far, they are all 
based on the antibiotic-inducible expression of genes that 
encode protective cellular functions, including specific 
resistance determinants that detoxify or remove the antimi-
crobial compounds from their site of action. To this end, 
cells must be able to perceive the threat on the outside of 
the cell and then subsequently transmit this information 
to the cytoplasm. This event ultimately initiates a cellular 
response, usually in the form of differential gene expres-
sion. In order to be efficient, these signaling events need 
to be triggered way before severe damage can occur to the 
envelope, that is, at sublethal antibiotic concentrations. 
Hence, the sensory systems must be exquisitely sensitive 
and the resulting cellular responses need to be mounted fast 
to provide sufficient and timely protection to the cell.
Bacteria possess three different regulatory principles 
to connect extracellular inputs to cellular responses, and 
all three have been shown to be involved in mediating 
CESR. One-component systems (1CSs), such as the baci-
tracin-responsive regulator BcrR of Enterococcus faecalis 
(Gauntlett et al. 2008; Gebhard et al. 2009), combine an 
extracellular input domain with an intracellular effector 
domain within a single polypeptide chain. The two func-
tional domains are connected by transmembrane helices 
that serve as intramolecular signal transmitters to convert 
the extracellular binding event with a structural change that 
activates the intracellular output domain. Because of the 
obvious molecular restriction of such simplified protein 
architectures, 1CSs are rarely found in bacterial CESRs. 
In fact, BcrR is so far the only known example of a mem-
brane-anchored transcriptional regulator that responds 
to envelope stress. In contrast, two-component systems 
(2CSs) and extracytoplasmic function σ factors (ECFs) are 
widely used in bacterial CESR networks. Both types of 
signaling devices split the input and output domains on two 
separate proteins, one acting as a membrane-anchored sen-
sor (histidine kinase or anti-σ factor, respectively), the other 
as a soluble transcriptional regulator (response regulator or 
σ factor, respectively). Members of both phylogenetically 
unrelated groups are commonly found among the signaling 
devices mediating the cellular response to AMP challenge 
(Jordan et al. 2008).
The CESR network in Bacillus subtilis is particularly 
well studied (Jordan et al. 2008) and will be the focus of 
this review. Our goal is to provide a chronological account 
of its dissection, split into five ‘pictures’ that represent the 
individual milestones that lead to our increasingly detailed 
insight into how this regulatory network behaves, using the 
best-understood B. subtilis CESR network, the response to 
bacitracin challenge, as a paradigm. We will start with sum-
marizing the initial transcriptome-driven identification of 
the signaling systems involved (the ‘static’ picture). Next, 
we will describe the dynamic behavior of the bacitracin 
network (the ‘dynamic’ picture) and then continue with a 
summary of the mechanistic insight we have gained over 
the last 10 years into how the individual signaling devices 
perceive their stimuli and mediate their responses (the 
‘mechanistic’ picture). After introducing this background 
knowledge, we will then highlight the most recent devel-
opments on the anatomy and regulatory interdependence 
within the CESR network (the ‘interdependent’ picture), 
before concluding this mini review with a brief description 
of current challenges followed by an outlook of what ques-
tions still need to be addressed in the future (the ‘increas-
ingly complex’ picture).
The static picture: signaling devices and inducer 
spectra
The development of DNA microarrays allowed for the first 
time to gain a comprehensive picture of the genome-wide 
alterations in transcriptional profiles upon perceiving stress 
conditions. Not surprisingly, numerous transcriptome pro-
filing studies were performed on antibiotic challenge of 
bacteria in the first decade of the twenty-first century, par-
ticularly using the Gram-positive model bacterium B. subti-
lis as the organism of choice [as summarized in Wecke and 
Mascher (2011)]. Such studies not only helped to identify 
compound-specific transcriptional profiles and putative 
resistance determinants encoded by the specifically induced 
genes, they also served as starting points for uncovering the 
underlying signal transduction and gene regulation.
A number of independent DNA microarray experiments 
compared the transcriptional profile of AMP-induced cul-
tures versus uninduced control samples. Together with 




detailed follow-up studies, four 2CSs and (at least) three 
ECFs were identified to be responsible for the observed 
CESR-specific differential gene expression (Fig. 1). Iden-
tification of the 2CSs was based on co-occurrence and 
genomic context conservation of the genes encoding the 
signaling devices next to their stress-inducible target genes. 
In contrast, the role of the ECFs was uncovered by the pres-
ence of specific target promoter motifs upstream of the dif-
ferentially expressed genes (Cao et al. 2002; Mascher et al. 
2003; Pietiäinen et al. 2005; Wecke et al. 2009).
Out of the four CESR-inducible 2CSs, three represent 
paralogous, so-called Bce-like systems, named for the best-
understood example, BceRS-BceAB (Fig. 1, blue). These 
systems are each composed of a 2CS and an ABC trans-
porter, which are functionally closely linked and encoded 
by two neighboring operons. Together, they form AMP-
specific detoxification modules that efficiently remove 
(extracellular) AMPs from their site of action, thereby 
mediating high levels of resistance (Dintner et al. 2011; 
Mascher et al. 2003), as discussed below. Bce-like systems 
are highly conserved and widely distributed in the Fir-
micutes bacteria (Dintner et al. 2011; Joseph et al. 2002). 
Each responds to a small number of closely related AMPs: 
the Bce system responds primarily to bacitracin, the Psd 
system is preferentially induced by a number of lantibiot-
ics, while the response of the Yxd system is triggered by 
the human AMP LL-37 (Pietiäinen et al. 2005; Staron´ et al. 
2011).
The fourth system, LiaRS, shows a much wider inducer 
spectrum. It strongly responds to a number of unrelated 
AMPs (Fig. 1, orange) that mostly interfere with the lipid 
II cycle of cell wall biosynthesis (hence the name: LiaRS 
stands for lipid II-interfering antibiotics regulator and sen-
sor) (Mascher et al. 2004). In addition, a number of rather 
unspecific triggers of the Lia response, such as alkaline 
shock or detergents, interfere with membrane integrity. 
LiaRS, together with its membrane-anchored inhibitor pro-
tein LiaF, is also highly conserved in the low G+C Gram-
positive bacteria (Mascher 2006). While homologous sys-
tems in streptococci and staphylococci are responsible for 
mounting general CESRs [summarized in Schrecke et al. 
(2012)], the Lia system of B. subtilis has evolved to coor-
dinate a phage-shock protein-like response, with the neigh-
boring liaIH operon representing the only relevant target 
of LiaR-dependent gene expression (Mascher et al. 2003, 
2004). For many years after its initial characterization, 
the physiological role of this strictly regulated response 
remained elusive and a clear function of the LiaRS system 
in the CESR of B. subtilis could only be established very 
recently (see later sections).
A unifying feature of all HKs involved in orchestrat-
ing the CESR is their unique protein architecture. Their 
input domains consist of two transmembrane helices that 
are connected by a very short extracytoplasmic loop of 
less than 10–20 amino acids. Because of this minimalistic 
architecture, it was initially assumed that such kinases can 
only perceive envelope stress from within the membrane 
interface. Hence, they were named intramembrane-sensing 
HK (Mascher 2006; Mascher et al. 2003), a concept that 
has meanwhile been modified (Mascher 2014), as will also 
be described below.
In contrast to the clearly defined 2CS-dependent 
responses, the differential gene expression mediated by 
ECFs in response to cell envelope stress is much more 
complex (Fig. 1, green). This is due to the fact that the reg-
ulons controlled by the major ECFs involved in CESR—
σM, σW, and σX—are rather complex (Helmann 2016): σM 
controls the largest regulon of about 60 genes, many of 
which are key for cell envelope homeostasis (Eiamphung-
porn and Helmann 2008). σW controls an ‘antibiosis regu-
lon’ that also consists of about 60 genes, with many of the 
functions related to antibiotic resistance, especially against 
membrane-active agents. Some of the about 30 σX-target 
genes (most of which are also regulated by σV) are cru-
cial for lantibiotic resistance and the homeostasis of the 
cytoplasmic membrane (Helmann 2016; Kingston et al. 
2013). Due to the highly similar promoter motifs of the 
three ECFs, there is a significant degree of regulatory over-
lap between the different regulons at the level of promoter 
Fig. 1  The regulatory network of CESR in B. subtilis. In B. subti-
lis, three ECF σ factors (green) and four two-component systems 
(orange and blue) respond to antibiotics targeting the cell envelope 
and its biosynthesis. X indicates activation of the specific system by 
the indicated compound (Jordan et al. 2008; Wecke et al. 2011). Bac 
bacitracin, CAP cationic antimicrobial peptides, Dap daptomycin, Fos 
fosfomycin, Fri friulimicin, LAN lantibiotics, Moe moenomycin; Ram 
ramoplanin, Rhl rhamnolipids, Van vancomycin. Modified from Jor-
dan et al. (2008)




recognition (Kingston et al. 2013; Mascher et al. 2007). 
Each of the three ECFs are activated by a number of dif-
ferent unrelated cell wall antibiotics and they most likely 
respond to some secondary effect of antibiotic action, 
such as the damage occurring in their presence. To a first 
approximation, the ECFs of B. subtilis orchestrate mostly 
general protective measures and homeostatic adaptations 
to envelope stress, while the 2CS-dependent responses are 
highly dynamic and rather specific, usually consisting of a 
single target operon each (Fig. 1). Taken together, this first 
stage of analyzing the CESR provided a detailed picture of 
the regulatory systems involved in responding to AMPs, the 
range of stressors activating them, and the genes controlled 
by them.
The dynamic picture: diffusion and temporal 
inducer gradients
The initial results described above are based on analyz-
ing the response of B. subtilis to a whole array of different 
AMPs, targeting different steps of the lipid II cycle. This 
allowed gaining a comprehensive picture of the CESR regu-
lation in this organism. In contrast, most of the increasingly 
detailed follow-up studies then focused on the response to 
a single compound, bacitracin. This cyclic non-ribosomally 
produced AMP is synthesized by strains of B. subtilis and 
B. licheniformis (Ming and Epperson 2002). While baci-
tracin is not produced by the laboratory wild-type strain of 
B. subtilis that was used for all studies, this antibiotic nev-
ertheless is expected to play a role in the natural habitat. 
Hence, it is not surprising that B. subtilis evolved a multi-
layered response towards bacitracin, involving all three 
types of signaling systems described above: It strongly trig-
gers the Lia and Bce response and, to weaker extend, also 
the Psd- and the ECF-dependent responses (Fig. 1). The lat-
ter also induces the expression of a second bacitracin resist-
ance determinant, a UPP phosphatase encoded by the bcrC 
gene. In addition, the σB-dependent general stress response 
was also transiently induced, indicative for the severity of 
the stress applied (Mascher et al. 2003).
Some years after the initial description of the bacitracin 
stress response (Mascher et al. 2003), we returned to this 
regulatory network. We realized that the initial microar-
ray studies, while providing a comprehensive picture on 
an organisms’ capacity to respond to a certain antimicro-
bial compound, represented a highly artificial situation. 
Challenging growing cultures of B. subtilis with sublethal, 
but nevertheless high amounts of an antibiotic, represents 
a sudden and rather drastic antibiotic shock that does not 
reflect the natural situation for which the stress response 
networks have evolved for: in the natural environment, the 
soil, antibiotic challenge (e.g., production of the antibiotic 
by neighboring competitors) will most likely occur as an 
increasing antibiotic gradient over time. We, therefore, 
wondered how the well-known bacitracin stress network 
would respond when confronted with gradually increasing 
bacitracin concentrations (Rietkötter et al. 2008).
Indeed, detailed studies demonstrate that the individual 
signal systems within the bacitracin stress response network 
have very different sensitivities and response characteristics 
towards this compound (Fig. 2) (Rietkötter et al. 2008). The 
Bce system is the most sensitive system and also shows the 
highest rate of induction even at very low bacitracin con-
centrations. In contrast, the Lia system and ECF-dependent 
gene expression are only activated at higher concentra-
tions. When faced with a bacitracin gradient increasing 
over time, this ultimately means that the Bce system is the 
first to respond. In many cases, B. subtilis will, therefore, 
only induce a single operon, bceAB, encoding the most effi-
cient bacitracin resistance determinant, the ABC transporter 
BceAB, which removes bacitracin from its site of action. 
Only if this response is not sufficient, and bacitracin stress 
prevails or even increases, will the other systems be induced 
at all, thereby providing additional layers of protection. 
These results, therefore, suggest that the bacitracin network 
has evolved for efficiency, that is, maximizing the benefits 
while simultaneously minimizing the costs.
In addition to unraveling the regulatory dynamics within 
the bacitracin stress response network, this second study 
also provided first insights into the signaling mechanism 
and regulatory specificity of the Bce system and its paral-
ogs (Rietkötter et al. 2008). It demonstrated that the ABC 
transporter BceAB—in addition to providing high-level 
resistance against bacitracin—is also mandatorily required 
for sensing this compound, as discussed in the next section. 
Moreover, we observed a regulatory crosstalk between the 
paralogous Bce and Psd systems at the level of the histidine 
kinase/response regulator interface: upon bacitracin treat-
ment, the histidine kinase BceS is able to phosphorylate 
the non-cognate response regulator PsdR (Rietkötter et al. 
2008). This observation represents one of the rare cases 
in which such a regulatory crosstalk has been observed in 
wild-type cells, that is, when both 2CSs involved still are 
intact. This result is indicative for the close phylogenetic 
relationship between the two systems, most likely as a 
result of a gene duplication event not too far away in the 
evolutionary history of B. subtilis.
The mechanistic picture: intramembrane-sensing 
histidine kinases, interprotein signal transfer 
and flux-sensing
Given that the inducer spectra of three CESR stress 
response modules (BceAB, LiaIH and BcrC) are very 




diverse, and that even for the same inducer (e.g., bacitracin) 
the expression of these modules occurs at different induc-
tion thresholds, a salient question arises: what are the actual 
cues that trigger the induction of these systems? Do they all 
respond directly to the compound, or rather to downstream 
effects on cell physiology? First steps towards answering 
these questions were derived from genetic observations, 
noting that the 2CSs regulating the expression of the CESR 
modules feature unusual histidine kinases (HKs) (Fig. 3). 
As mentioned above, these HKs are characterized by an 
N-terminal input domain consisting of two transmembrane 
helices with a short extracellular linker of less than 10–20 
amino acids (Mascher 2006), which is insufficient for 
stimulus perception per se. This originally led to the idea 
that these kinases sense their stimuli at or within the mem-
brane interface, coining the term ‘intramembrane-sensing 
histidine kinase’ (IM-HK) (Mascher et al. 2003). However, 
it later became clear that IM-HKs are genetically and func-
tionally linked to accessory membrane proteins (Mascher 
2006; Mascher et al. 2006), which are essential for stimulus 
perception (Jeong et al. 2012; Jordan et al. 2006; Luttmann 
et al. 2012; Rietkötter et al. 2008). As detailed below for 
the Bce and the Lia system, these accessory membrane pro-
teins typically act as sensors, whereas the role of the IM-
HKs is reduced to their ability to transfer the signal to the 
downstream response regulator (Mascher 2014). Hence, 
understanding the function of these accessory membrane 
proteins and their interaction with their cognate IM-HK is 
key for understanding the nature of the stimulus perceived 
by these signaling devices.
The BceRS-BceAB complex acts as an antibiotic flux 
sensor
The expression of the ABC transporter BceAB is regulated 
by the histidine kinase BceS and the response regulator 
BceR, which are encoded in an operon upstream of bceAB 
(Mascher et al. 2003). Strikingly, deletion of the BceB per-
mease completely abolished the ability of the BceRS 2CS 
to respond to bacitracin (Rietkötter et al. 2008), suggesting 
that the transporter itself might be involved in signaling. 
Moreover, a single point mutation in the Walker B motif of 
the ATPase BceA (exhibiting a highly reduced rate of ATP 
hydrolysis) also abolished signaling via BceRS, showing 
that ATP hydrolysis, and thus active transport of bacitracin, 
is required for stimulus perception (Rietkötter et al. 2008). 
Bacterial two-hybrid analyses together with in vitro pull-
down assays further showed that the permease BceB forms 
a complex with the histidine kinase BceS (Dintner et al. 
2014) (Fig. 3a), and amino acid residues crucial for this 
contact have been identified in the permease BceB (Kallen-
berg et al. 2013).
This lead to three plausible roles explaining the essenti-
ality of the BceAB transporter in the regulatory pathway: in 
the simplest scenario, the transporter acts as a mere ligand-
binding component in a sensory complex with the HK, 
allowing the cell to detect the ambient concentration of 
bacitracin (Bernard et al. 2007). Alternatively, it was pro-
posed that the transporter may act as an importer of bacitra-
cin, releasing it into the cytoplasm for degradation, where 
it might then be sensed by the HK (Hiron et al. 2011; Riet-
kötter et al. 2008). The third conceivable scenario was that 
the HK activity is determined by the transport activity of 
individual transporters (Rietkötter et al. 2008). Strikingly, 
using a systems approach combining quantitative gene 









































Fig. 2  Dose-dependent activation of resistance modules in an unper-
turbed CESR network. Target promoter activities of a PbceA, b PliaI 
and c PbcrC in B. subtilis, expressed as the specific luciferase activ-
ity (RLU/OD600) 1 h after addition of indicated amounts of bacitra-
cin. Measurements were performed during exponential growth phase 
in LB medium at 37 °C in a microtiter plate reader. Data points and 
error bars indicate means and standard deviations derived from at 
least three biological replicates. Data are based on Radeck et al. 
(2016)




recently show that only the last scenario is compatible with 
all available data, suggesting that the sensory complex of 
BceB-BceS acts as a ‘flux-sensor’ that measures the load 
of individual transporters (Fritz et al. 2015). This sensory 
strategy then allows the cell to detect its current capac-
ity to deal with the antibiotic challenge and thus precisely 
respond to the need for more transporters. Based on the fact 
that to date over 200 Bce-like systems are found in protein 
databases, and given that their HKs and ABC transporters 
have coevolved (Dintner et al. 2011), it seems likely that 
flux sensing is a widespread regulatory principle to control 
AMP resistance modules in Firmicutes bacteria.
The LiaRS-LiaF three-component system responds 
to inhibition of the lipid II cycle
The LiaRS 2CS regulates expression of the hexacistronic 
liaIH-liaGFSR operon (Jordan et al. 2006). In the absence 
of envelope stress, a weak constitutive promoter upstream 
of liaG ensures a basal expression level of liaGFSR, 
whereas inducing conditions lead to an upregulation of a 
major 1.1-kb transcript containing liaIH and a 4-kb tran-
script encompassing the entire locus. While the function 
of the small membrane protein LiaG is still elusive, the 
deletion of liaF resulted in a ‘locked-ON’ phenotype that 
displayed strong constitutive liaIH-liaGFSR expression 
even in the absence of envelope stress (Jordan et al. 2006), 
suggesting that LiaF acts as an inhibitor of LiaS in the 
absence of envelope stress (Fig. 3b). In line with these find-
ings, increased production of LiaS was sufficient to over-
come the inhibitory effect by LiaF, showing that the excess 
stoichiometry between LiaF and LiaS (~5:1) is impor-
tant to keep LiaS in an inactive (‘phosphatase ON’) state 
(Schrecke et al. 2013). LiaF is a membrane protein that 
contains four membrane-spanning regions in its N-terminus 
and features a domain of unknown function (DUF2154) 
in its C-terminus, which displays structural homology to a 
putative cell adhesion protein and is predicted to reside in 
the cytoplasm. Spontaneous in-frame deletions in the C-ter-
minus of LiaF revealed a locked-ON phenotype similar to 
the liaF deletion strain, suggesting that the C-terminus is 
functionally important for stimulus perception and/or sign-
aling to LiaS (Jordan et al. 2006).
Although the precise stimulus for the LiaFSR system 
remains elusive to date, later work suggested that it is 
unable to sense AMPs directly (Wolf et al. 2012). Specifi-
cally, the response of the PliaI promoter towards its inducers 
bacitracin, mersacidin, vancomycin, nisin and daptomycin 
was completely absent in inducible L-forms of B. subti-
lis, which were depleted of cell wall precursors by repres-
sion of the murE operon (Wolf et al. 2012). This strongly 

















































Fig. 3  Mechanism of signal transduction of the Bce and Lia systems 
and the ECF σ factor σM. a In the absence of bacitracin, the ABC 
Transporter BceAB and the associated IM-HK BceS remain inactive. 
After the addition of bacitracin and formation of the UPP-Bac com-
plex, BceB recognizes UPP-Bac and removes bacitracin from its tar-
get employing a so far unknown transport mechanism dependent on 
ATP hydrolysis by BceA. This transport activity is transmitted via a 
yet unknown mechanism and acts as the stimulus for BceS activation. 
The HK in turn activates the cognate response regulator BceR via 
phosphotransfer which then upregulates transcription of bceAB (Fritz 
et al. 2015; Ohki et al. 2003). b In the absence of a stimulus, LiaF 
acts as an inhibitor of the IM-HK LiaS. Cell envelope damage trig-
gers the activation of LiaS and hence phosphorylation of the cognate 
response regulator LiaR. LiaR dimerizes and activates transcription of 
liaIH (Jordan et al. 2006; Schrecke et al. 2013). c In the absence of 
stress, the anti-σ factor YhdKL sequesters σM to the membrane. Upon 
stimulus perception—triggered by cell envelope perturbations—
YhdKL release σM into the cytoplasm where it recruits the RNA poly-
merase to its target promoters, including PbcrC (Helmann 2016; Hors-
burgh and Moir 1999)




of a functional cell wall biosynthetic machinery, poten-
tially requiring lipid I and/or lipid II, to sense the down-
stream effects of the five antibiotics mentioned before. This 
prompted the notion that the LiaFSR system might act as 
an indirect, damage-sensing signal-transducing system, 
in line with its role as a secondary resistance determinant 
that is only activated if the primary resistance determi-
nant BceAB provides incomplete protection (Radeck et al. 
2016), as discussed below.
Regulation of cell wall homeostasis by the σM regulon
The third main player in the bacitracin stress response 
network is the UPP phosphatase BcrC, the correspond-
ing bcrC gene being under control of σM regulation (Cao 
and Helmann 2002). The gene encoding σM is co-tran-
scribed in an operon with the genes of the anti-σ factors 
YhdL and YhdK, which tightly control the activity of σM 
in response to cell envelope stress (Fig. 3c) (Horsburgh 
and Moir 1999). The small membrane protein YhdK fea-
tures three transmembrane helices and was shown to inter-
act with YhdL to negatively regulate σM in the absence of 
membrane stress (Yoshimura et al. 2004). Although the 
precise molecular mechanisms remain to be identified, it 
was demonstrated that the cytoplasmic N-terminus of YhdL 
is involved in σM binding, while the single transmembrane 
helix of YhdL is required for interaction with YhdK and 
the extracytoplasmic C-terminus might function as sensory 
domain (Fig. 3c) (Yoshimura et al. 2004). Like the LiaFSR 
system described above, σM is activated by a range of dif-
ferent cell envelope-perturbing conditions, but the precise 
molecular cues detected by YhdLK/σM are still a matter of 
debate, as discussed recently (Helmann 2016).
The interdependent picture: a network at last
More than a decade of studying the bacitracin-triggered 
CESR of B. subtilis has provided us with a detailed knowl-
edge on the composition of the systems mediating the 
underlying gene regulation. As outlined in the previous 
sections, the dynamic behavior of the systems, as well as 
their mechanism of signal transduction, has been uncov-
ered. But what was still missing was a proof that these 
signaling systems indeed form a regulatory network, that 
is, interact with and influence each other’s behavior such 
that the overall response can only be described and under-
stood in light of all of its constituents. Most recently, the 
first insights into this interdependence have been provided 
(Radeck et al. 2016). This work demonstrates a clear hier-
archy, co-dependence and active redundancy of signaling 
systems involved in mediating the bacitracin CESR, as will 
be summarized below (Fig. 4).
BceAB is the primary bacitracin resistance module 
that masks the contribution of the other CESR modules
So far, a role in mediating bacitracin resistance had only 
been established for BceAB and BcrC, but not for LiaIH 
(Cao and Helmann 2002; Ohki et al. 2003; Wolf et al. 
2010). This led to the question, if a potential role of 
LiaIH is masked by the efficiency of BceAB in remov-
ing bacitracin. To address the question of whether such 
masking effects exist within the bacitracin resistance net-
work, mutants deleted of all possible combinations of the 
three resistance modules were tested for their susceptibil-
ity towards bacitracin. These experiments confirmed that 
BceAB indeed acts as the primary resistance determinant, 
while the (full) potential of the secondary resistance deter-
minants LiaIH and BcrC was only revealed in a bceAB 
deletion mutant: in this genetic background, the presence 
of LiaIH increased the minimal inhibitory bacitracin con-
centration (MIC) by 6-fold, while BcrC mediated a 24-fold 
increased resistance. These data indicate that in wild-type 
cells, these two damage-induced systems act as “fallback”-
mechanisms in a redundant manner to BceAB (Radeck 
et al. 2016). Strikingly, this redundancy is also reflected 
in the interconnections of the three systems on the regula-
tory level: in a bceAB deletion mutant, the PbcrC and PliaI 
promoters were strongly induced already at low bacitracin 
concentrations, whereas overproduction of BceAB shifted 
the responses of PbcrC and PliaI to much higher bacitracin 
levels (Radeck et al. 2016). This further supported the 
notion that the activities of the secondary, damage-sensing 
layer of the CESR are directly slaved to the exhaustion of 
the primary layer of bacitracin resistance.
BcrC and LiaIH provide a secondary and redundant 
layer of bacitracin resistance that influences the overall 
behavior of the network
As highlighted above, the contribution of BcrC and espe-
cially LiaIH to bacitracin resistance is only modest and 
partially—or in the case of LiaIH completely—masked by 
the action of the primary resistance layer BceAB. Never-
theless, these two determinants are functionally important, 
since they can partially compensate for the loss or exhaus-
tion of BceAB activity. While the influence of BceAB lev-
els on LiaRS- and σM-dependent gene regulation described 
above was not surprising, controlled modulations of BcrC 
and LiaIH levels revealed additional layers of complexity 
within the bacitracin stress response network.
In case of BcrC, the basal activity of both PbceA and 
PliaI was increased by an order of magnitude in a bcrC 
mutant, even in the absence of bacitracin. Overproduc-
tion of BcrC, on the other hand, only slightly reduced the 
response of both promoters, but only in the presence of 




low concentrations of bacitracin (Radeck et al. 2016). This 
effect of BcrC levels is remarkable and highlights a tight 
integration of bacitracin stress response regulation with the 
native homeostasis of cell wall biosynthesis. Moreover, it 
indicates that a limitation in UPP-phosphatase levels can 
be perceived by both damage- (LiaRS) and drug-sensing 
(BceRS) CESR systems. Both aspects will be discussed in 
the last section of this review.
In contrast to BcrC and BceAB, LiaIH does not play a 
role in mediating bacitracin resistance in B. subtilis wild-
type cells. Accordingly, varying the amounts of LiaIH does 
not influence PbceA activity (Radeck et al. 2016). In contrast, 
elevated levels of LiaIH led to a tenfold increased basal 
activity of PliaI, even in the absence of bacitracin, indicat-
ing that overproduction of these proteins already results 
in generating envelope stress that can be perceived by the 
Lia system (Radeck et al. 2016). Interestingly, the native 
control of LiaIH production seems to be required for full 
PliaI activation at medium to high bacitracin concentrations. 
This observation indicates a potential auto-regulatory func-
tion of LiaIH output on LiaFSR sensing that has not been 
detected previously (Schrecke et al. 2013). The mechanism 
behind this phenomenon remains to be elucidated.
Interdependence of the bacitracin resistance 
determinants
Taken together, we propose the following model for the 
response to bacitracin (Fig. 4). In an unchallenged wild-
type cell, BceAB and LiaIH are present at very low lev-
els, whereas BcrC is highly expressed due to its crucial 
part in lipid II cycle progression. Upon addition of low 
amounts of bacitracin, it binds to a fraction of UPP, form-
ing inactive UPP-Bac (Economou et al. 2013; Storm and 
Strominger 1974), which cannot be dephosphorylated by 
BcrC. Under such conditions, there is still enough unbound 
UPP available for normal carrier recycling to continue 
cell wall synthesis. Moreover, already at this early stage, 
BceAB detects UPP-Bac and removes bacitracin from its 
target, thereby stimulating its own expression via a flux-
sensing mechanism (Fritz et al. 2015) and detoxifying the 
cell envelope before damage can occur. If the bacitracin 
level is increased further, despite upregulation of BceAB, 
cell wall synthesis is being affected and first damage to the 
cell envelope occurs. This induces the Lia system (Wolf 
et al. 2012), which is part of the secondary layer of resist-
ance that protects the cell envelope by a mechanism yet to 
be identified (Radeck et al. 2016). Finally, at even higher 
bacitracin concentrations, perturbations of the lipid II cycle 
lead to activation of σM, which in turn upregulates the 
expression of cell envelope protecting proteins, amongst 
them BcrC (Cao and Helmann 2002; Helmann 2016). This 
UPP phosphatase reduces the pool levels of UPP, thereby 
diminishing the number of cellular targets for bacitracin 
binding (Cao and Helmann 2002; Radeck et al. 2016). The 
overall efficiency of this intricately regulated, triple-layered 
resistance network is underscored by the fact that wild-type 
cells are about 5000-fold more resistant towards bacitracin 
than a triple mutant devoid of all three resistance modules 
(Radeck et al. 2016).
The increasingly complex picture: stressed 
inside out and further on
As outlined by the sections above, over 15 years of 
research have painted an increasingly detailed picture of 
the bacitracin stress response network, but at the same time 
showed that we still seem to miss many pieces of the puz-
zle. Some of the most interesting questions that remain to 
be addressed are a direct result of the most recent study on 
the anatomy and interdependence of the bacitracin stress 
response network (Radeck et al. 2016). Others go back to 
earlier studies, as will be described below.
Intrinsic cell wall homeostasis versus extrinsic AMP 
challenge
Probably the most remarkable observation from the recent 
study is the significantly increased basal expression from 
PbceA and PliaI in a strain lacking BcrC. This UPP phos-
phatase was initially described as a non-essential stress-
inducible protein (Cao and Helmann 2002; Petersohn et al. 
2001). But the elevated levels of bceA/liaI promoter activ-
ity indicate that the absence of BcrC generates a bottleneck 
in cell wall biosynthesis that is perceived as cell envelope 
stress. BcrC, therefore, plays a crucial role in the normal 
cycling of cell envelope building blocks, in addition to 
its inducible expression in the presence of bacitracin and 
other inhibitors of the lipid II cycle. This demonstrates 
that the rate of lipid II cycling is an important parameter 
in perceiving envelope stress—at least in the case of AMPs 
interfering with these membrane-anchored processes. A 
deeper understanding of the physiology behind the CESR, 
therefore, requires going beyond a ‘simple’ analysis of the 
behavior of the underlying regulatory network. Instead, an 
integrative approach will be necessary that combines the 
analysis of lipid II cycle homeostasis with its inhibition by 
AMPs, using the CESR-inducible reporters as indicators of 
the overall cellular stress perceived.
Drug sensing versus target sensing
The results described in the previous section raise another 
issue that adds to the complexity of the CESR. As 
described in the mechanistic picture section, BceRS-like 




2CS sense their stimuli indirectly through their associated 
BceAB-like ABC transporters via a flux-sensing mecha-
nism (Fritz et al. 2015). This mechanism not only allows 
the cell to accurately adjust the amount of BceAB trans-
porters to the current need. It also represents a direct con-
nection of the input (binding and hence sensing AMPs) 
with the output (removal of AMPs from their site of action) 
based on the transport mechanism itself. But what is the 
true nature of the substrate bound by the BceB permease? 
Initial evidence from cell wall-less L-forms of B. subti-
lis showed that the Bce system is triggered in the absence 
of cell wall biosynthesis (Wolf et al. 2012), arguing for a 
‘drug-sensing’ mechanism of stimulus perception. This 
view was supported by in vitro results indicating that BceB 
is able to bind bacitracin directly (Dintner et al. 2014). 
In vivo results, on the other hand, argued for BceB bind-
ing UPP and even suggested that this transporter might 
play a role as a UPP flippase of the cycle (Kingston et al. 
2014). The most recent observation that a tightened bottle-
neck in the lipid II cycle, provoked by the absence of the 
UPP phosphatase BcrC, increases PbceA activity (Radeck 
et al. 2016) indeed points towards UPP as a possible bind-
ing partner for BceB. If taken together, the combined evi-
dence can be interpreted such that BceB—while being able 
to bind to either bacitracin or UPP directly, but presumably 
with low affinity—most likely uses UPP-bound bacitracin 
as its natural high-affinity substrate. This would indeed be 
the physiologically most meaningful stimulus, since it pro-
vides a direct measure for the potentially ‘harmful’ fraction 
of bacitracin around a given cell. But further analysis will 
be necessary to prove this hypothesis.
Extrinsic AMP challenge versus intrinsic AMP 
production
As a soil organism, B. subtilis has to compete for the lim-
ited resources of this habitat. One aspect of this competition 
is the production of antibiotics that suppress the growth of 
other microbes trying to inhabit the same niche. Indeed, the 
genome of B. subtilis encodes a number of gene clusters 
that are predicted to be involved in the biosynthesis of anti-
microbial compounds, including AMPs. These AMPs are 
controlled by the master regulator of sporulation, Spo0A, 
and are produced as part of the complex differentiation 
cycle that ultimately results in the production of highly 
resistant endospores. To delay the commitment to sporulate, 
B. subtilis produces two cannibalism toxins, the sporulation 














Fig. 4  Proposed architecture of the bacitracin resistance network in 
B. subtilis. Bacitracin tightly binds to UPP, resulting in an inactive 
UPP-Bac complex that prevents UPP recycling in the lipid II cycle. 
As a result, the pool of lipid carrier available for cell wall synthesis 
is drastically reduced, resulting in a cessation of cell wall biosynthe-
sis. The presence of UPP-Bac is recognized by the ABC transporter 
BceAB, which in turn triggers upregulation of bceAB expression via 
the 2CS BceRS. BceAB efficiently removes bacitracin from UPP, 
which then allows BcrC to dephosphorylate UPP. Depletion of lipid 
II-cycle intermediates, such as UP or lipid II itself, might act as 
stimuli to induce bcrC expression (Inoue et al. 2013; Lee and Hel-
mann 2013; Meeske et al. 2015), but the precise mechanisms remain 
to be identified. BcrC itself contributes to bacitracin resistance by 
competing for the mutual target UPP. The damage caused by baci-
tracin action is also perceived by the LiaFSR three-component sys-
tem, resulting in a strong upregulation of liaIH expression. LiaIH, in 
turn, is needed to fully activate the Lia response by a so far unknown 
mechanism. Bac bacitracin, UP undecaprenyl phosphate, UPP unde-
caprenyl pyrophosphate




Both AMPs are secreted to the environment to kill sibling 
cells that have not yet activated Spo0A and hence neither 
produces the cannibalism toxins nor the corresponding 
auto-immunity proteins. In a multicellular context of a bio-
film, for instance, this SDP/SKF-sensitive subpopulation is 
thus sacrificed. Their death releases nutrients that allow the 
cannibal subpopulation to overcome temporary phases of 
starvation without the need to sporulate (Gonzalez-Pastor 
2011). In a recent report, it was demonstrated that the Bce 
and Psd system strongly respond to both cannibalism tox-
ins (Höfler et al. 2016). In liquid cultures, SKF seems to be 
the predominant stimulus, but SDP also contributes to the 
overall response (Höfler et al. 2016). Likewise, the Lia sys-
tem seems to be induced by yet another poorly character-
ized AMP encoded by the yydF gene (Butcher et al. 2007). 
The physiological relevance of the induction of multiple 
CESR modules by intrinsically produced AMPs remains to 
be identified, since no resistance phenotype could be dem-
onstrated in any of these cases.
The link of intrinsically produced AMPs to differen-
tiation might open another door into trying to understand 
the physiological relevance of the corresponding CESR: 
while sporulation and cannibalism are phenomena that can 
be observed in individual cells grown in liquid cultures, 
they nevertheless only start making sense in the context 
of multicellular communities. B. subtilis has emerged as a 
paradigm not only for understanding a complex regulatory 
cascade orchestrating a differentiation program, but also 
to studying this cascade in the context of bacteria as mul-
ticellular organisms (Kovács 2016). This aspect has been 
largely overlooked for the longest time, since the reference 
strains are highly domesticated after propagation in the 
defined laboratory environment over decades. This resulted 
in a loss of the more social phenotypes and complex behav-
ioral (that is, multicellular) traits associated with differen-
tiation and sporulation (Pollak et al. 2015). It is overdue, 
to return to the undomesticated ancestor strains for study-
ing intrinsic AMP production and the corresponding stress 
responses in the light of such social, multicellular aspects 
of differentiation.
Interdependence between σW and Lia response
The recently published study on the interdependence 
within the bacitracin stress response network is not the 
first report demonstrating that individual CESR sys-
tems affect each other’s activity. Indeed, it might be 
worthwhile to return to rather old observations that 
demonstrated a regulatory interference between the 
Lia response and σW-dependent gene expression. Chal-
lenging B. subtilis with alkaline shock (a sudden upshift 
of the external pH to about 9) strongly induces the σW 
response and also slightly triggers LiaR-dependent gene 
expression. Remarkably, this pH-dependent upregula-
tion of liaIH expression completely disappears if sigW 
is deleted (Wiegert et al. 2001). A comparable observa-
tion has been made in a second study on the response 
of B. subtilis towards the AMP LL-37, which belongs 
to the cathelicidin family of amphipathic and α-helical 
peptides of the human immune defense. Again, a strong 
induction of the σW response and a moderate activation of 
LiaR-dependent gene expression are reported, while the 
Lia response is lost under the same experimental condi-
tions if sigW is deleted (Pietiäinen et al. 2005). At first 
glance, both results are counter-intuitive, since loss of 
one stress-responsive system should increase the cellular 
stress observed by another damage-responsive system. 
But the fact that a strong induction of σW combines with a 
rather moderate activation of the Lia response might indi-
cate that the Lia system in fact does not directly respond 
to the stressor applied in the above experiments (alkaline 
shock and LL-37, respectively), but instead indirectly 
responds to the sudden upregulation of some of the σW-
controlled genes. The protein function encoded by these 
genes would then generate the stress that induces the Lia 
response. Given the size of the σW regulon, such a search 
may not be straightforward, but it might be a worthwhile 
endeavor in trying to identify the still elusive true stimu-
lus sensed by the Lia system.
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ABSTRACT 
The bacterial cell wall separates the cell from its surrounding and protects it from 
environmental stressors. Its integrity is maintained by a highly regulated process of 
cell wall biosynthesis. The membrane-located lipid II cycle provides cell wall building 
blocks that are assembled inside the cytoplasm to the outside for incorporation. Its 
carrier molecule, undecaprenyl-phosphate (UP), is then recycled by 
dephosphorylation from undecaprenyl-pyrophosphate (UPP). In Bacillus subtilis, this 
indispensable reaction is catalyzed by the UPP-phosphatases BcrC and UppP. Here, 
we study the physiological function of both phosphatases with respect to 
morphology, cell wall homeostasis and the resulting cell envelope stress response 
(CESR). We demonstrate that uppP and bcrC represent a synthetic lethal gene pair, 
which encodes an essential physiological function. Accordingly, cell growth and 
morphology were severely impaired during exponential growth if the overall UPP-
phosphatase level was limiting. UppP, but not BcrC, was crucial for normal 
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sporulation. Expression of bcrC, but not uppP, was upregulated in the presence of cell 
envelope stress conditions caused by bacitracin if UPP-phosphatase levels were 
limited. This homeostatic feedback renders BcrC more important during growth than 
UppP, particularly in defense against cell envelope stress.  
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INTRODUCTION 
The bacterial cell wall is an essential structure that gives the cell its shape and 
counteracts the turgor pressure. The sacculus is one large macromolecule made up 
of peptidoglycan that has amazing properties: It is rigid, yet flexible and is constantly 
expanded and recycled during growth and cell division in a highly regulated manner, 
both spatially and temporally (Laddomada et al., 2016). Due to its essentiality, it is a 
prime antibiotic target at virtually any of the numerous steps leading to cell wall 
assembly.  
 
Figure 1. Simplified scheme of the 
Lipid II-cycle. UPP is dephosphorylated 
to UP by the UPP-phosphatases BcrC, 
UppP and YodM. The peptide antibiotic 
bacitracin specifically binds to UPP, 
thereby inhibiting its 
dephosphorylation. The carrier UP is 
loaded with a cell wall precursor, 
resulting in lipid II. After incorporation 
of the cell wall precursor into the 
existing cell wall, UPP is released and 
recycled by the UPP phosphatases. De 
novo synthesis of UPP occurs from 
isoprenoids via the enzyme UppS. 
Undecaprenol can also serve as an 
unphosphorylated carrier, which is 
phosphorylated by the kinase DgkA to 
UP.  
Bac, Bacitracin; Und, Undecaprenol; 
UP, Undecaprenyl-phosphate; UPP, 
Undecaprenyl-pyrophosphate.  
The lipid II cycle describes the membrane-associated steps of this process (Fig. 1). 
Briefly, N-acetylmuramic acid (MurNAc)-pentapeptide building blocks are assembled 
in the cytosol and linked to the lipid carrier, a C55-phosphate called bactoprenol or 
undecaprenyl-phosphate (UP), thereby forming lipid I. An N-acetylglucosamine 
(GlcNAc) molecule is added, resulting in lipid II. This cell wall building block is 
subsequently shuttled across the membrane by the flippases Amj and MurJ (Meeske 
et al., 2015; Laddomada et al., 2016). On the outside, the GlcNac-MurNAc-
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pentapeptide building block is incorporated into the existing cell wall by 
transgylcosylation and transpeptidation reactions, thereby releasing the lipid carrier 
in its pyrophosphate form (undecaprenyl-pyrophosphate, UPP). For its recycling, UPP 
is then dephosphorylated to UP by specialized UPP-phosphatases (Bernard et al., 
2005; Manat et al., 2014) and flipped back to the cytosolic leaflet of the membrane, 
where it can be reloaded to enter the Lipid II cycle again.  
Apart from this recycling, the cellular UP pool can also be replenished by de novo 
synthesis of UPP via the UPP synthetase UppS (Guo et al., 2005). The subsequent 
dephosphorylation to UP is likely performed by the same UPP-phosphatases that are 
required for recycling UPP (Manat et al., 2014). In Gram-positive bacteria, UP can also 
originate from phosphorylating undecaprenol, e.g. by the kinase DgkA in B. subtilis 
(Higashi et al., 1970; Jerga et al., 2007).  
UP is the carrier for both peptidoglycan and wall teichoic acids (WTA) building blocks 
and its availability represents the central bottleneck for the synthesis of lipid II both 
in vitro and in vivo (Breukink et al., 2003; Breukink and de Kruijff, 2006; Egan et al., 
2015). Only ~ 2*105 UP molecules (0.5-1 % of all phospholipids) are present per cell 
(Kramer et al., 2004) and it has been estimated that each of the carriers shuttles one 
to three cell wall building blocks per seconds during exponential growth (McCloskey 
and Troy, 1980). The amount of WTA and peptidoglycan synthesis is reduced under 
UP-limitation, especially if conditions favor the competing pathway (Anderson et al., 
1972). Antibiotics that target the lipid II cycle benefit from this bottleneck, because 
blocking any step will lead to accumulation of intermediates, shortage of free carrier 
molecules and impaired cell wall biosynthesis that depends on UP.  
Because of the essentiality of the cell envelope, any threats are potentially lethal to 
bacteria. Consequently, bacteria have evolved appropriate countermeasures to 
detect and remove threats or damages. These responses are collectively termed cell 
envelope stress response (CESR) (Jordan et al., 2008). Bacillus subtilis is one of the 
main model organisms for studying the Gram-positive cell wall and member of the 
Firmicutes phylum (low G+C Gram-positives). In this organism, the CESR is 
orchestrated by two-component systems and extracytoplasmic sigma factors (ECFs) 
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(Radeck et al., 2016a). While many antibiotics can trigger the CESR, the molecular 
nature behind these stimuli has only been identified for very few cases. The antibiotic 
itself seems rarely to be detected directly. Instead, downstream effects of antibiotic 
threat, such as envelope damage or – more importantly – the accumulation of certain 
intermediates, are suspected to be the actual triggers of CESR (Meeske et al., 2015; 
Helmann, 2016). A similar effect to such an antibiotic-mediated blockade can also be 
achieved by reducing the availability of the corresponding enzyme. Consequently, the 
lipid II cycle, cell wall homeostasis and cell envelope stress (CES) are interconnected 
processes that can hardly be studied independently. In fact, a B. subtilis mutant with 
reduced UppS acitivity (and therefore reduced de novo synthesis of UPP) had altered 
antibiotic resistance properties and elevated σM-acitvity (Lee and Helmann, 2013). 
Here, we will focus on the CESR caused by limitations of the crucial UPP-phosphatase 
activity, provided e.g. by BcrC. 
The expression of bcrC is controlled by multiple stress-inducible alternative sigma 
factors, including σM, σI, σX, σV, and potentially also σW (Cao and Helmann, 2002; 
Tseng and Shaw, 2008; Guariglia-Oropeza and Helmann, 2011; Zweers et al., 2012). 
σM controls approx. 60 genes involved in cell wall synthesis, shape determination, 
detoxification and DNA damage response (Eiamphungporn and Helmann, 2008). It is 
activated by multiple triggers, including antibiotics, high salt, heat stress and acidic 
pH (Thackray and Moir, 2003). While all of these inducers affect cell envelope 
synthesis or integrity, the molecular cue for the activation of this and other ECFs is 
yet to be identified (as reviewed in Helmann, 2016).  
Induction of PbcrC can be triggered e.g. by the addition of the antibiotic bacitracin (Cao 
and Helmann, 2002; Radeck et al., 2016b). Bacitracin is a cyclic antimicrobial peptide 
produced by some strains of Bacillus licheniformis and B. subtilis (Azevedo et al., 
1993; Ishihara et al., 2002). It was shown that bacitracin tightly binds UPP, thereby 
blocking the dephosphorylation reaction mediated by UPP-phosphatases and 
consequently slowing down the lipid II cycle (Siewert and Strominger, 1967; Storm 
and Strominger, 1973; Economou et al., 2013). The deletion of bcrC may have similar 
consequences, since the loss of one UPP-phosphatase might reduce the rate of UPP 
dephosphorylation to UP. 
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A very sensitive indicator of CES is the LiaR-controlled liaI promoter (PliaI) (Mascher et 
al., 2004). The cognate three-component system, LiaFSR reacts to a broad range of 
cell envelope stressors, including alkaline shock, oxidative stress, or bacitracin 
addition (Jordan et al., 2006; Wolf et al., 2010). In turn, it regulates a phage-shock 
protein-like response that provides a secondary layer of protection against CES 
(Radeck et al., 2016b). The low basal activity and strong, highly dynamic induction of 
PliaI made this promoter an ideal candidate for the development of a highly sensitive 
CESR-inducible whole cell biosensor (Mascher et al., 2004; Wolf and Mascher, 2016; 
Kobras et al., 2017). Recently, we demonstrated that PliaI activity in response to 
bacitracin is elevated in a bcrC deletion mutant and decreased in a bcrC 
overexpression strain. These findings indicate that the CES caused by bacitracin is 
relieved in the presence of the UPP-phosphatase BcrC (Radeck et al., 2016b).  
In the same study, we observed that PbcrC activities were increased in a bcrC null 
mutant. Together, this lead to the hypothesis that changes in UP and UPP levels can 
be sufficient to create CES (Radeck et al., 2016b). Due to their crucial role in the lipid 
II cycle, we hypothesize that impaired UPP-phosphatase activity leads to a limitation 
in cell wall synthesis, which in turn should increase the CESR.  
Here, we aimed at challenging this hypothesis by studying the effects of enzymes 
potentially involved in UP turnover on B. subtilis physiology and stress responses in 
detail. Towards that end, we analyzed strains depleted for (combinations of) both the 
UPP-phosphatases BcrC/UppP and the undecaprenol kinase DgkA on cell physiology 
and morphology. First, we demonstrate the synthetic lethality of BcrC and UppP and 
a severe morphological defect in UPP-phosphatase depleted strains. Next, UppP is 
shown to be indispensable for efficient sporulation. Unexpectedly, uppP or bcrC 
deletion and complementation mutants did not activate a classical CESR, as judged 
by the lack of PliaI induction. Instead, the resulting limitation in UPP-phosphatase 
levels is perceived by the broader ECF-dependent signaling network. As a result, PbcrC 
activity was increased in those mutants, thereby providing a homeostatic feedback 
mechanism by which the cell can autoregulate its UPP-phosphatase level according 
to needs. Furthermore, we provide the first evidence that DgkA is indeed involved in 
UPP homeostasis: While a lack of this predicted undecaprenol kinase did not result in 
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an observable deficiency, a (most likely minor) role in UP turnover is indicated by an 
increased activity of PbcrC in a dgkA mutant in stationary phase. Taken together, our 
data provides the first insight into the fine-tuning of UP homeostasis that adjusts the 
Lipid II cycle, and hence cell wall biosynthesis, in response to growth rates and 
envelope stress levels.  
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RESULTS 
High level expression of UPP-phosphatases BcrC and UppP in B. subtilis 
The genome of B. subtilis encodes three UPP-phosphatases, BcrC, UppP and YodM. 
YodM and BcrC belong to the large group of type II phosphatidic acid phosphatases 
(PAP2s) that share their catalytic mechanism while pursuing a wide range of functions 
from signaling to export. Both proteins are homologues to the crystalized UPP-
phosphatase PgpB of E. coli (El Ghachi et al., 2005; Fan et al., 2014; Kelley et al., 2015). 
While YodM seems to be dysfunctional due to insufficient expression (Zhao et al., 
2016), BcrC has been studied to some extent. It seems to be the major B. subtilis UPP-
phosphatase (Bernard et al., 2005; Inaoka and Ochi, 2012) and is highly expressed at 
most culture conditions, as judged by a comprehensive tiling array study (Fig. 2) 
(Nicolas et al., 2012). The monocistronic gene bcrC (Fig. 2A) is regulated by the CES-
inducible ECFs σM and σX (Cao and Helmann, 2002). The latter respond to CES that 
might be caused by changing UP levels or other intermediates of the lipid II cycle 
(Helmann, 2016). Under our experimental conditions, the activity of PbcrC remained 
at high levels (Fig. 2C) from early exponential to late stationary phase - with exception 
of the known decrease during transition state, which is frequently observed for online 
promoter activity measurements (Radeck et al., 2013). As discovered previously, PbcrC 
activity was increased by the addition of bacitracin (30 µg ml-1; Fig. 2C) (Mascher et 
al., 2003; Radeck et al., 2016b). 
The minor UPP-phosphatase UppP (Inaoka and Ochi, 2012) is homologous to BacA 
from E. coli. The latter accounts for about 75% of the UPP-phosphatase activity in this 
organism (El Ghachi et al., 2004). uppP is the second gene of the yubA-uppP operon 
and its PyubA-dependent expression is not induced by bacitracin (Cao and Helmann, 
2002). YubA is predicted to be a membrane protein belonging to the autoinducer-2 
exporter (ai-2e) family and might be associated with cell wall synthesis (Fenton et al., 
2016; UniProt, 2017). The activity of PyubA is comparable to Pbcrc during exponential 
growth, but about 3-fold higher during stationary phase (Fig. 2B). In contrast to Pbcrc, 
and in agreement with a previous study, PyubA was not significantly induced by 
bacitracin (Fig. 1C, Cao and Helmann, 2002). Our data based on the promoter-lux  
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Figure 2. Expression of UPP phosphatase genes. (A, B) Figures modified from subtiwiki 2.0 (Nicolas 
et al., 2012; Michna et al., 2016). Details on the experimental conditions can be obtained from (URL) 
by clicking on the points of interest. (A) Genomic context of UPP-phosphatase genes and respective 
mRNA levels (+ or – strand, respectively) across 104 conditions. The scale indicates the genomic 
position. (B) Comparison of expression profiles for uppP, bcrC and yodM. Sporulation and early 
sporulation are indicated with a bracket and arrow, respectively. (C, D) Growth (OD600) and activity 
levels of PbcrC and PyubA (RLU/OD600) in B. subtilis W168 (TMB1620 and TMB3688) from early 
exponential to late stationary phase in absence or presence of 30 µg ml-1 bacitracin (+ bac; dashed 
lines), respectively. PbcrC actictivity was significantly increased upon bacitracin addition (p=0.021, 2-
way ANOVA), but not PyubA (p=0.29, 2-way ANOVA). Measurements were obtained in a microtiter 
plate reader at 37°C in MCSEC medium. Data is shown for three independent biological replicates 
(mean and SD). 
MANUSCRIPT I: UPP PHOSPHATASES AND ENVELOPE STRESS IN BACILLUS 
148 
fusions agrees well with the tiling array data on mRNA levels of uppP and bcrC (Fig. 
2B, Nicolas et al., 2012). At most conditions, bcrC (red) is expressed at a slightly higher 
level than uppP (yubB, in blue). One exception is sporulation, during which bcrC 
expression drops at early sporulation and uppP only at late sporulation (see arrow).  
For the third UPP-phosphatase, the tiling array data shows that there is almost no 
transcription of yodM (yellow), but instead high levels of counter-transcription (Fig. 
2A). This finding has recently been verified (Zhao et al., 2016). Due to these 
observations, YodM and its promoter, PyodM, were not considered further for our 
analysis.  
In summary, there are two well-transcribed UPP-phosphatase genes in B. subtilis 
cells, BcrC and UppP. We therefore decided to study their role in cell wall homeostasis 
and CES in B. subtilis. Towards that goal, we investigated single and combined 
deletion and complementation strains for their effect on cell morphology, 
sporulation, CESR and antibiotic resistance. 
uppP and bcrC are a synthetic lethal gene pair 
Initially, we aimed at replacing all three UPP-phosphatase genes with resistance 
cassettes (bcrC::tet, uppP::MLS and yodM::spec) in single and double mutants. For 
simplicity reasons, all allelic replacements are noted as deletions throughout the 
manuscript and figure legends. All single mutants and double mutants with ΔyodM 
were readily obtained. Since the lack of any observable phenotype during the initial 
characterization of all ΔyodM strains can readily be explained by the lack of yodM 
expression (Fig. 2A and (Zhao et al., 2016)), these strains were not considered further. 
In contrast to the single mutants, multiple attempts to construct a ΔuppP ΔbcrC 
double mutant failed, indicative of synthetic lethality of bcrC and uppP. To support 
this assumption, we constructed complementation strains, in which uppP or bcrC 
were ectopically integrated into the thrC locus under control of the xylose-inducible 
promoter PxylA. In strains carrying a complementation copy of either bcrC or uppP, the 
deletion of both native genes was possible in the presence of xylose. These strains 
(ΔuppP ΔbcrC PxylA-bcrC and ΔuppP ΔbcrC PxylA-uppP) will be referred to as depletion 
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strains to distinguish them from the complementation strains ΔbcrC PxylA-bcrC and 
ΔuppP PxylA-uppP. Our findings are in agreement with a recent study from the 
Helmann laboratory, which independently demonstrated the synthetic lethality of 
the bcrC/uppP gene pair using a CRISPR-dCas9 knockdown approach (Zhao et al., 
2016). 
Cell morphology is impaired in UPP-phosphatase mutants during exponential 
growth 
Depletion of essential envelope-associated proteins often leads so bulging, 
filamentation or lysis of cells (Peters et al., 2016). Since uppP and bcrC are synthetic 
lethal and the lipid II-cycle and cell wall synthesis depend on the recycling of UP by 
UPP-phosphatases, we hypothesized that a depletion of UPP-phosphatases in fast-
growing cells leads to a morphological phenotype similar to that observed for other 
essential cell envelope functions. 
 
Figure 3. Cell morphology during 
exponential growth in bcrC and uppP 
complementation mutants.  
Strains W168, TMB3739, TMB3740 
were inoculated from fresh overnight 
cultures (day 1) or 24h-cultures (on day 
2), grown in MCSEC at 37°C, 220 rpm 
without xylose (xyl-) to deplete the 
respective UPP phosphatase or with 
0.2% xylose (xyl+) to fully induce the 
production in complementation 
mutants. Overnight cultures were 
always supplemented with xylose, 
whereas the inoculum for day 2 was 
taken from samples either with (xyl+) or 
without (xyl-) xylose added. Phase 
contrast pictures were taken in late 
exponential phase (OD600~0.6, ~6 h 
post-inoculation). (A) Fraction of cells 
with normal (grey) or bulging 
morphology (white). At least 1000 cells 
were counted for each of the three 
independent biological replicates. (B) 
Representative pictures of cells with 
normal or bulging morphology. Samples 
were taken from day 1. The scale bar 
represents 2 µm. 
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Single uppP or bcrC deletions, the respective complementation mutants, and the wild 
type showed no or less than 0.1% misshaped cells (data not shown). In contrast, both 
UPP phosphatase depletion strains TMB3739 (ΔuppP ΔbcrC PxylA-bcrC) and TMB3740 
(ΔuppP ΔbcrC PxylA-uppP) showed a severe phenotype during exponential growth 
phase (Fig. 3). In the absence of xylose, about 20-30% (TMB3739) or 80% (TMB3740) 
of the cells are bulging and sometimes bending (Fig. 3A). This phenotype could be 
completely suppressed by the addition of xylose, resulting in high expression levels 
of the complemented UPP-phosphatase (Fig. 3B). This phenotype could not be 
observed at slow growth e.g. in stationary phase (Fig. S1) even though some cells look 
swollen compared to wild type cells (e.g. the ΔuppP mutant TMB3408).  
In summary, we could show that a very low expression of only uppP or bcrC lead to 
severe morphological changes, e.g. bulging cells during exponential growth – 
concomitant with depleted peptidoglycan or WTA synthesis (Muchova et al., 2011; 
Botella et al., 2014) caused by a lack of UP. This phenotype was most severe for the 
uppP depletion strain.  
UppP is important for efficient sporulation 
During the morphology studies, we observed altered sporulation rates between the 
wild type and UPP phosphatase mutants, especially ΔuppP. We therefore quantified 
the sporulation efficiency in our strains by determining the fractions of vegetative 
versus sporulating cells and endospores in a culture 24 h after inoculation 
(summarized in Fig. 4, see Fig. S2 for the complete dataset). Under our experimental 
conditions, about 30% of the wild type cells (Fig. 4B, i) were in the process of 
sporulation or had already sporulated. Mutants with a native copy of uppP (ii-iv), and 
mutants with wild type copy of bcrC in combination with an ectopic inducible copy of 
uppP (viii, ix) had similar sporulation rates. Sporulation was impaired (<7%), if the 
native copy of uppP was lost and no ectopic copy was introduced (v, vi), or if uppP 
was depleted in the phosphatase double mutant (x). The sporulation deficiency of 
the latter could partially be restored by the addition of xylose to induce uppP 
expression (xi).  
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Figure 4. Sporulation 
efficiencies of bcrC and uppP 
deletion and 
complementation mutants. 
Strains (W168, TMB0297, 
TMB3694, TMB3739, 
TMB3408, TMB3695, and 
TMB3740) were grown as 
described in Fig. 3 and phase 
contrast microscopy pictures 
were taken 24 hours post-
inoculation. (A) 
Representative pictures for 
normal cells (grey), prespores 
without fully established 
phase-bright endospore 
(small checkered), completed 
endospores (white), free 
spores (black) and small free 
spores (striped). (B) Cell type 
fractions are shown as 
stacked bar graphs. Data is 
shown for at least 1000 cells 
per measurement and the 
error bars represent the 
standard deviation between 
independent biological 
triplicates. The full data set is 
shown in Fig. S2.  
The reduced sporulation frequencies in ΔuppP mutants did not originate from 
delayed sporulation, since a similar reduction in sporulation rates (2-5% compared to 
> 30% in the wild type) was also observed after 48h (data not shown). However, using 
a spore-crust marker (GFP-CotZ), we detected that some of the phase-grey particles 
in a ΔuppP mutant were spores instead of cells (Fig. S3). This phenotype is indicative 
of alterations in stage IV or V of sporulation, where mutants have thinner or no germ 
cell wall or cortex (Coote, 1972; Piggot and Coote, 1976). Both spore layers consist of 
peptidoglycan, a defect in their synthesis therefore points towards UppP being the 
responsible UPP-phosphatase for the lipid II cycle during sporulation. This 
observation is in agreement with a recent screen for sporulation mutants, in which a 
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reduced sporulation efficiency and phase-grey spores were also detected in a uppP 
mutant (Meeske et al., 2016).  
Here we could show that the rates of normal, phase bright spores drastically 
decreased in absence of UppP. In the presence of BcrC, low levels of UppP still allow 
a normal sporulation (Fig. 4, vii, viii), while this residual UppP amount is not sufficient 
in the absence of BcrC (x). Either the native copy of uppP or the combination of native 
bcrC and an ectopic version of uppP is required for efficient sporulation. 
The combined results from our sporulation counts (Fig. 4) and the cell morphology 
study (Fig. 3) demonstrate that limited amounts of either UPP-phosphatase alone 
(TMB3739, TMB3740 without xylose) are not sufficient to retain normal cell shape 
during fast growth or ensure efficient sporulation. While each native phosphatase is 
sufficient to keep normal cell shape in exponential growth, BcrC cannot compensate 
for the lack of UppP during sporulation. Both phenotypes point towards defects in 
cell wall synthesis. This provoked the question if under such circumstances this 
bottleneck in cell wall synthesis leads to a CESR, which is normally triggered by the 
external addition of cell wall antibiotics, such as bacitracin (Radeck et al., 2016a). To 
address this question, two well established reporters for CESR (the PliaI and PbcrC 
promoters fused to the lux reporter cassette (Radeck et al., 2016b)) were combined 
with the mutant collection and probed for their activity under UPP phosphatase-
limiting conditions.  
Limitations in UPP-phosphatases are perceived as envelope stress by the PbcrC 
reporter 
PliaI is a very sensitive reporter of cell envelope damage due to its wide inducer 
spectrum and high dynamic activity range (Mascher et al., 2004; Rietkötter et al., 
2008). But we did not observe any UPP phosphatase-dependent induction of the PliaI-
controlled CESR, even if we additionally challenged the cells with bacitracin (data not 
shown).  
In contrast to the damage-sensing PliaI reporter, the PbcrC-derived reporter is 
postulated to respond to alterations/limitations in cell wall homeostasis (Minnig et  
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al., 2003) and could therefore be more suitable to detect stress caused by changes in 
the UPP-phosphatase levels. In light of this study, PbcrC is particularly relevant since it 
controls the expression of one of the two UPP phosphatases, BcrC. It therefore 
provides a direct read-out for the cells ability to respond to limitations in UPP 
 
Figure 5. Growth and PbcrC promoter activities in the wild type and bcrC and uppP 
complementation mutants. Strains were grown in MCSEC at 37°C in 96-well plates in a microtiter 
plate reader. OD600 and luminescence was measured every 15 minutes for 15 hours. (A-D) Growth 
and PbcrC-activity in bcrC deletion, complementation and depletion strains. (E-H) Growth and PbcrC-
activity in uppP deletion, complementation and depletion strains. The strains are defined by the 
color, while solid or dashed lines indicate the absence or presence of 30 µg ml-1 bacitracin. (D, H) 
Samples were grown with 0.2 % xylose to fully induce PxylA-driven gene expression. In these cultures, 
promoter activity steadily decreased from the transition phase onwards. This phenomenon was 
observed for all strains either harboring PbcrC or the constitutive reference promoter PlepA (data not 
shown). We therefore postulate that the change in promoter dynamics is caused by the presence 
of an additional C-source (xylose). Thin lines represent the standard deviation of at least three 
biological replicates 
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phosphatases by upregulating bcrC expression. Towards this end, we measured PbcrC-
activity in the wild type as well as bcrC and uppP deletion, complementation and 
depletion strains. Promotor activity as relative luminescence units normalized to cell 
density (RLU/OD600) and growth (OD600) were measured in a microtiter plate reader 
for 15 hours (Fig. 5).  
For the wild type reporter strain (TMB1620), PbcrC activity of 3-5*105 RLU/OD600 was 
observed during exponential growth and the transition phase (Fig. 5 A, C; black lines, 
0-3 h). The activity decreased about 10-fold during early stationary phase (4-6 h), 
briefly increased (6-8 h) and then steadily declined during late stationary phase. Upon 
bacitracin addition (30 µg ml-1), the promotor activity was increased about 10-fold, 
while no change in growth behavior was detected. 
In the ΔbcrC mutant (TMB1628, green) and the bcrC depletion strain (TMB3784, 
blue), the PbcrC activity increased without and especially with bacitracin addition and 
a slightly reduced optical density was observed during stationary phase compared to 
the wild type (Fig. 5A-D). These effects were revoked by the addition of xylose 
(TMB3784) or the introduction of a complementing copy of bcrC (TMB4123, orange), 
even without xylose.  
Deletion of uppP (TMB3428, green) only had a minor effect on PbcrC activity (approx. 
three-fold elevation during late stationary phase upon bacitracin addition, Fig. 5 E, 
G). However, in the uppP depletion strain (TMB3787, blue) impaired growth – 
especially in the presence of bacitracin – and strongly increased PbcrC activity was 
observed throughout growth, even without bacitracin addition. A subsequent in-
depth analysis supported these findings: The uppP depletion strain (TMB3740), but 
not the bcrC depletion strain (TMB3739) showed a clear growth defect in absence of 
xylose. All phenotypes of complementation mutants reverted to wild type levels in 
presence of xylose (see Fig. S4 for details). 
Taken, the single bcrC deletion, as well as two phosphatase depletion strains (ΔbcrC 
ΔuppP PxylA-bcrC and ΔbcrC ΔuppP PxylA-uppP) had the strongest effect on PbcrC activity, 
especially in the presence of bacitracin.  
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The undecaprenol kinase DgkA contributes to the cellular UP pool 
The results described in the previous section demonstrate that the cell is indeed 
capable of perceiving limitations in UPP phosphatase levels, most likely at the level 
of the resulting UP shortage. A second enzymatic activity potentially contributing to 
the cellular UP pool is the undecaprenol kinase DgkA that phosphorylates 
undecaprenol to UP (Jerga et al., 2007). Based on the results of the previous section, 
the activity of the PbcrC reporter might provide an ideal read-out to probe if DgkA 
indeed provides a measurable contribution to the UP pool, particularly if the cellular 
amount of UPP phosphatases is severely limited. We therefore deleted dgkA in the 
wild type and all phosphatase deletion, complementation and depletion strains and 
then measured the PbcrC activity throughout the growth cycle.  
 
Figure 6. PbcrC promoter 
activity depends on DgkA. 
Strains were grown as 
described in Fig. 5. Black, wild 
type; green, dgkA mutant. 
Samples induced with 
bacitracin are shown as 
dashed lines. Thin lines 
represent the standard 
deviation of three biological 
replicates.  
  
Surprisingly, a strong DgkA-dependent effect was already observed in the wild type 
reporter strain: the PbcrC activity was elevated ~10-fold in the dgkA mutant during late 
stationary phase relative to the wild type, both in the presence or absence of 
bacitracin (Fig. 6). A similar effect was observed for all phosphatase mutants (Fig. S5). 
This result indicates that a DgkA-dependent phosphorylation of undecaprenol indeed 
detectably contributes to the cellular UP pool, even though a dgkA mutant did not 
show any (additional) morphological phenotype during fast growth (data not shown). 
It has previously been shown that a B. subtilis dgkA mutant produces less and cortex-
deficient endospores – a peptidoglycan structure that depends on UP for its synthesis 
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(Amiteye et al., 2003 and Fig. S2). This suggests that the role of DgkA to contribute to 
the UP-pool is rather during sporulation. 
Deletion and Depletion of UPP-phosphatases increases sensitivity towards the UPP-
binding antibiotic bacitracin 
 
Figure 7. Minimal inhibitory 
bacitracin concentration of bcrC and 
uppP deletion and complementation 
mutants. Strains (W168, TMB297, 
TMB3694, TMB3739, TMB3408, 
TMB3695, and TMB3740) were 
inoculated from fresh overnight 
cultures (xyl+) in MCSEC at 37°C with 
or without 0.2% xylose. During 
exponential growth, cells were 
embedded in soft agar and plated as 
an overlay on MCSEC agar. One Etest® 
strip (bacitracin 0.016-256 µg ml-1) 
was placed on the soft agar (see 
Material and Methods). The MIC was 
determined after 24h of incubation at 
37°C. Data is shown for at least three 
independent biological replicates 
(two replicates, if MIC>256 µg ml-1) 
with mean and standard deviation. 
The full data set is depicted in Fig. S6. 
 
B. subtilis wild type cells are highly resistant against the UPP-binding antibiotic 
bacitracin (minimal inhibitory concentration, MIC, >256 µg ml-1). The primary 
resistance determinant is the bacitracin-specific ABC-transporter BceAB (Mascher et 
al., 2003; Ohki et al., 2003; Rietkötter et al., 2008). But BcrC provides a (secondary) 
layer of bacitracin resistance, most likely by competing with the antibiotic for the 
same target molecule, UPP (Bernard et al., 2005; Radeck et al., 2016a; Radeck et al., 
2016b). The inhibitory effect of bacitracin is based on depleting the UP pool by 
formation of a UPP-bacitracin complex, finally leading to an arrest of the lipid II cycle 
(Fig. 1). It stands to reason to postulate that deletions in genes encoding UPP 
phosphatases or undecaprenol kinases might also contribute to the sensitivity of the 
cells towards bacitracin. We therefore measured the MIC for bacitracin in UPP-
phosphatase deletion and depletion mutants, using Etest® strips (Fig. 7 and Fig. S6).  
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While the individual deletion of uppP had no measurable effect on bacitracin MIC, 
the deletion of bcrC lead to the known reduction of the MIC to ~ 120 µg ml-1. This 
phenotype could be complemented by the addition of xylose, thereby inducing the 
ectopically integrated PxylA-bcrC. Without xylose, the MIC of this strain is comparable 
to the bcrC deletion mutant, indicating very little background activity of PxylA under 
non-inducing conditions. If uppP is deleted in this genetic background, the MIC was 
even further decreased to ~ 15 mg ml-1. In this depletion strain, the PxylA-mediated 
expression of bcrC can no longer fully compensate for the loss of both UPP-
phosphatases (MIC of ~150 compared to >256 µg ml-1 in ΔuppP). The uppP depletion 
mutant (TMB3739, ΔbcrC ΔuppP PxylA-uppP) exhibited the lowest MIC (~3 µg ml-1). 
Upon addition of xylose, a 35-fold increase in bacitracin MIC could be observed (Fig. 
7). 
Taken together, the resistance towards the UPP-binding bacitracin is indeed severely 
reduced in mutants limited for UPP-phosphatases. This phenotype can be (almost 
fully) compensated for by induction of ectopically integrated UPP-phosphatase genes 
under control of PxylA. Again, the phenotype of the uppP-depletion strain (TMB3740) 
is more severe than that of the bcrC-depletion (TMB3739), in line with the 
morphological defects observed above (Fig. 3). The additional deletion of dgkA or 
yodM had no effect on the observed MIC in any of the mutants tested, again 
indicating a very minor contribution of these two gene products. Removing the main 
bacitracin resistance determinant, bceAB, lead to an overall lower basal MICs, but 
had no additional influence on the behavior described above (Fig. S6). 
DISCUSSION 
Together, bcrC and uppP encode the essential UPP phosphatase function of B. 
subtilis 
In our study, we demonstrated that uppP and bcrC constitute a synthetic lethal gene 
pair – a result that is perfect agreement with an independent study performed in 
parallel using CRISPR-dCas9 knock-downs to study the effect of UPP-phosphatase 
levels in B. subtilis (Zhao et al., 2016). These observations thereby correct two 
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previous studies, which independently reported the successful construction of a 
uppP/bcrC double deletion mutant that showed the same phenotype as a single bcrC 
deletion mutant (Bernard et al., 2005; Inaoka and Ochi, 2012). Both groups used 
deletion constructs based on the vector pMUTIN, which disrupted either uppP or bcrC 
by integrating via single homologous recombination (Vagner et al., 1998; Kobayashi 
et al., 2003; Bernard et al., 2005; Inaoka and Ochi, 2012). Based on their data, it must 
be postulated that these deletion constructs generated a gene fragment up- or 
downstream the integration site, which was still large enough to maintain (residual) 
UPP phosphatase activity. In contrast, both recent studies only used complete allelic 
replacement mutants based on double homologous recombination of a resistance 
cassette (this study and Zhao et al., 2016).  
According to our results, the basal expression of bcrC driven by PxylA is still sufficient 
for growth at normal doubling times. This is in agreement with the parallel study, 
which initially failed to generate uppP or bcrC depletion strains due to the high basal 
activity of Pspac(hy) which was used for complementation: The strains still grew in the 
absence of IPTG, despite the knock-out of the native uppP and bcrC genes (Zhao et 
al., 2016).  
In contrast, the third UPP phosphatase, YodM, did not provide a measurable 
contribution to the cellular UP pool. While the Zhao et al. study demonstrated that 
the gene product of yodM indeed has UPP phosphatase activity, this was only 
sufficient to support growth if expression was artificially improved (Zhao et al., 2016), 
in line with our own observations. This is not surprising, considering the expression 
profiles from a comprehensive transcriptome study, which demonstrates a lack of 
yodM expression, but instead a strong counter-transcription (Fig. 2). Together, the 
data provided in this study and the recent report from the Helmann group 
unequivocally demonstrates that the UPP phosphatase activity in B. subtilis is 
primarily – if not exclusively – provided by BcrC and UppP. While both can functionally 
complement each other, our study indicates that the two phosphatases have slightly 
different functions in wild type cells. 
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BcrC is more relevant during vegetative growth, while UppP is important for 
efficient sporulation 
Table 1 summarizes the main findings of our study with regard to bacitracin 
sensitivity, PbcrC activity, cell morphology and growth rates. While our data 
demonstrates that either phosphatase is sufficient to support growth, the respective 
mutants do show significant differences in their overall behavior. The ΔbcrC single 
mutant had a decreased MIC for bacitracin and an elevated PbcrC activity, in contrast 
to the ΔuppP strain. If the UPP phosphatase levels are further reduced or if the 
cultures are additionally challenged with bacitracin, the phenotypes are overall less 
severe if BcrC is complemented compared to UppP under similar conditions. 
Hence,the uppP depletion strain (that completely lacks BcrC) shows a severe growth 
defect and strong CESR in the absence of xylose. While an elevated PbcrC activity is 
also measured for the bcrC depletion strain, this effect is rather weak in the absence 
of bacitracin and only a mild growth defect is observed. Our data therefore not only 
supports previous findings that BcrC is the major UPP phosphatase during vegetative 
growth in B. subtilis (Bernard et al., 2005; Inaoka and Ochi, 2012), but also 
demonstrates that an ectopically complementing copy of bcrC is more efficient in 
providing the UPP phosphatase activity than a similar construct for uppP. 
In contrast, UppP seems to play the more prominent role with regard to sporulation. 
At strongly reduced levels of UppP, BcrC can support but never fully compensate the 
function of UppP. Its role in the formation of mature spores was recently also 
observed in a screen for sporulation mutants (Meeske et al., 2016).  
When triggering a CESR, as monitored by an increased σM-dependent PbcrC activity 
(this study,Cao and Helmann, 2002; Radeck et al., 2016b), we recently observed that 
a deletion of bcrC further increases the CESR (Radeck et al., 2016a; Radeck et al., 
2016b). Here, we could demonstrate that this effect holds true for UPP phosphatases 
in general: While a uppP deletion alone does not trigger the CESR, very low levels of 
UPP phosphatase activity (especially in the uppP depletion strain) cause a stronger 
CESR than the bcrC single mutant (Fig. 5). This finding perfectly fits to the working 
model that low levels of UP (or downstream effects thereof) are the stimulus for σM 
MANUSCRIPT I: UPP PHOSPHATASES AND ENVELOPE STRESS IN BACILLUS 
160 
activation, rather than the protein levels of BcrC (Lee and Helmann, 2013; Zhao et al., 
2016). It is also supported by the finding that PbcrC is induced in presence of bacitracin, 
which blocks the dephosphorylation to UP by binding to UPP (Cao and Helmann, 
2002).  
Outlook and open questions 
Our study clearly demonstrates the essential role of UPP phosphatases for the lipid II 
cycle, in perfect agreement with results from an independent study performed in 
parallel (Zhao et al., 2016). In addition, we could demonstrate that these 
phosphatases also provide a direct link in connecting cell envelope homeostasis with 
CESR. Nevertheless, some questions are still open and need to be addressed in 
subsequent studies. 
Quite surprisingly, PbcrC activity is unchanged in the uppP depletion strain treated with 
xylose, while the native uppP copy present in ΔbcrC is not sufficient to prevent CESR. 
This phenomenon could not be observed with regard to the bacitracin sensitivity and 
provokes the question if and how uppP is regulated during growth and CES. For 
further investigations, protein and/or activity levels of UPP-phosphatases and the 
abundance of UPP and UP in challenged and non-challenged cells will help to better 
understand the stoichiometry of UPP dephosphorylation, a crucial step of the lipid II 
cycle.  
Another aspect that needs to be taken into account is the substantial contribution of 
UPP de novo synthesis to the lipid II cycle: Reducing the UppS protein levels by 50% 
significantly altered cell wall antibiotic sensitivities (Lee and Helmann, 2013). But so 
far, very little is known about the stoichiometry between UPP recycling and de novo 
synthesis, which are both essential and depend on UPP phosphatases. 
Two reactions are known to generate UP independent of UPP phosphatases: (i) 
recycling from WTA-shuttling, which depends on UP and is therefore not self-
sustaining (Brown et al., 2013), and (ii) phosphorylation of undecaprenol, e.g. via 
DgkA (Jerga et al., 2007; Van Horn and Sanders, 2012). The cellular abundance and 
dynamics of undecaprenol has so far not been studied for B. subtilis, but data from 
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other species indicates that this molecule is present in the membrane of Gram-
positive bacteria and absent in Gram-negative bacteria (Higashi et al., 1970; 
Barreteau et al., 2009). In Staphylococcus aureus, a UP phosphatase activity was 
detected, but could not be assigned to a certain protein (Willoughby et al., 1972). 
Future studies – particularly for B. subtilis – will hopefully address the source of 
undecaprenol and its role as a possible resource for the lipid II cycle. 
The localization and cellular dynamics of UPP phosphatases throughout the growth 
cycle and into sporulation might provide further insights into their activity pattern 
and hence their cellular roles. Such studies would also allow studying their proximity 
to active cell wall biosynthesis clusters (peptidoglycan and WTA), which could be a 
relevant proxy for efficient carrier supply (Kawai et al., 2011; Typas et al., 2012). 
Unfortunately, our initial attempts to generate functional translational GFP-fusions 
to the N- or C-terminus of UppP or BcrC were not successful. Some fusion constructs 
did not provide (sufficient) UPP phosphatase activity to complement the synthetic 
lethal gene pair in a uppP and bcrC deletion background. And those constructs that 
maintained the phosphatase activity lacked a fluorescent signal, potentially due to 
the fluorophore localizing to the extracellular side of the membrane (data not 
shown). Future studies, that employ linkers or fluorophors that mature in the 
periplasm (such as mCherry or superfolder GFP (Dammeyer and Tinnefeld, 2012)) will 
hopefully circumvent these obstacles.  
The data provided by our and other recent studies (Meeske et al., 2016; Zhao et al., 
2016) are an important first step in gaining a mechanistic understanding on UPP 
phosphatases. But despite the insights gained during these studies, there is still a lot 
to be learned about the dynamics of the UP pool and how the functions that make 
and break this essential intermediate of cell envelope biosynthesis contribute to cell 
growth, differentiation and cellular stress responses. 
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EXPERIMENTAL PROCEDURES 
Bacterial strains and growth conditions 
E. coli strains were routinely grown in lysogeny broth (LB) and B. subtilis in MOPS-
based chemically defined medium with succinate and glutamate (MCSE) (Radeck et 
al., 2013), supplemented with casamino acids (1%, CAA) and L-threonine (50 µg ml-1) 
(MCSEC) at 37°C with agitation (220 rpm). Addition of CAA was necessary to prevent 
background activity of Phom, which is located upstream of the integration site of the 
uppP and bcrC complementation constructs (Radeck et al., 2013). Transformations of 
B. subtilis were carried out as described previously (Harwood and Cutting, 1990). All 
B. subtilis strains used in this study are derivatives of the laboratory wild type strain 
W168 and are listed in Table S1. All allelic replacements are shown as gene deletions 
in the main text and figure captions for better readability. Selective media for E. coli 
contained ampicillin (100 µg ml-1) or chloramphenicol (35 µg ml-1). Selective media 
for B. subtilis contained chloramphenicol (5 µg ml-1), kanamycin (10 µg ml-1), 
spectinomycin (200 µg ml-1), tetracycline (12.5 µg ml-1) and/or a combination of 
erythromycin (1 µg ml-1) and lincomycin (25 µg ml-1) for macrolide-lincosamide-
streptogramin B (MLS) resistance. Solid media additionally contained 1.5% (w/v) 
agar. For complementation studies, full induction of the promoter PxylA was achieved 
by adding xylose to a final concentration of 0.2% (w/v). Overnight cultures contained 
xylose per default to ensure normal growth of depletion strains.  
DNA manipulation 
Plasmids were generated by using standard cloning techniques (Sambrook and 
Russell, 2001) with enzymes and buffers from New England Biolabs® (NEB) according 
to the manufacturer’s protocols. Phusion® polymerase was used for polymerase chain 
reaction (PCR) amplification for cloning purposes, otherwise OneTaq® was used. PCR 
purification was performed with HiYield PCR Gel Extraction/PCR Clean-up Kit (Süd-
Laborbedarf Gauting, SLG®). For complementation studies, uppP or bcrC were placed 
under control of the xylose-inducible promoter PxylA inserted into the thrC-integration 
vector pBS4S. For measurements of promoter activity, promoter fragments spanning 
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about 400 bp upstream of the Shine-Dalgarno sequence of the respective gene were 
cloned into pAH328, which carried the luxABCDE operon as an online luminescence 
reporter (Schmalisch et al., 2010). All plasmids generated during this study and a brief 
description of the construction are provided in Table S2. 
Allelic replacement mutations of bcrC and uppP were generated via long flanking 
homology PCRs, as described previously (Mascher et al., 2003). The integration of 
plasmids or DNA fragments into the B. subtilis genome via double recombination was 
verified with threonine auxotrophy (thrC) or colony PCR (sacA, uppP, bcrC, yodM, 
dgkA). All primer sequences are listed in Table S3. 
Luciferase assay 
Luciferase activities of B. subtilis strains harboring promoter-lux fusions were assayed 
using a SynergyTM NEOALPHAB multi-mode microplate reader from BioTek® 
(Winooski, VT, USA). The reader was controlled using the software Gen5TM (version 
2.06). 100 µl culture volume were used per well in 96-well plates (black wall, clear 
bottom, clear lid, Greiner Bio-One). Incubation in the reader occurred at 37°C with 
linear agitation (567cpm) and luminescence and OD600 were measured every 5 min. 
Strains were grown in MCSEC medium. Overnight cultures contained 0.2% xylose, to 
ensure protein production in complementation strains. (i) Day cultures (containing 
0.2 % xylose) were inoculated 1:5,000 from fresh overnight cultures, and strains were 
grown until exponential phase (OD600= 0.1-0.4) (ii) Cells were harvested by 
centrifugation, washed twice in MCSEC, resuspended in MCSEC and the optical 
density was adjusted to OD600=0.025. (iii) 0.2 % xylose was added if indicated and 
incubation in the reader occurred for 3 hours. (iv) 30 µg ml-1 of bacitracin was added, 
if applicable, and the incubation and measurement continued for 17 hours. Specific 
luminescence activity is given by the raw luminescence output (RLU) normalized by 
cell density (RLU/OD) (Radeck et al., 2013). For the depletion assay, cultures were 
handled as described, but the resuspended cultures (ii) were set to OD600=0.1 and 
1:2, 1:4, 1:8, 1:16, and 1:100 dilutions thereof. 
MANUSCRIPT I: UPP PHOSPHATASES AND ENVELOPE STRESS IN BACILLUS 
164 
Microscopy  
Cell morphologies and sporulation frequencies were studied with an Olympus 
Microscope (AX70, 100x oil objective, camera XC10) and the accompanying software 
(Olympus cellSens Dimension 1.14). Phase contrast and GFP fluorescence channels 
(filter cube: U-MNIB, FF blue longpass, Ex. 470-490 nm, Em. 515-∞) were used. The 
exposure time for the GFP-channel was 100 ms. Strains were grown as described 
above, but day cultures were supplemented with 0.2% xylose (as indicated in figure 
legends), and incubated for up to 48 hours in flasks. Samples were taken at late 
exponential phase (OD600 ~0.6-0.8, typically after 5-6 h), late / very late stationary 
phase (24 h/48 h post inoculation). Phase contrast pictures were adjusted in 
brightness and contrast to improve cell shape detection. All GFP-channel pictures 
were adjusted in brightness and contrast with the identical settings. 
Determination of minimal inhibitory concentration 
Bacitracin resistance in B. subtilis strains was determined using Etest® strips on 
bacterial lawns (bioMérieux, Marcy l’Etoile, France), as described previously (Radeck 
et al., 2016b), with the following changes: (i) MCSEC medium was used instead of 
MH, (ii) overnight cultures contained 0.2 % xylose, and (iii) day cultures, soft agar and 
agar plates contained 0.2 % xylose, if applicable (see figure legends). 
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Figure S1. Sporulation efficiency of bcrC and uppP deletion and complementation 
mutants.  
Strains (W168, TMB297, TMB3694, TMB3739, TMB3957, TMB3408, TMB3695, 
TMB3740, and TMB3958) were grown as described in Fig. 2 and phase contrast 
microscope pictures were taken 24 h post-inoculation. The scale bar is 10 µm. 
  




Figure S2. Sporulation efficiency of bcrC and uppP deletion and complementation 
mutants.  
Strains (W168, TMB297, TMB3694, TMB3739, TMB3957, TMB3408, TMB3695, 
TMB3740, and TMB3958) were grown as described in Fig. 2 and phase contrast 
microscopy pictures were taken 24 h post-inoculation. Legend: normal cells (grey), 
prespores without fully established phase-bright endospore (small checkered), 
completed endospores (white), free spores (black) and small free spores (striped). 





































































Figure S3. Detection of spores in uppP mutant via crust marker GFP-CotZ 
Strains (TMB2112, TMB4150, and TMB4151) were grown as described in Fig. 3 and 
phase contrast as well as green fluorescence were documented 24 h post-
inoculation. Prespores, endospores, free spores, phase-dark free spores, and small 
free spores can have fully developed spore crusts where GFP-CotZ is located (see 
white arrowheads with black border). However, not all small phase-dark particles can 
be classified as spores with this marker (see black arrowheads with white border, no 
GFP signal). A. Wild type. Please note that small spores only appear small in the phase 
contrast picture, but their crust has (almost) normal size as visualized in the GFP-
channel. B. spoVB mutant (lipidII flippase, active during sporulation). Sporulation is 
strongly impaired. This strain was used as a control. C. uppP mutant. Hardly any 
developed phase-bright spores were formed. But prespores as well as some phase-
dark spores (which could be mistaken for small cells) clearly show a spore crust. The 
scale bars are 2 or 10 µm, respectively. 
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Figure S4. Growth of the wild type and bcrC and uppP complementation mutants. 
Strains were grown in MCSEC supplemented with 0.2% xylose at 37°C to OD600=0.2-
0.6, washed and resuspended to an optical density of OD600 = 0.1 in MCSEC (A, C, E), 
or MCSEC + 0.2% xylose (B, D, F). Cultures, as well as their 1:2, 1:4, 1:8, 1:16 and 1:100 
dilutions were grown in 96-well plates in a microtiter plate reader at 37° where OD600 
was measured every 5 minutes for 15 hours. A-F. Graphs show the OD600-values as a 
measure for cell density, or the doubling time during exponential growth, with the 
color saturation decreasing with increasing dilutions. A, B. W168. C, D. TMB3739, 
ΔbcrC ΔuppP PxylA-bcrC. E, F. TMB3740, ΔbcrC ΔuppP PxylA-uppP. Data was obtained in 
biological triplicates, of which one representative sample is shown. G. The doubling 
times were calculated with Prism5, using the exponential growth equation and OD600-
values from 0.007 to 0.15 (TMB3740 –xyl) or 0.24 (all other strains), respectively. 
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Figure S5. Growth and PbcrC promoter activities in the wild type and bcrC and uppP 
complementation mutants. See legend of Fig. 5. Black, without xylose; green, + 0.2% 
xylose; solid line, without bacitracin; dashed line, + 30 µg ml-1 bacitracin. Thin lines 
represent the standard deviation of three biological replicates.  
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Figure S6. Minimal inhibitory bacitracin concentration of bcrC and uppP deletion 
and complementation mutants. Description, see Fig. 7. 
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Name Descriptiona Source 
E. coli strains 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F′::Tn10 proAB lacIq Δ(lacZ)M15] 
Stratagene 
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
NEB 
B. subtilis strains 
W168 wild type, trpC2 Laboratory stock 
For luminescence analysis 
TMB3688 W168 sacA::pJRlux101 (PyubA-lux) This study 
TMB1620 W168 sacA::pCHlux104 (PbcrC-lux) (Höfler et al., 2016) 
TMB1628 W168 bcrC::tet sacA::pCHlux104 (PbcrC-lux) This study 
TMB4123 W168 bcrC::tet thrC::pJR4S01 (PxylA-bcrC) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3784 W168 bcrC::tet uppP::MLS thrC::pJR4S01 (PxylA-bcrC) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3428 W168 uppP::MLS sacA::pCHlux104 (PbcrC-lux) This study 
TMB4125 W168 uppP::MLS thrC::pJR4S02 (PxylA-uppP) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3787 W168 bcrC::tet uppP::MLS thrC::pJR4S02 (PxylA-uppP) sacA::pCHlux104 (PbcrC-lux) This study 
TMB4201 W168 dgkA::kan sacA::pCHlux104 (PbcrC-lux) This study 
TMB4204 W168 dgkA::kan bcrC::tet sacA::pCHlux104 (PbcrC-lux) This study 
TMB4202 W168 dgkA::kan bcrC::tet thrC::pJR4S01 (PxylA-bcrC) sacA::pCHlux104 (PbcrC-lux) This study 
TMB4119 W168 dgkA::kan bcrC::tet uppP::MLS thrC::pJR4S01 (PxylA-bcrC) sacA::pCHlux104 (PbcrC-lux)  
TMB4205 W168 dgkA::kan uppP::MLS sacA::pCHlux104 (PbcrC-lux) This study 
TMB4203 W168 dgkA::kan uppP::MLS thrC::pJR4S02 (PxylA-uppP) sacA::pCHlux104 (PbcrC-lux) This study 
TMB4121 W168 dgkA::kan bcrC::tet uppP::MLS thrC::pJR4S02 (PxylA-uppP) sacA::pCHlux104 (PbcrC-lux)  
Cell morphology, sporulation efficiency, and bacitracin MIC 
TMB0297 W168 bcrC::tet (Rietkötter et al., 2008) 
TMB3694 W168 bcrC::tet thrC::pJR4S01 (PxylA-bcrC) This study 
TMB3739 W168 bcrC::tet uppP::MLS thrC::pJR4S01 (PxylA-bcrC) This study 
TMB3957 W168 dgkA::kan bcrC::tet uppP::MLS thrC::pJR4S01 (PxylA-bcrC) This study 
TMB3408 W168 uppP::MLS This study 
TMB3695 W168 uppP::MLS thrC::pJR4S02 (PxylA-uppP) This study 
TMB3740 W168 bcrC::tet uppP::MLS thrC::pJR4S02 (PxylA-uppP) This study 
TMB3958 W168 dgkA::kan bcrC::tet uppP::MLS thrC::pJR4S02 (PxylA-uppP) This study 
GFP-CotZ 
TMB4517 W168 amyE::p1CSV-CotZ-N-GFP (PcotYZ-gfp-cotZ) (Julia Bartels, unpublished) 
TMB4150 W168 spoVB::MLS amyE::p1CSV-CotZ-N-GFP (PcotY-gfp-cotZ) This study 
TMB4151 W168 uppP::MLS amyE::p1CSV-CotZ-N-GFP (PcotY-gfp-cotZ) This study 
Supplemental bacitracin MIC 
TMB3923 W168 dgkA::kan This study 
TMB3568 W168 yodM::spec This study 
TMB0035 W168 bceAB::kan (Rietkötter et al., 2008) 
TMB0713 W168 bceAB:kan bcrC::tet (Radeck et al., 2016) 
TMB4104 W168 yodM::spec bcrC::tet bceAB::kan This study 
TMB4110 W168 dgkA::cat bceAB::kan This study 
TMB4102 W168 uppP::mls bceAB::kan This study 
TMB4105 W168 yodM::spec uppP::mls bceAB::kan This study 
TMB4103 W168 yodM::spec bceAB::kan This study 
TMB3716 W168 yodM::spec bcrC::tet This study 
TMB3738 W168 yodM::spec uppP::mls This study 
TMB4106 W168 bcrC::tet thrC::pJR4S01 (PxylA-bcrC) bceAB::kan This study 
TMB4108 W168 bcrC::tet uppP::MLS thrC::pJR4S01 (PxylA-bcrC) bceAB::kan This study 
TMB4107 W168 uppP::MLS thrC::pJR4S02 (PxylA-uppP) bceAB::kan This study 
TMB4109 W168 bcrC::tet uppP::MLS thrC::pJR4S02 (PxylA-uppP) bceAB::kan This study 
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Table S2. Vectors and plasmids used in this study  
Name Description Resistance in E. coli / B. subtilisa Primers and Enzymes used for cloning
b Source 
Vectors 
pAH328 sacA'…'sacA, luxABCDE, cat, bla Amp
r / cmr  (Schmalisch et al., 2010)  
pBS4S thrC'…'thrC, spc, bla Ampr / spcr  (Radeck et al., 2013) 
pBS1C amyE’…’amyE, cat, bla Ampr / cmr  (Radeck et al., 2013) 
Plasmids 
pCHlux104 pAH328-derivative, sacA::PbcrC-lux, cat, bla 
Ampr / cmr  (Höfler et al., 2016) 
pJRlux101  pAH328-derivative, sacA::PyubA-lux, cat, bla Amp
r / cmr PyubA: TM4738/TM5121; EcoRI, SalI This study 
pJR4S01  pBS4S-derivative, thrC::PxylA-bcrC, spc, bla Amp
r / spcr PxylA:TM2968/ TM2969; EcoRI, SpeI. bcrC: TM2731/ TM2732; XbaI ,PstI  This study 
pJR4S02  pBS4S-derivative, thrC::PxylA-uppP, spc, bla Amp
r / spcr 
PxylA:TM2968/ TM2969; EcoRI, SpeI. 
uppP: 3 fragments (TM5122/ TM5125, 
TM5124/ TM5127, TM5126/ TM5123) 








Ampr / cmr  (Julia Bartels,  unpublished) 
b Ampr, ampicillin resistance; cmr, chloramphenicol resistance; spcr, spectinomycin resistance. 
b Genomic DNA of B. subtilis W168 was used as template for PCR. SpeI and XbaI generate compatible 
DNA overhangs. If two DNA-pieces were inserted, the vector was opened using the upstream 
restriction site of the promoter and the downstream restriction site of the gene, respectively.  
c Two silent mutations with similar codon usage were introduced into uppP to allow cloning in 
BioBrickTM standard: P103: CCTÆCCA, A195: GCAÆGCG. 
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Table S3. Primers used in this study 
a Recognition sites for endonuclease restriction enzymes are in bold. Introduced mutations are in bold 




name Description Sequence (5'->3')
 a 
Primers used for cloning 
TM4738 PyubA-fwd GATCGAATTCGCGGCCGCTTCTAGAGTTCGGGCTCGCTATGTATAC 
TM5121 PyubA-rev TAAGTCGACTCATACATAGTTTAATTAAATTGTACAC 
TM2968 PxylA-fwd GATCGAATTCGCGGCCGCTTCTAGAGAAGGCCAAAAAACTGCTGCC 
TM2969 PxylA-rev GATCACTAGTATTCGATAAGCTTGGGATCCC 
TM2731 bcrC-fwd GATCGAATTCGCGGCCGCTTCTAGAAAGGAGGTGGCCGGCTTGAACTACGAAATTTTTAAAGCAATC 
TM2732 bcrC-rev GATCACTAGTATTAACCGGTGAAATTTTGATCGGTTGGTTTTTTC 
TM5122 uppP-fwd CCTAGAATTCGCGGCCGCTTCTAGAAAGGAGGTGGCCGGCATGACTCTATGGGAATTGTTTG 
TM5123 uppP-rev GCCGGACTGCAGCGGCCGCTACTAGTATTAACCGGTTTACATCATGATCAAAAGTAAAATCAC 
TM5124 uppP-PstImut1-fwd CCGTCGGACTCGTGCCaGCAGCTGTTCTCGGCTTTTTG 
TM5125 uppP-PstImut1-rev CAAAAAGCCGAGAACAGCTGCtGGCACGAGTCCGACGG 
TM5126 uppP-PstImut2-fwd GATTAAACCACCGAGCTGCgGCCGACTTTACGTTTATTATGG 
TM5127 uppP-PstImut2-rev CCATAATAAACGTAAAGTCGGCcGCAGCTCGGTGGTTTAATC 
Primers used for LFH-PCRs 
TM4749 uppP-up-fwd GAGATTATCATTTCGATCGTCAC 
TM4750 uppP-up-rev CCTATCACCTCAAATGGTTCGCTGGTACTCTGTTAATCCTTCTACG 
TM4751 uppP-do-fwd CGAGCGCCTACGAGGAATTTGTATCGTTGCAATCTATCGAATTATTCTC 
TM4752 uppP-do-rev AATGGAACTGTATGAGTGTATCC 
TM0139 MLS-fwd CAGCGAACCATTTGAGGTGATAGGGATCCTTTAACTCTGGCAACCCTC 
TM0140 MLS-rev CGATACAAATTCCTCGTAGGCGCTCGGGCCGACTGCGCAAAAGACATAATCG 
TM0057 MLS-check-fwd CCTTAAAACATGCAGGAATTGACG 
TM0148 MLS-check-rev GTTTTGGTCGTAGAGCACACGG 
TM5303 dgkA-up-fwd CAAGAGTCGGCGCATATTATC 
TM5304 dgkA-up-rev CCTATCACCTCAAATGGTTCGCTGGAAATTCCGCTCCGTCCG 
TM5305 dgkA-down-fwd CGAGCGCCTACGAGGAATTTGTATCGCAGCCATTGAACATACGGTTG 
TM5306 dgkA-down-rev GGATAGAATTGCGGCCCTTC 
TM0137 kan-fwd CAGCGAACCATTTGAGGTGATAGG 
TM0138 kan-rev CGATACAAATTCCTCGTAGGCGCTCGG 
TM0056 kan-check-fwd CATCCGCAACTGTCCATACTCTG 
TM0147 kan-check-rev CTGCCTCCTCATCCTCTTCATCC 
TM0135 cat-fwd CAGCGAACCATTTGAGGTGATAGGCGGCAATAGTTACCCTTATTATCAAG 
TM0136 cat-rev CGATACAAATTCCTCGTAGGCGCTCGGCCAGCGTGGACCGGCGAGGCTAGTTACCC 
TM0173 cat-check-fwd CTAATGTCACTAACCTGCCC 
TM0146 cat-check-rev GTCTGCTTTCTTCATTAGAATCAATCC 
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ABSTRACT 
Bacillus subtilis combines natural competence for genetic transformation with highly 
efficient homologous recombination. These features allow using vectors that 
integrate into the genome via double homologous recombination. So far, their 
utilization is restricted by the fixed combination of resistance markers and integration 
loci, as well as species- or strain-specific regions of homology. To overcome these 
limitations, we developed a toolbox for the creation of personalized Bacillus vectors 
in a standardized manner with a focus on fast and easy adaptation of the sequences 
specifying the integration loci. We based our vector toolkit on the Standard European 
Vector Architecture (SEVA) to allow the usage of their vector parts. The Bacillus SEVA 
siblings are assembled via efficient one-pot Golden Gate reactions from four entry 
parts with the choice of four different enzymes. The toolbox contains seven Bacillus 
resistance markers, two Escherichia coli origins of replication, and a free choice of 
integration loci. Vectors can be customized with a cargo, before or after vector 
assembly, and could be used in different B. subtilis strains and potentially beyond. 
Our adaptation of the SEVA-standard provides a powerful and standardized toolkit 
for the convenient creation of personalized Bacillus vectors. 
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INTRODUCTION 
The diversity of plasmid vectors in molecular cloning 
In molecular cloning, vectors are vehicles to transfer foreign nucleic acids into a living 
cell. In the context of this article, we restrict the term “vector” to “plasmid vectors”, 
small circular DNA molecules that originate from bacteria. They are easy to handle 
for inserts up to 10-15 kb, replicate independently of the bacterial chromosome and 
can be isolated in large amounts through standard plasmid preparation procedures. 
Over the last decades, vectors were increasingly modified to meet custom needs. For 
instance, they may contain promoters for ready-to-use gene expression, or reporter 
genes to measure transcription or translation rates, respectively. More elaborated 
vector types can contain biosafety features, internal measuring standards or may be 
used for clean chromosomal gene deletions or dual expression systems 1-4. Synthetic 
biology strives to implement and extend the principles of engineering 
(standardization, decoupling, abstraction) into biology 5. Especially standardization in 
vector and plasmid construction offers the clear advantage of comparability, 
compatibility, flexibility and reusability of single parts and whole vectors, as 
exemplified by the Standard European Vector Architecture (SEVA). 
The Standard European Vector Architecture provides standardized vectors for 
Gram-negative bacteria 
In 2013, the group of Victor de Lorenzo developed a standardized vector toolbox for 
the use in Gram-negative bacteria, with a special interest in Pseudomonas putida. 
With SEVA, they set the stage for a community-driven development platform and for 
evolving a standardized vector collection. This platform facilitates finding, creating, 
and naming of suitable vectors as well as their downstream handling 6,7. Currently, 
the SEVA database lists 135 SEVA vectors and 49 SEVA siblings 8 
(http://seva.cnb.csic.es/, March 2017). Subsequently, linker sequences were 
developed to make the vectors compatible to different cloning methods 9. 
Each SEVA vector contains at least three functional elements (Fig. 1a), (i) the origin 
of replication (ori) for vector replication in the host cell, (ii) a selectable marker, e.g. 
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an antibiotic resistance cassette to select for vector uptake and maintenance, and (iii) 
a multiple cloning site (MCS) for insertion of the DNA of interest. In the SEVA 
standard, the latter part is called cargo, irrespective of the size and nature of the 
insert. The cargo is isolated by flanking double transcriptional terminators (T1, T0), to 
avoid unwanted transcriptional read-through into other elements of the backbone. 
All parts are flanked by defined rare endonuclease restriction sites and assemble in a 
fixed order and orientation (Fig. 1a). They must not contain these and further 
restriction endonuclease recognition sites. Additionally, the transcriptional 
terminators and the origin of transfer (oriT, for plasmid conjugation) are predefined, 
whereas the selectable marker, ori and cargo can be chosen freely, as long as they 
adhere to the standard. An easy number-based nomenclature assures the fast 
determination of vector features from the vector’s name 6,7. 
Distinct features of vectors for Bacillus subtilis 
Bacillus subtilis is the best studied low-G+C Gram-positive bacterium (phylum 
Firmicutes) and one of the leading workhorses of the biotechnological industry 10-12. 
Its ease of genetic manipulation is based on its natural competence, which includes 
the active uptake of (any) DNA and recombination of homologous regions into the 
chromosome 13. These features enable to routinely use integrative instead of 
replicative vectors. This ensures genetic stability even without maintaining a constant 
selective pressure. Moreover, copy number effects are avoided, which can otherwise 
influence the promoter activity on replicative vectors, particularly at the single cell 
level 14,15. 
For cloning convenience, vectors designed for integration into the B. subtilis genome 
usually replicate in E. coli but do not contain an ori for B. subtilis. Instead, two 
homology regions of at least 400 bp, which define the insertion locus, flank the cargo 
and the resistance marker for B. subtilis. The plasmids are linearized in the E. coli part 
of the vector before B. subtilis transformation to avoid integration via single crossing 
over events. Consequently, only the DNA segment that is located between the 
homology regions will integrate into the chromosome, resulting in genetic stability of 
single copy number inserts even in the absence of selective pressure. 
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The currently available vectors combine known and effective selection cassettes with 
well-characterized integration loci 16-20. This status quo limits the combination of 
resistance markers and integration sites, and does not allow targeting entirely new 
chromosomal regions. Moreover, existing vectors cannot be used in another Bacillus 
strain, which differs in the nucleotide sequence at the specified integration site. 
Due to the genetic accessibility of B. subtilis, PCR-based methods, such as long-
flanking homology (LFH)-PCR 21, can be used to target new or strain-specific loci. 
While this approach is very convenient for generating knock-out mutants, it is 
restricted with respect to the cargo: fusing several PCR products, and obtaining large 
fragments, e.g. the luxABCDE bioluminescence reporter operon (5.7 kb) that allows 
online measurement 17,19, with sufficient yield for efficient transformation (> 1 µg 22) 
can be tedious. In these cases, transformants have to be sequenced each time to 
ensure the integrity of the cargo (e.g. lack of mutations). In order to combine the 
advantages of vectors (stability and reusability) with those of PCR-based methods 
(flexibility) for the use in B. subtilis and related species, we designed, constructed and 
tested a new vector concept: the Bacillus SEVA siblings. 
Concept of Bacillus SEVA siblings as customized vectors 
Here, we describe a toolkit that was developed for the fast and easy generation of 
genomic integration vectors for B. subtilis, thereby overcoming the traditional 
limitations described above. Each vector contains a resistance marker, cargo and 
flanking homology regions of choice. To ensure compatibility and reusability of 
already existing parts for replication in E. coli, we based our system on SEVA and 
added flanking homology regions as well as Bacillus resistance markers at defined 
positions (Fig. 1b). Our vectors will be named Bacillus SEVA siblings, which is in line 
with the current SEVA regulations 6. 
Our toolbox offers seven functional antibiotic resistance cassettes for selection in B. 
subtilis and high and medium copy number E. coli vectors modified to be assembled 
with your homology regions of interest in a one-pot Golden Gate assembly 23,24. We 
tested the assembly efficiencies for five different enzymes and the B. subtilis 
transformability of every part provided. As proof of concept for efficient assembly 
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and functionality, we analyzed the expression levels of the red fluorescing protein 
mKate2 under control of the xylose-inducible promoter PxylA at different 
chromosomal insertion loci. 
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RESULTS 
Vector layout for double cross-over homologous recombination in B. subtilis 
We designed and constructed our vector building toolkit with the main goal to easily 
exchange the target loci for double homologous integration into the genome. This is 
important for two major reasons: Current vector collections do not allow the free 
combination of integration loci and selectable markers. Moreover, they omit the use 
of Bacillus strains if they differ from the reference lab strains in their nucleotide 
sequence, so that the integration sites of standard vectors are not compatible. For 
our collection of customizable vectors, we focus on allelic replacement via double 
recombination, where the DNA-sequence to be integrated into the chromosome 
(here termed integration part) is flanked by two regions of homology (Fig. 1b).  
For B. subtilis, approximately 400 bp of identical sequence are required for efficient 
integration. Shorter sequences (70 bp) can sometimes be sufficient, but are not 
recommended due to the significantly reduced efficiency 25. For ease of construction, 
the integration part is combined with an ori and selectable marker for E. coli (here 
 
Figure 1. Configuration of a SEVA vector and its Bacillus SEVA sibling. (a) The basic SEVA vector is 
composed of six parts, separated by defined endonuclease restriction sites. The transcriptional 
terminators T0 and T1 as well as the origin of transfer oriT are fixed, whereas the cargo, the ori and 
the antibiotic marker can be chosen freely from a pool of SEVA-compatible parts. (b) For genomic 
integration, three parts were added to the SEVA layout to create the Bacillus SEVA sibling pBS: 
Flanking homology regions up and down, as well as an antibiotic marker for Bacillus. Vector 
verification and propagation occurs in E. coli and only the part in between the homology regions 
will integrate into the genome. Vectors are drawn not to scale. Functional transcriptional units are 
indicated with an arrow (promoter) and black bar (terminator). 
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termed replication part). Before B. subtilis transformation, the vector is linearized in 
the replication part to avoid single cross-over events and ensure double cross-over 
integration.  
Although our toolkit was optimized for the exchange of integration sites, it can be 
customized in manifold ways as will be outlined in the discussion. A quick user manual 
with helpful information for vector construction can be found in the supplemental 
material (Text S2). 
The customizable vector collection is based on SEVA to allow re-use of E. coli parts 
Currently, most vectors and plasmids used for genetic manipulation of B. subtilis are 
propagated in E. coli. As demonstrated for NarK and β-carotene production, the E. 
coli vector propagation strongly depends on the ori and resistance markers in ways 
that cannot be foreseen yet 9. Consequently, we designed our vectors to be flexible 
not only with respect to their cargo, but also their ori and E. coli resistance marker. 
For this purpose, we based our vector toolkit on SEVA. This standard was designed 
for vectors to allow exchanging of the cargo, resistance marker and ori, using defined 
rare type II restriction enzymes 7. The accompanying vector collection was very well-
received by scientists and is still growing. It can be used to adapt the vectors of our 
toolbox, which are therefore named Bacillus SEVA siblings. SEVA restriction sites 
were removed from critical parts of the entry vectors, so that the final vectors adhere 
to the SEVA standard, if no forbidden restriction sites are present in the customized 
parts. 
Bacillus SEVA siblings are assembled de novo from multiple fragments via Golden 
Gate cloning 
As depicted in Fig. 1b, the integration and replication parts of an integration vector 
are separated by the regions of homology, called up and down. Consequently, the 
exchange of both up and down fragments with standard cloning techniques would 
involve two cloning and verification steps without a selectable marker. To avoid 
laborious stepwise cloning, advanced cloning techniques for the easy, fast, efficient 
and directed one-pot assembly of multiple fragments are available, such as Gibson 
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assembly 26,27 or Golden Gate cloning 23,24. The latter is based on a ligase and type IIS 
endonucleases (e.g. BsaI), which cut outside (next to) their recognition site. 
Consequently, the restriction site can be designed according to need and separated 
from the recognition site during the cloning procedure. The reaction mix can include 
linear and circular DNA, containing restriction sites for the same enzyme but different 
overhangs. This allows the easy and efficient assembly of up to ten parts in the correct 
order and loss of the recognition sites in the final vector 23. For our vector toolbox, 
we chose Golden Gate assembly for the following reasons: (i) Gibson assembly usually 
must be established in a lab to run smoothly, whereas restriction based cloning is 
more robust. (ii) The up and down regions need to be PCR-generated and Gibson 
assembly asks for longer overhangs thus increasing the primer costs.  
 
Figure 2. Assembly of a Bacillus SEVA sibling pBS. (a) Collection of entry parts needed for the 
assembly of a pBS vector: one cargo vector, one destination vector, one up and one down flanking 
homology fragment. The latter two are depicted as PCR fragments, but can also be located on a 
vector. Each of the desired fragments is flanked by IIS-restriction sites where the recognition site 
(R) is located outside the desired fragment. The compatibility of the resulting overhangs is indicated 
with letters and a color gradient, e.g. E1 and E2 overhangs can anneal. (b) Intermediate stage of the 
Golden Gate assembly, showing the desired fragments and some of the by-products (grey). (c) 
Creation of the final vector, including some possible by-products (grey). Only the destination vector 
and the final vector carry the ampicillin resistance marker and will be selected for after 
transformation of the reaction mix into E. coli. The destination vector will be counter-selected by a 
red/white screen based on an mRFP-marker. 
Instead of re-using and modifying preexisting vectors, each new vector will be freshly 
assembled by combining four fragments via Golden Gate assembly (Fig. 2): the up 
and down fragments, the replication part, and the cargo which includes an antibiotic 
marker for selection in Bacillus and a MCS. Therefore, all vectors and sequences 
offered through the Bacillus Genetic Stock Center (BGSC) and the SEVA collection (see 
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Table 1 and supplementary data S3) are entry vectors to allow customized assembly, 
but no final Bacillus vectors.  
Architecture of Bacillus SEVA siblings  
Fig. 1 compares a final Bacillus SEVA sibling (pBS), with a standard SEVA vector for E. 
coli. SEVA suggests a designated location for the insertion of special features that are 
not part of the cargo. They are positioned at the terminator sequences and next to, 
but not obstructing the AscI and SwaI recognition sites which allow the exchange of 
SEVA vector parts. In line with this regulation, the homology regions and resistance 
marker are located at both terminator sequences. The respective Bacillus resistance 
cassette is placed between the cargo and the T0-terminator and directed counter-
clockwise in order to not interfere with the transcription of the cargo. SEVA-vectors 
are named according to their features in a number-based code, see SEVA 2.0 for a 
comprehensive description 6. We suggest the naming of final vectors to be based on 
the SEVA-standard, in which the E. coli features are specified in three digits: the first 
digit describes the E. coli resistance marker, e.g. 1 for Ampicillin resistance or 2 for 
kanamycin. The second digit indicates the ori, e.g. 4 for pRO1600/ColE1 or 9 for 
pBR322/ROP. The third digit encodes the cargo, e.g. 1 for the default MCS or 3 for the 
lacZα-pUC18 MCS. pSEVA243 consequently is a vector mediating kanamycin 
resistance [2] with a high copy number [4= pRO1600/ColE1] that carries a MCS for 
blue/white screening [3=lacZα-pUC18]. Bacillus-specific features should be added 
behind, so pBS143K-amyE is a vector with an E. coli ampicillin resistance marker [1], 
pRO1600/ColE1 ori [4] and lacZα-pUC18 MCS [3] that carries a kanamycin Bacillus 
resistance marker [K] and integrates into the amyE-locus [amyE]. 
We conceptualized the assembly so that SEVA-parts can be exchanged before or after 
the assembly of the final vectors, e.g. to accommodate the presence of either SEVA- 
or Golden Gate-forbidden restriction sites. 
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Table 1: Vectors of the Bacillus SEVA siblings toolbox 
BGSC* Name$ Description# 
Resistance 
in E. coli / 
B. subtilis 
Source 
Vectors for default assembly 
Destination vectors 
ECE701 pBSd141R mRFP1, MCS-IIS F2, bla, ori pRO1600/ColE1, MCS-IIS B1 Ampr / - This study  
ECE702 pBSd191R mRFP1, MCS-IIS F2, bla, ori pBR322/ROP, MCS-IIS B1 Ampr / - This study 
Vectors for flanking homology regions§ 
 pSEVA243 lacZα-pUC18 MCS, neo, ori pRO1600/ColE1 Kanr/- SEVA7 
ECE703 pSEVA243X lacZα**-pUC18 MCS incl. MCS-IIS B2+C1 for up, neo, ori pRO1600/ColE1 Kanr/- This study  
ECE704 pSEVA243Y lacZα**-pUC18 MCS incl. MCS-IIS E2+F1 for down, neo, ori pRO1600/ColE1 Kanr/- This study  
Cargo-Resistance vectors 
ECE706 pBSc241B MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, bleO Kanr/bler This study  
ECE707 pBSc241C MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, cat Kanr/cmr This study  
ECE708 pBSc241M MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ermC Kanr/MLSr This study  
ECE709 pBSc241S MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, aad(9) Kanr/spcr This study  
ECE710 pBSc241T MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, tetL Kanr/tetr This study  
ECE711 pBSc241Z MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ble-Sh Kanr/zeor This study  
ECE720 pBSc291K MCS-default, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2, aph(3’)IIIa Kanr/kanr This study  
ECE713 pBSc243B lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, bleO Kanr/bler This study  
ECE714 pBSc243C lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, cat Kanr/cmr This study  
ECE715 pBSc243M lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ermC Kanr/MLSr This study  
ECE716 pBSc243S lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, aad(9) Kanr/spcr This study  
ECE717 pBSc243T lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, tetL Kanr/tetr This study  
ECE718 pBSc243Z lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ble-Sh Kanr/zeor This study  
ECE721 pBSc293K lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2, aph(3’)IIIa Kanr/kanr This study  
Vectors for customizable resistance markers 
ECE705 pBSc241 MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2 Kanr/- This study  
ECE712 pBSc243 lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2 Kanr/- This study  
ECE719 pBSc291 MCS-default, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2 Kanr/- This study  
ECE725 pBSc293 lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2 Kanr/- This study  
ECE722 pBSc391 MCS-default, MCS-IIS E1, cat, ori pBR322/ROP, MCS-IIS C2 Cmr/- This study  
ECE726 pBSc393 lacZα*-pUC18 MCS, MCS-IIS E1, cat, ori pBR322/ROP, MCS-IIS C2 Cmr/- This study  
Plasmids for activity-test 
pSEVA243X-amyE pSEVA243X-derivative carrying a 550bp amyE up fragment Kanr/- This study  
pSEVA243Y-amyE pSEVA243Y-derivative carrying a 580bp amyE down fragment Kanr/- This study  
pBSc241M_PxylA-mkate2 
(2195) pBSc241M-derivative carrying mkate2 under the control of xylose-inducible PxylA 
Kanr/- This study 
pBS141M-amyE_mkate2 PxylA-mkate2,‘amyE, bla, ori pRO1600/ColE1, amyE’, erm Ampr/MLSr This study  
pBS141M-ypqP_mkate2 PxylA-mkate2,‘ypqP, bla, ori pRO1600/ColE1, ypqP’, erm Ampr/MLSr This study  
pBS141M-ykoS_mkate2 PxylA-mkate2,‘ykoS, bla, ori pRO1600/ColE1, ykoS’, erm Ampr/MLSr This study  
pBS191M-ndk_mkate2 PxylA-mkate2,‘ndk, bla, ori pBR322/ROP, ndk’, erm Ampr/MLSr This study  
pBS141M-thrC_mkate2 PxylA-mkate2,‘thrC, bla, ori pRO1600/ColE1, thrC’, erm Ampr/MLSr This study  
Vectors used for vector construction (templates for PCR reactions) 
pDG148 bla, kan, ble/phle, Pspac Ampr/kanr 37,40 
pDG780 pBluescriptKS+, kan Kanr/kanr 41 
pBS3Clux pAH328 derivative; sacA'…'sacA, luxABCDE, bla, cat Ampr/cmr 17 
pBS4S pDG1731 derivative; thrC'…'thrC, 'hom, thrB', spc, bla Ampr/spcr 17 
pSB1A3-mkate-B0014 bla, BBa_K823051 (Bsu codon-adapted red fluorescing protein mkate2, terminator B0014), pMB1 ori (high copy number) Amp
r/- Lab stock 
* Bacillus Genetic Stock Center (BGSC, http://www.bgsc.org/) 
$ The vector names act as identifiers for the SEVA or SEVA siblings collection. p, Plasmid. BS, Bacillus SEVA sibling. 
d, destination vector / c, cargo vector / f, final vector. Numbers according to SEVA standard: 1st position, 
resistance marker (1, amp. 2, kan). 2nd position, origin of replication (4, pRO1600/ColE1, a narrow-host-range ori 
with high copy number in E. coli and varying copy number in Pesudomonas aeruginosa and close relatives7). 9, 
pBR322/ROP (medium copy number ori in E. coli and few other bacteria42).). 3rd position, cargo (1, MCS default. 
3, lacZα-pUC18 MCS which allows for blue-white screening with X-Gal). 
#  lacZα*, premature stop codon (C202A, Q68Stop). lacZα**, premature stop codon (pSEVA243X: G390A, 
W130Stop, pSEVA243Y: G399A, W133Stop). Both variants are still suitable for blue-white screening. Genes 
encoding antibiotic resistance markers are explained in detail in Table 2. 
§ Flanking homology regions can be stored in those vectors. If the PCR fragment contains the restriction sites 
needed for assembly, it can be ligated blunt end into pSEVA243 via SmaI. If restriction sites should be added for 
all enzymes, the PCR fragments can be ligated blunt end into pSEVA243X (for up) or pSEVA243Y (for down) via 
EcoRV. In this case, the correct orientation needs to be verified by sequencing.
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Golden Gate shuffling to assemble Bacillus SEVA siblings with type IIS restriction 
enzymes 
In our current set-up, four different fragments are needed to assemble the final 
vector: the up and down homology fragments, the cargo with the Bacillus resistance 
cassette and the part for replication and selection in E. coli, which we call destination 
vector. These entry parts can be combined using Golden Gate assembly as detailed in 
Fig. 2. The up and down homology fragments can be used either as PCR products (as 
depicted) or as cargo of the specialized vectors containing the up (pSEVA243X) and 
down (pSEVA243Y) fragments, respectively. Each entry part is flanked by recognition 
sites for a type IIS restriction endonuclease, which creates overhangs that allow for 
the directional assembly of all entry parts. Compatible overhangs are named with the 
same capital letter in Fig. 2a. 
As necessary for Golden Gate assembly, the recognition sites are located “outside” 
of the part desired for the assembly, so that correctly assembled parts cannot be re-
cleaved – in contrast to the re-ligation products of entry vectors. By this means, 
assembly of mostly correct final vectors is ensured. The destination vector carries a 
different antibiotic marker than all other entry vectors to select for vectors carrying 
the correct backbone. An mRFP1-cassette present on the original destination vector 
is used for red/white screening. This part is removed during assembly of the final 
vector so that colonies carrying the original vector appear red and colonies carrying 
the correct final vector appear white. 
Classic Golden Gate assembly uses BsaI and BbsI (=BpiI) as type IIS restriction 
enzymes 23,28, but BsmBI and BtgZI were recently found to also be suitable 29,30. Our 
Bacillus SEVA siblings toolbox accommodates all four of them for assembly to 
circumvent compatibility issues with the desired genomic region, e.g. the presence 
of one or more recognition sites in the up and down fragments. In addition to BsaI, 
BbsI, BsmBI and BtgZI, we also included a fifth restriction enzyme (AarI)– not reported 
previously for its use in Golden Gate assembly. 
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Golden Gate assembly restriction sites are arranged in special MCS-IIS 
All four entry parts are flanked by MCSs that contain recognition sites for all five type 
IIS restriction enzymes (MCS-IIS). Inside each MCS-IIS, recognition and restriction 
sites are designed so that the same overhang sequence is created, independent of 
the enzyme used. The overhangs are non-palindromic and differ in at least two 
nucleotides to ensure the correct assembly of the desired vector. For ease of 
understanding, fusion sites were named with capital letters B, C, E, and F as indicated 
in Fig. 2. Fig. 3 shows the annotated MCS-IIS C2, in which all five enzymes create the 
overhang GCGA. For the detailed sequence of all 8 MCS-IIS, see Fig. S1. 
 
Figure 3. Architecture of the 
MCS-IIS C2.  This DNA-
sequence is located on the 
cargo vector between the E. 
coli ori and the Bacillus 
antibiotic marker. The 
recognition sites for five type 
IIS restriction enzymes (AarI, 
BtgZI, BbsI, BsaI, BsmBI), 
each designed to create a 5’ 
GCGA-overhang are 
encoded on the DNA stretch. 
Architecture of all MCS-IIS 
can be found in Fig. S1. 
To compare the assembly efficiency as a function of the enzyme of choice, we used 
one set of entry vectors to construct final vectors with identical features. However, 
nucleotide sequences differ at the assembly scar sites, due to the MCS-IIS. We used 
pSEVA23X-amyE (up), pSEVA243Y-amyE (down), pBSc243M and pBSd141R as entry 
vectors. In this case, the cargo carries a lacZα-fragment that allows for blue-white 
screening and colonies carrying the correct vector appear blue in the presence of 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal). Red colonies carry the 
original destination vector and white colonies an incorrect vector. We checked colony 
color, test digest and sequencing results and found good assembly efficiencies for 
four enzymes: AarI, BbsI, BsaI and BsmBI (Table 3). For BtgzI however, we failed in 
finding conditions allowing the correct assembly of the final vector. This was 
surprising, since its use in Golden Gate assembly has been described previously in 
combination with BsmBI 30. Even if the desired fragments were digested and gel 
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purified separately, the ligation yielded no correct vector. But in principle, BtgZI can 
be used for assembly once suitable conditions are found. In contrast, BsaI, BpiI and 
BsmBI were particularly well-suited with efficiencies of >95% in routinely vector 
assembly (data not shown). The optimized conditions we used for each enzyme are 
given briefly in the Methods section and are described in more detail in the 
Supplemental Text S2. 
Taken together, Bacillus SEVA siblings vectors can be efficiently assembled using one 
of four type IIS restriction endonucleases. In addition to the established enzymes 
(BsaI, BbsI and BsmBI), AarI was also found to be suitable for Golden Gate assembly. 
Because of its 7 bp recognition site, it should be found less frequently in genomic 
sequences compared to the “classical” enzymes with a 6bp recognition site.  
Our collection of entry parts for the assembly of Bacillus SEVA siblings 
For the assembly of Bacillus SEVA siblings vectors, four different categories of entry 
parts are needed: cargo and resistance, up, down, and the replication part. They will 
be described in more detail below. The entry vectors offered with our toolbox are 
depicted in Fig. 4 and listed with detailed descriptions in Table 1.  
pBSc: Cargo and resistance. Since for most experiments the same cargo will usually 
be combined with the same resistance marker, both are located on the cargo vector 
pBSc. As a result, only four instead of five parts have to be assembled, thereby 
increasing cloning efficiency. For our collection of cargo vectors, we used well-
established antibiotic resistance markers to enable selection on phleomycin D, 
chloramphenicol, kanamycin, macrolide and streptogramin B antibiotics (MLS), 
spectinomycin, tetracycline, and zeocin (Table 2). Forbidden restriction sites were 
removed and transcriptional terminators were added where necessary. Transcription 
occurs in the opposite direction to the cargo. Per default, the cargo vector uses the 
high copy number ori pRO1600/ColE1. For the kanamycin resistance marker, this 
vector was unstable, so the medium copy number ori pBR322/ROP was used. All 
cargo vectors are offered with the default SEVA MCS (pUC18-related polylinker 
without lacZα, 7) or the lacZα*-pUC18 MCS (Table 1). The cargo of choice can be  
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Table 2: Description of antibiotic markers used in this study 
Abbr. Gene Description* Antibiotic  Conc.  
[µg ml-1] 
Source 
 ampr bla β-lactamase (Eco) Ampicillin 100  pSEVA143 7 
 kanr neo neomycin-kanamycin phosphotranferase 
type I (Eco) 
Kanamycin 50  pSEVA241 7 
 cmr cat chloramphenicol O-acetyltransferase (Eco) Chloramphenicol 35$ pSEVA341 7 
B  bler bleO# bleomycin binding protein (phleomycin D) Phleomycin D1 100  pDG148 40 
C cmr cat chloramphenicol O-acetyltransferase Chloramphenicol 5 pBS3Clux 17,19 
K kanr aph(3’)IIIa aminoglycoside O-phosphotransferase 
APH(3')-IIIa 
Kanamycin 10  pDG780 41 







S spcr aad(9 aminoglycoside nucleotidyltransferase 
ANT9 
Spectinomycin 200  pBS4S 16,17 
T tetr tetL tetracycline efflux MFS transporter Tetracycline 12.5  pDG1513 41 
Z zeor ble-Sh# phleomycin/bleomycin binding protein 
(codon-optimized for Bsu) 
Zeocin 100  This study  
* Eco, E. coli; Bsu, B. subtilis 
$ 5 µg ml-1 were used for medium copy number vectors. 
# bleO and ble-Sh both mediate resistance against phleomycin or zeocin (both from the bleomycin 
family) by binding to the antibiotic, respectively. There are differences in amino acid sequence of the 
encoded proteins and in the properties of the antibiotics, but mediation of cross-resistance cannot be 
excluded. 
 
Figure 4. Vector suite for the generation 
of Bacillus SEVA siblings.  Schematic 
representation of the vector 
architectures, details are listed in Table 1. 
(A). Vectors for flanking homology 
regions. Up fragments (PCR product) can 
be stored in pSEVA243X and down in 
pSEVA243Y, each linearized with EcoRV. 
The respective MCS-IIS are encoded on 
the vectors. If required restriction site are 
already encoded on the primer 
overhangs, fragments can be stored in 
pSEVA243 or used directly for Golden 
Gate assembly. (B) Cargo vectors carry 
one of the following Bacillus antibiotic 
markers: Ble, Cat, Kan, MLS, Spc, Tet, Zeo 
and either the default MCS (pBSc241res) 
or the lacZα*-pUC18 MCS for blue/white-
screening. Vectors carrying the Bacillus 
kanamycin resistance marker utilize the 
medium copy number pBR322/ROP ori, all 
others the high copy number 
pRO1600/ColE1. Backbones are also 
available without Bacillus marker to allow 
insertion of a new or customized marker. 
(C) Destination vectors carry an mRFP1-
cassette as cargo for red/white screening 
and an ampicillin resistance marker for 
selection in E. coli. They are available with 
high (pRO1600/ColE1) or medium 
(pBR322/ROP) copy number origins of 
replication. 
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inserted into the cargo vector or into the final vector, depending on enzyme 
compatibility and cloning strategy. 
Up and down flanking homology regions. The choice of up and down flanking 
homology regions depends on and needs to be adjusted to the Bacillus strain and 
experiment. The regions need specific overhangs for the subsequent assembly. This 
can be achieved by either of the following two strategies: (i) PCR-amplified fragments 
of choice (without overhangs) are cloned blunt end into the EcoRV-linearized 
pSEVA243X (up) or pSEVA243Y (down), respectively. As a result, the insert receives 
the matching MCS-IIS encoded on these vectors which can be used for Golden Gate 
assembly. (ii) Incorporation of one restriction site to the primers will directly allow 
the use of the PCR product for Golden Gate assembly.   
pBSd: replication part in E. coli. The destination vector carries the replication part of 
the final vector. Its resistance (ampicillin marker) differs from all other entry vectors 
to allow selection for the correct backbone after vector assembly. A high copy 
number (pBSd141R) and medium copy number version (pBSd191R) are provided. 
Both carry an mRFP cassette in their default MCS, thereby allowing red/white 
screening: After Golden Gate assembly, colonies with the original destination vector 
will appear red and therefore can be discarded. If different E. coli features are 
required for the final vector, they can be exchanged in the destination vector or the 
final vector, depending on needs and enzyme compatibilities. 
Assembly, transformation and integration of pBS vectors 
The reaction for the vector assembly contains the entry parts, one of the type IIS 
restriction enzymes, ligase and buffer. The specific protocols depend on the enzyme 
used and can be found in the Materials and Method section. Competent E. coli cells 
are subsequently transformed with the reaction mix and plated on selective media 
containing ampicillin (and X-Gal in case of blue/white screening). Verification of the 
final vector can be achieved in a two-step procedure using test digests followed by 
sequencing. For the latter, primers TM3782 and TM3783 (if pBSd141R was used as 
destination vector) or TM3783 and TM5128 (pBSd191R) are recommended. The 
sequencing results should cover the up and down region as well as the adjacent 
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assembly scars to ensure correct assembly of all parts. We tested all entry parts of 
the toolbox (Table 1) for their assembly efficiencies (Tables S4-S6) and found that in 
all cases it was more than sufficient to test six colonies of the correct color to obtain 
a correct final vector. If the high copy number destination vector is used, or selection 
for the correct cargo is possible, e.g. via blue/white screening, assembly efficiencies 
are even higher. 
Table 3: Assembly efficiencies* depending on restriction enzyme 






AarI 36.8 (±26.1) 0.9 (±0.9) 62.2 (±25.5) 3017 (±1292) 14/18 3/3 ++ 4/4 
BbsI 41.5 (±34.2) 0.7 (±0.1) 57.7 (±34.1) 3568 (±1084) 15/18 3/5 ++ 4/4 
BsaI 52.8 (±13.1) 6.1 (±2.2) 41.1 (±13.9) 4004 (±1443) 15/18 3/3 ++ 4/4 
BsmBI 49.8 (±11.0) 3.7 (±0.5) 46.5 (±10.9) 2000 (±412) 13/18 3/3 ++ 4/4 
BtgZI 0 0 100 182 0/6 0/3 n.a. n.a. 
 
* entry parts: pBSc243M, pBSd141R, pSEVA243X-amyE (up) and pSEVA243Y-amyE (down). 
$ Colonies appear blue if carrying the correct final vector and red if the destination vector is unchanged. 
If available, only blue colonies were used for test digest and correct test digests were used for 
sequencing. Data is shown for 3 independent Golden Gate assemblies with AarI, BbsI, BsaI or BsmBI. 
The total number of colonies as well as their apparent color is shown as average and standard 
deviation. BtgZI did not lead to correct assemblies of final vector and data is derived from a single 
experiment only. 
# Test digests, sequencing and transformation results are given in total. 
§ ++ indicates >1000 colonies per 100 µl of B. subtilis W168 transformation mixture. The correct 
insertion locus was verified with a starch test.  
Prior to transformation of B. subtilis W168, all vectors have to be linearized, e.g. using 
ApaI, to ensure chromosomal integration by double homologous recombination. All 
transformations were successful – except for vectors carrying the tetracycline 
resistance marker where only for one of two loci could be targeted (Tables S4, S5). 
The transformation efficiencies depended on the selection marker (Tables 2,3 and 
S4-S6). Correct integration was verified by colony PCR or physiological tests; e.g. a 
starch test for integration into the amyE locus. 
As a proof of concept, we analyzed the expression of the reporter gene mkate2 under 
control of the xylose-inducible promoter PxylA at five loci spread across the 
chromosome (Table 4): amyE, ykoS, ypqP (prophage SPβ), nkd, and thrC at positions 
28, 111, 183-195, 203, and 283° on the circular chromosome, respectively. amyE and 
thrC are early-discovered and frequently used integration loci close to the ori, 
encoding a starch-hydrolyzing alpha-amylase and the threonine synthase, 
respectively. The 130 kb-large prophage SPβ, which itself is inserted at the ypqP locus, 
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is known to be not essential and was targeted to demonstrate the possibility of 
deleting large genomic regions. The two remaining genes, ndk and ykoS, encode a 
nucleoside diphosphate kinase and a gene of unknown function, respectively. Those 
non-essential genes were chosen based on their chromosomal location.  
Table 4: Assembly efficiencies* and reporter activity depending on integration sites 
Locus % Light 
red $ 








amyE 69.8 19.8 10.3 1160 6/6 1/1 + 4/4 
ypqP 92.2 2.9 4.9 1236 6/6 1/1 + 4/4 
ykoS 91.6 3.2 5.3 1900 6/6 1/1 ++ 4/4 
ndk &  75 25 496 12/12 1/1 ++ 4/4 
thrC 92.1 5.2 2.6 4580 6/6 1/1 + 4/4 
* Data is shown for one Golden Gate assembly using BsaI and the following entry parts: PCR products 
up and down with BsaI-overhangs, pBSd141R and pBSc141M_Pxyl-mkate2. 
$ Colonies appear light red if carrying the correct final vector and red if the destination vector is 
unchanged. Only light red colonies were used for test digest and correct test digests were used for 
sequencing. The correct chromosomal integration was verified as described in Material and Methods. 
# Number of colonies per 100 µl of transformation mixture: ++, >1000; +, >100 and number of colonies 
with verified chromosomal integration from number of tested colonies. 
& pBSd191R was used as destination vector. No colonies of “light red” color could be identified due to 
lower copy number of the final vector, in comparison to the other constructs. As a consequence, white 
colonies were used for further verification. 
Since the same reporter was used in all vector constructs, the reporter-cargo was 
added at the entry vector level to pBSc241M, resulting in pBSc241M-PxylA-mkate2. 
pBSd141R (ori pRO/ColE1, high copy number) was chosen as the destination vector 
and primers were designed for PCR-product assembly of up and down fragments via 
BsaI. Assembly and verification of four final vectors was achieved within five working 
days. The vector carrying homology regions for integration into ndk was instable 
(small colonies), necessitating a change to pBSd191R (ori pBR322/ROP, medium copy 
number) as a destination vector. After transformation of B. subtilis W168, the 
resulting integrants were verified by starch or threonine auxotrophy tests (amyE and 
thrC, respectively), or colony PCR for the remaining loci (Table 4).  The xylose-
inducible promoter PxylA was fully induced with xylose in exponentially growing 
cultures. The fluorescence intensity of B. subtilis cells was quantified in triplicates in 
a microtiter plate reader as a measure for mKate2 production (Fig. 5). The results 
highlight a dependence of the expression levels on the chromosomal location: As 
demonstrated previously, genes close to the ori (0°/360°) tend to be expressed at 
higher levels than those close to the termination region (180°).  
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Figure 5. Maximal promoter activity of PxylA 
depends on chromosomal location. The 
reporter construct PxylA-mkate2 was 
integrated into the B. subtilis genome at five 
different chromosomal loci, as indicated. 
mKate expression was maximally induced 
with the addition of 0.2% xylose and 
fluorescence intensity was measured as an 
indicator for mKate abundance. The 
fluorescence intensity is given as a function 
of the chromosome position. The error bars 
show the standard deviation of three 
independent biological replicates. The data 
was fitted to two second order polynomial 
functions: dashed line: no constrains, 
R2=0.85; dotted line: minimum was set to 
X=180, R2=0.72. 
One exception was the ykoS-locus, located at the replication termination site, which 
had a higher reporter activity than the constructs inserted at the ori-proximal ypqP 
or ndk sites. Nevertheless, these results are in good agreement with a recent study 
31, thereby demonstrating that our vector toolbox can for example be used to study 
the effect of chromosome location on expression levels in a simple and 
straightforward manner.  
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DISCUSSION 
B. subtilis is a versatile heterologous host with powerful genetics allowing precise 
genomic manipulation. But so far, the available integrative vectors could not easily 
be adapted to different strains or, more importantly, other bacilli, since no modular 
toolbox was available to allow free combination of resistance markers and 
integration sites. To fill this gap, we present a rigorously evaluated toolbox for the 
construction of integrative vectors with customizable flanking homology regions for 
Bacillus sp. The final pBS vector can be assembled within one week from four entry 
parts via efficient Golden Gate cloning. Our vector suite offers the choice of four type 
IIS restriction endonucleases (AarI, BbsI, BsaI and BsmBI) for Golden Gate assembly, 
seven Bacillus antibiotic resistance markers, and two different MCSs, available on 
either a high or medium copy number E. coli backbone. The toolbox is adjusted to 
and widely compatible with the E. coli SEVA standard to allow reusability of its cargos 
or vector parts. All components provided in this toolbox were successfully tested for 
assembly efficiency, functionality, and usability in B. subtilis. The supplementary 
assembly guide (Text S2) provides necessary information to facilitate a fast and 
efficient cloning process. 
In the course of developing our vectors, a few combinations were discovered which 
were difficult to handle on high copy number vectors (ori pRO1600/ColE1): (i) The 
Bacillus kanamycin resistance marker was prone to mutations and is therefore 
offered with the medium copy number ori pBR322/ROP. (ii) The lacZα*-pUC18 MCS 
differs from the original lacZα-pUC18 MCS in a single-nucleotide polymorphism 
causing a premature stop codon in lacZα that does not impair blue/white screening. 
There was a strong selection pressure against the original lacZα-pUC18 MCS (very 
small colonies), which caused transposon integrations and single nucleotide 
polymorphisms in lacZα. Consequently, we used the mutated but fully functional 
lacZα*-pUC18 MCS for our constructs. (iii) The final ndk-vectors only contained the 
ndk down fragment when using the high copy number pBSd141R as destination 
vector. However, assembly with the medium copy number vector pBSd191R was 
successful in the first attempt.  
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Based on our experience, the use of a medium copy number vector is highly 
recommended as the first trouble shooting strategy in case of cloning issues, 
especially if slowly growing colonies occur. Also, low copy number oris (e.g. p15A and 
pSC101) or different directionality of the inserts could be used in case toxicity issues 
occur, which result in genetic instabilities even on medium copy number vectors.  
Furthermore, the tetracycline resistance marker could not confer resistance in B. 
subtilis W168 when the amyE locus was targeted. However, when using a different 
integration locus (lacA), the transformation was successful. Due to the dependence 
of expression levels on the chromosomal region, we suspect this to be causing the 
transformation issues. 
The Bacillus SEVA siblings toolbox was developed to provide a versatile starting point 
for the efficient construction of personalized, yet standardized vectors. Both, the 
entry parts as well as final vectors can be customized to meet personal needs. The 
MCS or cargo and ori can easily be exchanged according to the SEVA standard and 
new or modified resistance markers can be inserted in markerless cargo vectors via 
MluI, e.g. markers flanked with target sites for recombinases. These systems would 
allow directed, recombinase-mediated removal of the marker after chromosomal 
integration (for reviews on recombinase-mediated cassette exchange, e.g. by Flp and 
Cre/loxP, see 32,33).  
It should also be pointed out that the free choice of chromosomal integration loci 
provided by our vector toolbox allows for replacing even larger (non-essential) 
chromosomal areas directly in the process of plasmid integration. We have 
demonstrated this possibility by integrating an mkate2-expressing plasmid into the 
ypqP locus of the B. subtilis chromosome, thereby deleting the 130kb prophage SPβ 
(Table 4). This combined integration/deletion at any desired chromosomal position 
will greatly enhance the possibilities in genetically manipulating B. subtilis. 
The current resistance markers located on cargo vectors were tested for their 
functionality only in B. subtilis W168. Since they originate from broad host range 
vectors, they are expected to be functionally expressed in many low G+C Gram-
positive bacteria (phylum Firmicutes). The Bacillus SEVA siblings might therefore be 
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suitable for e.g. other bacilli, increasing the number of species where customized 
vectors can be used for genetic manipulation. Indeed, preliminary results from an 
ongoing study using our vectors reported similar or even better vector assembly 
efficiencies as those described in Table 3. Choramphenicol- or erythromycin-resistant 
mutants were readily obtained in Paenibacillus polymyxa (order: Bacillales, family: 
Paenibacillaceae) (Christoph Engl, personal communication). 
If transformation efficiencies are too low, conjugation can be performed using the 
oriT already included in the SEVA standard, which provides efficient transfer into 
various Gram-negative and -positive hosts7,34,35. It can be exchanged with a 
conjugation marker of choice in the destination or final vector to meet the needs of 
the target organism. Recombination efficiency of homologous sequences into the 
chromosome varies more than 30-fold along the B. subtilis chromosome 36, and even 
more between species. In general, integration rates can be improved by using longer 
stretches of DNA or a vector with a temperature-sensitive replicon (e.g. based on 
pMAD 3,37). Vector replication not only increases the number of vectors per cell and 
number of cells carrying a vector (by passing it on to the next generation), but also 
supports the second recombination event during which the vector backbone is 
excised from the chromosome 3. A temperature-sensitive origin of replication can 
therefore be added to the destination or final vector to improve recombination with 
the chromosome. 
Moreover, the construction logic described for the Bacillus SEVA siblings – that is, the 
restriction enzymes used for the assembly of the final integrative plasmids – can of 
course also be applied for developing other SEVA-compatible integration vectors for 
completely unrelated microorganisms in a similar fashion. But this would require 
adjusting the corresponding resistance cassettes applicable to these bacteria.  
Here, we present the first fully modular, yet standardized vector toolkit for 
integrative vectors in B. subtilis and beyond. We hope that the Bacillus SEVA siblings 
vector toolbox will prove to be useful for projects throughout the Bacillus world. In 
case personalized entry vectors (pBSc, pBSd) are created, we would like to encourage 
sharing them with the Bacillus community, e.g. via the SEVA or BGSC collections, to 
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further improve the tools available for genetically manipulating these powerful 
organisms.   
MANUSCRIPT II: BACILLUS SEVA SIBLINGS 
206 
MATERIAL AND METHODS 
Bacterial strains and growth conditions 
All strains used in this study are listed in Table S1. B. subtilis and E. coli were routinely 
grown in lysogeny broth (LB) medium (1% (w/v) tryptone, 0.5 % (w/v) yeast extract, 
1 % (w/v) NaCl) at 37°C with agitation (220 rpm). Solid media additionally contained 
1.5 % (w/v) agar. Selective media contained appropriate antibiotics, as provided in 
Table 2.  
Transformation 
E. coli (XL1 blue, Agilent Technologies, Santa Clara, CA, USA) competent cells were 
prepared and transformed according to the rubidium chloride method 38, achieving 
~5*106 colony forming units (CFU) per µg pUC18 DNA. Transformations of B. subtilis 
were carried out as described previously 17,22. The integration of plasmids into the B. 
subtilis genome was checked on starch plates (amyE), with minimal medium lacking 
threonine (thrC) or colony PCR (lacA, ypqP, ykoS, ndk). Detailed protocols were 
published previously 17,39. 
DNA manipulation 
Vectors and plasmids used in this study are listed in Table 1. General cloning 
procedure, such as endonuclease restriction digest, ligation and PCR, was performed 
with enzymes and buffers from New England Biolabs® (NEB; Ipswich, MA, USA) or 
Thermo ScientificTM (Waltham, MA, USA) according to the respective protocols. 
Phusion® polymerase was used for PCRs if the resulting fragment was further used, 
otherwise OneTaq® was the polymerase of choice. PCR-purification was performed 
with the HiYield PCR Gel Extraction/PCR Clean-up Kit (Süd-Laborbedarf GmbH (SLG), 
Gauting, Germany). Plasmids were prepared using alkaline lysis and subsequent DNA 
precipitation. All plasmids created during this study are listed in Table 1, their 
construction is described in supplemental Table S2 and all primer sequences are given 
in Table S3. 
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Golden Gate assemblies of final vectors 
Golden Gate assemblies were performed using T4 DNA ligase (30 WU) from Thermo 
ScientificTM with the accompanied buffer. BsaI, BbsI, BsmBI and BtgZI were purchased 
from NEB, AarI from Thermo ScientificTM. Entry parts were diluted to 20 or 40 nM 
stock concentrations and 2 or 1 µl were used per 15 µl reaction, respectively. For all 
enzymes, 0.5 µl were used per reaction, except for AarI where 1.5 µl were necessary 
because of its lower activity. BsaI and AarI are active in ligase buffer, but for AarI the 
accompanying oligonucleotides were supplemented for optimal efficiency. For BbsI 
half of the ligase buffer was replaced by NEBuffer 2.1 and for BsmBI half was replaced 
by NEBuffer 3.1.  
The general assembly protocol was 37°C, 30 min; 16°C, 30 min; (37°C, 3 min; 16°C, 5 
min) x 15; 37°C, 10 min; 50°C, 10 min; 80°C, 10 min. The exception was BsmBI, where 
55°C were required for the first incubation step and ligase was only added afterwards. 
7.5 µl of the final reaction were used for E. coli transformation. 
Measurement of PxylA activity 
Fluorescence intensity of strains carrying a transcriptional fusion of the xylose-
inducible promoter PxylA and the fluorescence reporter mkate2 were assayed using a 
SynergyTM NEOALPHAB multi-mode microplate reader from BioTek ® (Winooski, VT, 
USA). The reader was controlled using the software Gen5TM (version 2.06). Cells were 
inoculated 1:1000 from fresh overnight cultures and grown to OD600 ~ 0.2, treated 
with 0.2% xylose and grown for two hours. Cells were harvested by centrifugation 
and resuspended in phosphate buffered saline  (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4). 200 µl per well in 96-well plates (black walls, 
clear bottom; Greiner Bio-One, Frickenhausen, Germany) were measured for their 
OD600, and mKate-fluorescence using the monochromator with following 
parameters: endpoint measurement, gain: 100, excitation wavelength: 588 nm, 
emission wavelength: 633 nm. 
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Data availability 
The vectors generated in this study are available from the Bacillus Genetic Stock 
Center (BGSC, http://www.bgsc.org/ , accession numbers ECE701-26) and the SEVA 
collection (http://wwwuser.cnb.csic.es/~seva/?page_id=19). For sequence 
information, the following accession numbers apply: GenBank, KY995178 to 
KY995203; ACS Synthetic Biology Registry (https://acs-registry.jbei.org/ , 
JPUB_008862 to JPUB_008887). 
Supplementary data 
Text S1 (.pdf): Figure S1 (Architecture of all MCS-IIS) and Tables S1-S7 (Strains and 
oligonucleotides used in this study, details on plasmid construction, and assembly 
efficiencies of further pBS vectors).  
Text S2 (.pdf): Protocol for Bacillus SEVA siblings vector assembly. 
Supplementary Data S3 (.zip that contains .gbk-files): Annotated vector sequences. 
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Figure S1: Architecture of all MCS-IIS. These DNA-sequences are located on the entry vectors (see 
Figure 2) and allow the Golden Gate assembly of the final vector via one of five type IIS restriction 
enzymes (AarI, BtgZI, BbsI, BsaI, BsmBI). In each MCS-IIS, the same 4-nt overhang is created, 
irrespective of the enzyme used. The overhangs are designed to allow assembly in the specified 
order depicted in Figure 2. 
 
Table S1. Bacterial strains used in this study 
 
  
Name Description Source 
E. coli strains 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F′::Tn10 proAB lacIq Δ(lacZ)M15] 
Agilent Technologies 
NEB5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New England Biolabs® 
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Thermo ScientificTM 
B. subtilis strains 
W168 Wild-type, trpC2 Laboratory stock 
TMB3717 W168 amyE::pBSf141mls-amyE_mkate2 (PxylA-mkate2, ermC) This study 
TMB3718 W168 ypqP::pBSf141mls-ypqP_mkate2 ( PxylA-mkate2, ermC) This study 
TMB3719 W168 ykoS::pBSf141mls-ykoS_mkate2 ( PxylA-mkate2, ermC) This study 
TMB3720 W168 ndk::pBSf191mls-ndk_mkate2 ( PxylA-mkate2, ermC) This study 
TMB3721 W168 thrC::pBSf141mls-thrC_mkate2 ( PxylA-mkate2, ermC) This study 
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Table S2. Construction of Vectors and Plasmids used in this study 
Name Primers and Enzymes used for cloninga 
pBSd141R 800bp DNA-fragment (synthesized by Thermo ScientificTM containing MCS-IIS B1, T1, MCS default, T2, MCS-IIS F2) 
was ligated into pSEVA243 via SwaI+AscI to create vector pSEVA141BF. Monomeric red fluorescent protein (mRFP 
BBa_E1010)) was codon-optimized for expression in Bacillus with B. subtilis W168 rpsB promoter and yvtI terminator 
from Bacillus licheniformis DSM13, synthesized, cut with KpnI+BbsI and ligated into pSEVA141BF (BamHI+KpnI). 
pBSd191R BsmBI-free pBR322 origin of replication was created by PCR-joining two fragments with primers TM4150+TM4153: 
TM4150+TM4151, pMAD and TM4152+4153, pMAD. This fragment was cut with FseI+AscI and ligated with the 1500bp 
and 600bp fragments of pSEVA141BF cut with SwaI, FseI and AscI. mRFP from pBSd141R was inserted via 
EcoRI+XbaI. 
pSEVA243X DNA-fragment containing MCS-IIS B2, EcoRV and MCS-IIS C1 was synthesized by Thermo ScientificTM and cloned into 
pSEVA243 via EcoRI+SpeI. 
pSEVA243Y DNA-fragment containing MCS-IIS E2, EcoRV and MCS-IIS F1 was synthesized by Thermo ScientificTM and cloned into 
pSEVA243 via EcoRI+SpeI. 
pBSc241B ble-cassette was amplified by PCR (TM3773+TM3774, pDG148), cut with MluI and ligated into  
pBSc241 (cut with AscI).  
pBSc241C cat-cassette was amplified by PCR (TM3771+TM3772, pBS3Clux), cut with MluI and ligated into pBSc241 (cut AscI). 
pBSc241M SacI-free mls-cassette was created by PCR-joining 2 fragments with TM3767+TM3768: TM3767+TM3770, pDG647 
and mls-back TM3769+TM3768, pDG647, cut with MluI and ligated into pBSc241 (cut with AscI).  
pBSc241S KpnI+SwaI-free spec-cassette (incl. terminator BBa_B0014) was created by PCR-joining 3 fragments with 
TM3762+TM3761: TM3762+TM3764, pBS4S, TM3763+TM3765, pBS4S and TM3766+TM3761, pSB1A3-mkate-
B0014, cut with MluI and ligated into pSEVA241EC (cut with AscI).  
pBSc241T BsmBI+AarI-free tet-cassette was created by PCR-joining 2 fragments with TM3752+TM3753: TM3752+TM3755, 
pDG1513 and TM3754+TM3753, pDG1513, cut with MluI and ligated into pBSc241 (cut with AscI). 
pBSc241Z zeo-cassette was synthesized by Thermo ScientificTM (codon adapted for B. subtilis, with kan-promoter from pDG780 
and cat-terminator from pBS3Clux flanked with MluI restriction sites), cut with MluI and ligated into pBSc241 (cut with 
AscI). 
pBSc291K BbsI-free kan-cassette (incl. terminator BBa_B0014) was created by PCR-joining of 3 fragments with TM3756+TM3761: 
TM3756+TM3758, pDG780, TM3757+TM3759, pDG780 and TM3760+TM3761, pSB1A3-mkate-B0014, cut with MluI 
and ligated into pBSc291 (cut with AscI). 
pBSc243B lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241B via PacI+SpeI. 
pBSc243C lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241C via PacI+SpeI. 
pBSc243M lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241M via PacI+SpeI. 
pBSc243S lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241S via PacI+SpeI. 
pBSc243T lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241T via PacI+SpeI. 
pBSc243Z lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241Z via PacI+SpeI. 
pBSc293K lacZα*-pUC18-MCS from pBSc243 was ligated into pBSc291K via PacI+SpeI. 
pBSc241 DNA-fragment containing MCS-IIS C2, T1, MCS default, T0, MCS-IIS E1 was synthesized by Thermo ScientificTM, cut 
with MluI+ScaI and ligated into pSEVA243 (cut with SwaI+AscI). 
pBSc243 lacZα*-pUC18-MCS from pSEVA143* was ligated into pBSc241 via PacI+SpeI. 
pBSc291 BsmBI-free ori pBR322 from pBSd191R cut with AscI+FseI was ligated into pSEVA243 cut with AscI+FseI+SpeI (both 
800bp and 1300bp fragments), creating pSEVA293*. DNA-fragment containing MCS-IIS C2, T1, MCS default, T0, MCS-
IIS E1 was synthesized by Thermo ScientificTM, cut with MluI+ScaI and ligated into pSEVA293* (cut with SwaI+AscI). 
pBSc293 lacZα*-pUC18-MCS from pBSc243 was ligated into pBSc291via PacI+SpeI. 
pBSc391 BtgZI/BsmBI/ScaI-free cat cassette was synthesized by Thermo ScientificTM and ligated into pSEVA243 via 
PshAI+SwaI, creating pSEVA343*. BsmBI-free ori pBR322 cut from pBSd191R with AscI+FseI ligated into pSEVA343* 
cut with AscI+FseI+SpeI (both: 800+1500bp bands were used), creating pSEVA393*. DNA-fragment containing MCS-
IIS C2, T1, MCS default, T0, MCS-IIS E1 was synthesized by Thermo ScientificTM, cut with MluI+ScaI and ligated into 
pSEVA393* (SwaI+AscI). 
pBSc393 lacZα*-pUC18-MCS from pBSc243 was ligated into pBSc392 via PacI+SpeI. 
pSEVA243X-
amyE 








Insert PxylA (BBa_K1351039, EcoRI+SpeI) and red fluorescent protein mkate2 (BBa_K823029, codon-adapted to B. 




Golden Gate reaction with BsaI and the vectors pBSc141M_PxylA-mkate2 and pBSd141R, as well as the PCR fragments 
(~500 bp) BsaI-amyE-up (TM4518+TM4519, W168) and BsaI-amyE-do (TM4983+TM4984, W168). 
pBS141M-
ypqP_mkate2 
Golden Gate reaction with BsaI and the vectors pBSc141M_PxylA-mkate2 and pBSd141R, as well as the PCR fragments 
(~500 bp) BsaI-ypqP-up (TM5100+TM5101, W168) and BsaI-ypqP-do (TM5102+TM5103, W168). 
pBS141M-
ykoS_mkate2 
Golden Gate reaction with BsaI and the vectors pBSc141M_PxylA-mkate2 and pBSd141R as well as the PCR fragments 
(~500 bp) BsaI-ykoS-up (TM5108+TM5109, W168) and BsaI-ykoS-do (TM5110+TM5111, W168). 
pBS191M-
ndk_mkate2  
Golden Gate reaction with BsaI and the vectors pBSc141M_PxylA-mkate2 and pBSd191R as well as the PCR fragments 
(~500 bp) BsaI-ndk-up (TM5112+TM5113, W168) and BsaI-ndk-do (TM5114+TM5115, W168). 
pBS141M-
thrC_mkate2 
Golden Gate reaction with BsaI and the vectors pBSc141M_PxylA-mkate2 and pBSd141R as well as the PCR fragments 
(~500 bp) BsaI-thrC-up (TM5116+TM5117, W168) and BsaI-thrC-do (TM5118+TM5119, W168). 
a lacZα*-pUC18: contains a premature stop codon (C202T => Q68*) in the lacZα-open reading frame. lacZα is still 
functional for blue-white screening. Non-mutated fragments (can) lead to plasmid instability if combined with 
the high copy number ori pRO1600/ColE1. 
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Table S3: Oligonucleotides used in this study 
Number Name Sequencea (5’ to 3’) 
TM0057 mls-check-fwd CCTTAAAACATGCAGGAATTGACG 
TM0718 cat-check-fwd AATAGCGACGGAGAGTTAGG 
TM0498 kan-check-fwd GCCGGTATAAAGGGACCACC 
TM0058 spec-check-fwd GTTATCTTGGAGAGAATATTGAATGGAC 
TM5222 tet-check-fwd TGTTTTAGGTGGGCTTTCGTTC 
TM3680 pSEVA PS1 AGGGCGGCGGATTTGTCC 
TM3681 pSEVA PS2 GCGGCAACCGAGCGTTC 
TM3682 pSEVA PS3 GAACGCTCGGTTGCCGC 
TM3683 pSEVA PS4 CCAGCCTCGCAGAGCAGG 
TM3684 pSEVA PS5 CCCTGCTTCGGGGTCATT 
TM3685 pSEVA PS6 GGACAAATCCGCCGCCCT 
TM3782 pSEVAcheck-sites1 CGCAAAAAACGCACCACTACG 
TM3783 pSEVAcheck-sites2 GGTTATTGTCTCATGAGCGG 
TM3784 pSEVAcheck-sites3 CTTGTATTACTGTTTATGTAAGCAG 
TM4154 SEVA141BF-T0SpeI-fwd CTGGCGACTAGTCTTGGAC  
TM5128 pSEVAcheck-sites4 GGTTACTGATGATGAACATGC 
TM3752 MluI-Tet-fwd GATCACGCGTGGATTTTATGACCGATGATGAAG 
TM3753 MluI-Tet-rev GATCACGCGTTAAAAAAAGGATCAATTTTGAACTCTC 
TM3754 Tet-BsmBI,AarI mut fwd GAAATGGTTTTGAACGTCagcTTACCTGATATTGCAAATGATTTTAATAAA
CCtCCTGCGAGTACAAACTGG 
TM3755 Tet-BsmBI,AarI mut rev CCAGTTTGTACTCGCAGGaGGTTTATTAAAATCATTTGCAATATCAGGTA
AgctGACGTTCAAAACCATTTC 
TM3756 MluI-kan-fwd GATCACGCGTTTCTGGTATTTAAGGTTTTAGAATGC 
TM3757 Kan-BbsI mut fwd  GGATTGCGAAAACTGGGAAGAgGACACTCCATTTAAAGATCCGC 
TM3758 Kan-BbsI mut rev GCGGATCTTTAAATGGAGTGTCcTCTTCCCAGTTTTCGCAATCC 
TM3759 Kan w/o term rev GAGCCAGTGTGAGGTACTAAAACAATTCATCCAG 
TM3760 B0014-kan-fusion fwd GAATTGTTTTAGTACCTCACACTGGCTCACCTTCG 
TM3761 MluI-B0014-rev GATCACGCGTAAAATAATAAAAAAGCCGGATTAATAATC 
TM3762 MluI-spec-fwd GATCACGCGTTAACAACTATGGATATAAAATAGG 
TM3763 Spec-KpnImut fwd CAATTATTATTCAGCAAGAAATGGTtCCGTGGAATCATCCTCCC 
TM3764 Spec-KpnImut rev GGGAGGATGATTCCACGGaACCATTTCTTGCTGAATAATAATTG 
TM3765 Spec-SwaImut-w/oterm rev TTATAATTTTTTTAATCTGTTgTTTAAATAGTTTATAGTTAAATTTAC 
TM3766 B0014-spec-fusion fwd CTATTTAAAcAACAGATTAAAAAAATTATAATCACACTGGCTCACCTTCG 
TM3767 MluI-mls- fwd GATCACGCGTGATCCTTTAACTCTGGCAACCCTC 
TM3768 MluI-mls-rev GATCACGCGTGCCGACTGCGCAAAAGACATAATC 
TM3769 MLS-SacImut fwd CTCATCATGTTCATATTTATCAGAGgTCGTGCTATAATTATACTAATTTTA
TAAGG 
TM3770 MLS-SacImut rev CCTTATAAAATTAGTATAATTATAGCACGAcCTCTGATAAATATGAACATG
ATGAG 
TM3771 MluI-cat-fwd GATCACGCGTAAGTGGGATATTTTTAAAATATATATTTATG  
TM3772 MluI-cat-rev GATCACGCGTCAGGTTAGTGACATTAGAAAACC  
TM3773 MluI-bleo-fwd GATCACGCGTACGATGACCTCTAATAATTGTTAATC  
TM3774 MluI-bleo-rev GATCACGCGTTCTTTTATTCAGCAATCGCGC  
TM4150 pBR322-AscI fwd TATTTTGGCGCGCCAATATCCCGCCGCATCCATACC  
TM4151 pBR322-BsmBImut rev GCTTACAGACAAGCTGTGACgcTCTCCGGGAGCTGCATG  
TM4152 pBR322-BsmBImut fwd CATGCAGCTCCCGGAGAgcGTCACAGCTTGTCTGTAAGC  
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TM4153 pBR322-FseI-rev TTAAATGGCCGGCCCGTAGAAAAGATCAAAGGATC  
TM4230 SEVA-amyE-up-fwd ATGTTTGCAAAACGATTCAAAACC 
TM4231 SEVA-amyE-up-rev CGATCAGACCAGTTTTTAATTTG 
TM4981 SEVA-amyE-do fwd CTGGGCGGTGATAGCTTC 
TM4982 SEVA-amyE-do rev CTTTTGTTGTATTCGCATCTGC 
TM4518 BsaI-amyE-up-fwd CTCAAGGGGTCTCCACCCATGTTTGCAAAACGATTCAAAACC 
TM4519 BsaI -amyE-up-rev CTCAAGGGGTCTCCTCGCCGATCAGACCAGTTTTTAATTTG 
TM4983 BsaI -amyE-do-fwd CTCAAGGGGTCTCCGAGACTGGGCGGTGATAGCTTC 
TM4984 BsaI -amyE-do-rev CTCAAGGGGTCTCCTGAGCTTTTGTTGTATTCGCATCTGC 
TM5100 BsaI-ypqP-up-fwd CTCAAGGGGTCTCCACCCCAAAGTTGAACATATGATGCATGG 
TM5101 BsaI-ypqP-up-rev CTCAAGGGGTCTCCTCGCGTACTGATATTAATGACATGCTGC 
TM5102 BsaI-ypqP-do-fwd CTCAAGGGGTCTCCGAGAGTATCTCCTGTGAACACAATGG 
TM5103 BsaI-ypqP-do-rev CTCAAGGGGTCTCCTGAGGATGCAATTCTTCAATAATCTGAGC 
TM5108 BsaI-ykoS-up-fwd CTCAAGGGGTCTCCACCCAAAGGAAGATGCCCATATCCG 
TM5109 BsaI-ykoS-up-rev CTCAAGGGGTCTCCTCGCCGTCATAAATGCAATACTGCCT 
TM5110 BsaI-ykoS-do-fwd CTCAAGGGGTCTCCGAGATTGTTATATACGTGAGCTTTGCG 
TM5111 BsaI-ykoS-do-rev CTCAAGGGGTCTCCTGAGCGTTTACCGAGTTCATCGAC 
TM5112 BsaI-ndk-up-fwd CTCAAGGGGTCTCCACCCCGCAGGAACAGCTTGAACC 
TM5113 BsaI-ndk-up-rev CTCAAGGGGTCTCCTCGCTGTTCGGCGTAGTGTTTCTC 
TM5114 BsaI-ndk-do-fwd CTCAAGGGGTCTCCGAGAACCTGTATTCGCAATGGTGTG 
TM5115 BsaI-ndk-do-rev CTCAAGGGGTCTCCTGAGAGTCTCGCTGTCTTTTTGTCC 
TM5116 BsaI-thrC-up-fwd CTCAAGGGGTCTCCACCCGCGTGAGCTTTGAAAAAATCC 
TM5117 BsaI-thrC-up-rev CTCAAGGGGTCTCCTCGCAATGCATTTCATGTTAGCACGG 
TM5118 BsaI-thrC-do-fwd CTCAAGGGGTCTCCGAGAGAAAATCCGGAAACAATAGCG 
TM5119 BsaI-thrC-do-rev CTCAAGGGGTCTCCTGAGGCTTTCAAAGACGGTCAGC  
a Endonuclease restriction enzyme recognition sites in italics, restriction site in bold for IIS enzymes; 
Underlined nucleotides do not anneal with the original template. Introduced mutated nucleotides in 
lower case. 
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Tables S4-6. Assembly efficiencies for BSs vectors. Colonies appear blue (Table S4 
and first five constructs of Table S6) or white (Table S5 and remaining constructs of 
Table S6) if carrying the correct final vector and red if the destination vector is 
unchanged. Only colonies of the correct color were used for test digest and correct 
test digests were used for sequencing. Data is shown for one Golden Gate assembly 
each. Number of colonies per 100 µl of B. subtilis W168 transformation mixture: ++, 
>1000; +, >100; o,>10; θ, <10; -, no colony with verified chromosomal integration. 
Number of colonies with correct insertion locus as verified with a starch test (out of 
colonies tested) is given in the last column.  
 
Table S4. Assembly efficiencies for pBSc241-derivatives with pSEVA243XamyE (up) , 
pSEVA243YamyE (down), pBSd141R and BsaI. 








pBSc241 90.8 9.2 8592 3/6 1/1 n.a. n.a. 
pBSc241B 93.6 6.4 6336 4/6 1/1 o 2/4 
pBSc241C 86.5 13.5 4384 3/6 1/2 ++ 3/4 
pBSc291K 84.5 15.5 3564 4/6 1/2  o 2/11 
pBSc241M 84.1 15.9 3328 2/6 1/1 ++ 3/4 
pBSc241S 90.6 9.4 6816 5/6 1/1 o 3/10 
pBSc241T 90.3 9.7 1480 2/6 1/1 -; θ* 0/1;3/3a 
pBSc241Z 91.2 8.8 2448 6/6 1/1 o 4/4 
a B. subtilis transformation was not successful for integration into the amyE locus. However, 
transformation was successful if the lacA locus was targeted (data only shown in column “B. subtilis 
transformation”). 
 
Table S5. Assembly efficiencies for pBSc243-derivatives with pSEVA243XamyE (up) , 
pSEVA243YamyE (down), pBSd141R and BsaI. 








pBSc243 81.5 9.6 8.9 7248 6/6 1/1 n.a. n.a. 
pBSc243B 75.4 17.8 6.8 4224 6/6 1/1 o 4/4 
pBSc243C 68.0 18.4 13.6 5056 3/6 1/2 ++ 4/4 
pBSc293K 76.8 11.8 11.4 2640 4/6 1/1 o 4/4 
pBSc243M 71.3 7.2 21.5 6024 3/6 1/1 ++ 4/4 
pBSc243S 82.8 4.4 12.8 3248 6/6 1/1 o 7/20 
pBSc243T 78.9 5.0 16.1 2576 5/6 1/1 -; θa 0/7;9/9a 
pBSc243Z 77.9 16.1 6.0 2988 6/6 1/1 o 4/4 
a B. subtilis transformation was not successful for integration into the amyE locus. However, 
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Table S6. Efficiencies for BsaI-mediated pBS assembly with mixed combinations of 
cargo, up, down and destination vectors and parts. 








34V 44.8 3.0 52.2 3248 6/6 1/1 ++ 4/4 
34P 73.4 10.8 15.8 3336 6/6 1/2 + 4/4 
39V 67.7 19.4 12.9 744 6/6 1/1 ++ 4/4 
39P 68.0 30.9 1.1 4200 6/6 1/1 ++ 4/4 
39Pkan 62.1 36.6 1.3 3672 6/6 1/1 o 4/4 
14V n.a. 38.1 61.9 2560 4/6 1/1 + 4/4 
14P n.a. 82.0 18.0 2000 3/6 1/1 ++ 4/4 
19V n.a. 95.7 4.3 1128 3/6 1/1 ++ 4/4 
19P n.a. 99.2 0.8 2380 1/6 1/1 ++ 4/4 
19Pkan n.a. 98.6 1.4 2840 1/6 1/1 o 4/4 
a The abbreviations encode for entry parts and are outlined in Table S7. 
 
Table S7. Legend for Table S6. 
Name Cargo Destination Up Down 
34V pBSc243M pBSd141R pSEVA243XamyE pSEVA243YamyE 
34P pBSc243M pBSd141R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
39V pBSc243M pBSd191R pSEVA243XamyE pSEVA243YamyE 
39P pBSc243M pBSd191R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
39Pkan pBSc293K pBSd191R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
14V pBSc241M pBSd141R pSEVA243XamyE pSEVA243YamyE 
14P pBSc241M pBSd141R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
19V pBSc241M pBSd191R pSEVA243XamyE pSEVA243YamyE 
19P pBSc241M pBSd191R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
19Pkan pBSc291K pBSd191R BsaI-amyE-up (PCR) BsaI-amyE-down (PCR) 
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HOW TO BUILD YOUR OWN BACILLUS SEVA SIBLING (PBS) 
EXPLANATION OF BACILLUS SEVA SIBLINGS 
1) Bacillus SEVA siblings (pBS) are vectors that are made for Bacillus sp. and are based 
on the Standard European Vector Architecture (SEVA) for replicative E. coli vectors. 
 
 
Figure 1. Comparison of SEVA vector (a) and Bacillus SEVA sibling (b) 
2) They are assembled from 4 parts (up, cargo-resistance pBSc, down, and destination 
pBSd) via the one-pot Golden Gate assembly (compatible overhangs are marked 
with the same letter, see Fig. 2), so that the homology regions for genomic 
integration can be easily adjusted to your strain of interest. 
3) Single parts of the vector can be exchanged before or after the assembly according 
to the SEVA-Standard. 
4) List of available Entry vectors, see Table 1 and 2: destination vectors (pBSd); up and 
down vectors; cargo-resistance vectors (pBSc). Sequences can be downloaded from 
the SEVA and Bacillus Genetic Stock Center (BGSC) collections. 
Table 1. Quick guide of entry vectors 
Name description Remarks/What to do with it? 
pSEVA243X For up fragments Linearize (EcoRV) and insert your PCR product to 
receive appropriate MCS-IIS (B2+C1). Allows 
blue/white screening. 
pSEVA243Y For down fragments Linearize (EcoRV) and insert your PCR product to 
receive appropriate MCS-IIS (E2+F1). Allows 
blue/white screening. 
pSEVA243a For up and down fragments Linearize (SmaI) and insert PCR product that 




Cargo-resistance vector with  
- default MCS (pUC18) 
- MCS lacZα-pUC18 
*Resistances available: -, ble, cat, kan, mls, spec, 
tet, zeo. kan is offered in a medium copy vector 




Destination vectors with 
- high copy ori: pRO1600/ColE1 
- medium copy ori: pBR322/ROP 
Both carry mRFP1 for red/white screening 
Adjust E. coli ori before or after BSs assembly 
a pSEVA243 seems to be prone to transposal integration in the lacZα-region in some E. coli strains, as manifesting 
in white (and only small blue) colonies on X-Gal. In this case, consider changing the strain, ori or lacZα-version.  
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Figure 2. Schematic assembly of Bacillus SEVA sibling from entry parts 
PLANNING THE ASSEMBLY 
Useful questions to plan your vector assembly 
1) Is it helpful to insert “your” construct of interest into the cargo region before or 
after pBS assembly? (test same construct/promoter etc. in different loci or rather 
use one locus and different cargos?) Æboth is possible 
2) Which resistance marker to choose? (The tet marker was not working properly for 
integration into the amyE locus.) 
3) Which MCS to choose (with lacZa (= encoded by “3” as a third digit) for blue-white 
screening, or without (encoded by “1”))? 
Table 2. Entry vectors available for BSs assembly 
BGSCa Nameb Description 
Resistance in E. 
coli / B. subtilis 
Vectors for default assembly 
Destination vectors 
ECE701 pBSd141R mRFP1, MCS-IIS F2, bla, ori pRO1600/ColE1, MCS-IIS B1 Ampr / - 
ECE702 pBSd191R mRFP1, MCS-IIS F2, bla, ori pBR322/ROP, MCS-IIS B1 Ampr / - 
Vectors for flanking homology regions 
 pSEVA243 lacZα-pUC18 MCS, neo, ori pRO1600/ColE1 Kanr/- 
ECE703 pSEVA243X lacZα*-pUC18 MCS incl. MCS-IIS B2+C1 for up, neo, ori pRO1600/ColE1 Kanr/- 
ECE704 pSEVA243Y lacZα*-pUC18 MCS incl. MCS-IIS E2+F1 for down, neo, ori pRO1600/ColE1 Kanr/- 
Cargo-Resistance vectors 
ECE706 pBSc241B MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, bleO Kanr/bler 
ECE707 pBSc241C MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, cat Kanr/cmr 
ECE708 pBSc241M MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ermC Kanr/mlsr 
ECE709 pBSc241S MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, aad(9) Kanr/spcr 
ECE710 pBSc241T MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, tetL Kanr/tetr 
ECE711 pBSc241Z MCS-default, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ble-Sh Kanr/zeor 
ECE720 pBSc291K MCS-default, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2, aph(3’)IIIa Kanr/kanr 
ECE713 pBSc243B lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, bleO Kanr/bler 
ECE714 pBSc243C lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, cat Kanr/cmr 
ECE715 pBSc243M lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ermC Kanr/mlsr 
ECE716 pBSc243S lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, aad(9) Kanr/spcr 
ECE717 pBSc243T lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, tetL Kanr/tetr 
ECE718 pBSc243Z lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pRO1600/ColE1, MCS-IIS C2, ble-Sh Kanr/zeor 
ECE721 pBSc293K lacZα*-pUC18 MCS, MCS-IIS E1, neo, ori pBR322/ROP, MCS-IIS C2, aph(3’)IIIa Kanr/kanr 
a Bacillus Genetic Stock Center (http://www.bgsc.org/order.php) 
b Numbers according to SEVA standard: 1st position, resistance marker (1, amp; 2, kan). 2nd position, 
origin of replication (4, pro1600/colE1 (high copy number). 9, pBR322/ROP (medium copy number). 
3rd position, cargo (1, MCS default. 3, lacZα-pUC18 MCS which allows for blue-white screening with X-
Gal). For further annotations, please see main publication. 
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4) Which locus and homology regions to choose? (For B. subtilis >400 bp is 
recommended; <800 bp is useful for sequencing reasons) 
5) Which enzyme (BsaI, BbsI, BsmBI, AarI) to choose for the Golden Gate assembly 
(check Cargo and homology regions for the respective recognition sites!)? Æ BsaI is 
a good default. BtgZI was not working as intended. [Personal experience: the 
assembly can work fine, even if one unwanted restriction site is present, as long as 
it is incompatible to the overhangs used for assembly.] 
6) Choose destination vector (high (“4” as second digit) or medium copy number(“9”)). 
For assemblies with parts known to be difficult to handle on high copy number 
vectors (e.g. the Bacillus kan-cassette), the medium copy number version should be 
chosen. 
7) Reusability of integration sites 
a) Use once/few times or only with one of the enzmyes? Æ use PCR product 
with overhangs containing the necessary restriction sites. It can also be 
stored in a vector that does not mediate ampicillin resistance in E. coli, e.g. 
pSEVA243. 
b) Flexibility in choosing the enzyme for the assembly? Æ use primers without 
overhangs and insert into pSEVA243X and pSEVA243Y to add overhangs for 
all enzymes (check for correctly directed insertion!). 
Primer design (and cloning) of up and down integration sites 
8) If you choose to only use one enzyme sites (7a): Add the respective overhangs to 
primers for up and down integration site (see example primers below) Æ the 
fragment can still be stored e.g. in pSEVA243 (via SmaI; direction of ligation into 
vector is not important) and either the PCR product or the vector can be used for 
Golden Gate assembly.  
Table 3. Example primers with Golden Gate overhangs.  










BsaI -amyE-up-rev ctcaaggGGTCTCCTCGCCGATCAGACCAGTTTTTAATTTG 
BsaI -amyE-do-fwd ctcaaggGGTCTCCGAGAATGGATGAGCGATGATGATATC 
BsaI -amyE-do-rev ctcaaggGGTCTCCTGAGTCAATGGGGAAGAGAACCG 
AarI-amyE-up-fwd ctcaaggCACCTGCaatgACCCATGTTTGCAAAACGATTCAAAACC 
AarI -amyE-up-rev ctcaaggCACCTGCaatgTCGCCGATCAGACCAGTTTTTAATTTG 
AarI -amyE-do-fwd ctcaaggCACCTGCaatgGAGAATGGATGAGCGATGATGATATC 
AarI -amyE-do-rev ctcaaggCACCTGCaatgTGAGTCAATGGGGAAGAGAACCG 
a The recognition site, restriction site (in all cases a 3’ overhang will be generated), and annealing part 
are indicated. The annealing part needs to specified for “your” fragments. Lower case letters ensure 
binding of the enzyme to the PCR-product and can be changed, but work fine as they are. 
 
9) If you choose to be flexible with the restriction enzyme (7b): Amplify your up and 
down fragment with primers without overhang and ligate into EcoRV-site of 
pSEVA243X (up) or pSEVA243Y (down). Check for correct direction of integration via 
sequencing. Use the vector for Golden Gate assembly.  
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10) If desired, different directionality of the integration part can be achieved by adding 
overhangs to the up and down fragments using primer overhangs vice versa to the 
default version. 
Preparation 
1) Make sure that you have all fragments/vectors and the enzymes ready for your 
assembly. All entry vectors except for the destination vector (= pBSc and 
pSEVA243X, pSEVA243Y) mediate kanamycin resistance in E. coli (50 µg ml-1), 
whereas the destination vectors pBSd mediate ampicillin resistance (100 µg ml-1). 
2) Enzyme supplier: Thermo ScientificTM: T4 DNA ligase 30 WU + buffer, AarI + Oligo; 
New England Biolabs®: BsaI (not “HF”), BsmBI, BbsI, NEBuffer 2.1, 3.1 
ASSEMBLY 
Preparation 
1) Prepare and purify vectors or PCR products (Midi, Mini plasmid or PCR prep kits 
with DNA-binding columns). If you use PCR products, please ensure to clean the 
product from primer-dimers via gel extraction, since those carry the restriction 
sites needed for assembly and will be inserted into the final vector instead of the 
correct part. 
2) Dilute all vectors and fragments to 40 nM (=fmol/µl), or 20 nM. 
Calculation from µg/ml to nM: c (nM) = x (conc. in ng µl-1) *1520/ length (bp) 
We recommend estimating the DNA concentration on an agarose gel. For PCR products 
please ensure there are no “primer clouds” or other fragments as they all contain the correct 
overhangs and will be part of the assembly! 
Golden Gate assembly 
For each assembly (in µl) 
Cargo (40nM) 1 
Destination (40nM) 1 
Up (40nM) 1 
Down (40nM) 1 
T4 DNA-Ligase (30WU)* 0.5 
10x BSA 1.5 
H2O Ad 15+ 
+taking into account the enzyme-specific volume given below 
Add the following components according to the enzyme to be used: 
AarI 1.5 BsaI 0.5 BbsI 0.5 BsmBI* 0.5 
50x Oligo 0.3   Puffer 2.1 0.75 Puffer 3.1 0.75 
Ligase buffer 1.5 Ligase buffer 1.5 Ligase buffer 0.75 Ligase buffer 0.75 
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E. coli transformation into and selection 
3) Use competent cells of at least 5*106 CFU/µg DNA. Below 106 is not 
recommended. 
4) Plate on selective media (100 µg ml-1 ampicillin). For vectors containing lacZα, 
IPTG (1µM) and X-Gal (100 µg ml-1) can be supplemented to allow blue/white-
screening. 
5) Colonies containing the original destination vector will appear red, those 
containing the correct vector will be white or blue (if lacZα is present). Prolonged 
incubation or storage can enhance colors of the colonies. 
6) Pick colonies for Colony PCR or plasmid preparation (for lacZα also use a replica 
plate without X-Gal, since “blue” is the “dominant” phenotype over “red”) and 
perform test digest. (e.g. with PvuII or enzymes cutting “your” up and down 
fragments or cargo). 
7) Verify the correct insert and assembly break points via sequencing (TM3782 and 
TM3783 for high copy number, TM5128 and TM 3783 for medium copy number 
vectors). 
Table 3. Oligonucleotides recommended for sequencing 





8) If the ratio of colonies displaying the correct color is far off (20 red: 1 white e.g.), 
the procedure should be optimized, because most likely those white colonies 
contain wrong vectors. 
9) Correct colonies might be small or not present, if some parts of the vector are toxic 
in E. coli. In this case, the medium copy number destination vector should be 
chosen. 
Naming 
The central features of all entry and final vectors can be described in the SEVA number code. 
They do not comply with the standard perfectly, so they are called SEVA siblings and will be 
named: 
10) Entry vectors: pBSd### for destination vector, pBSc###res for cargo vector, 
pSEVA243Xlocus (=up) or pSEVA243-enzyme-locus-up (if restriction sites were 
added by primer overhangs), pSEVA243Ylocus (=down) or pSEVA243-enzyme-locus-
down 
11) Final vectors: pBS###res-locus_cargo (res = capital letter representing the 
resistance marker) 
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USE OF THE VECTOR 
1) Modification of the final vector, e.g. by changing the cargo, if applicable. 
2) Transformation of your desired organism according to the respective protocols. For 
B. subtilis W168 natural competence can be used (check Radeck et al., 2013 for 
detailed protocols in supplemental material S3) 
3) Usually, in the replication part of the vector (=not integrative part), linearization 
should occur before transformation. Towards that end, e.g. ApaI can be used (check 
your cargo and integration sites!). 
4) Check for spontaneous antibiotic resistant mutants using a “no DNA” control.  
5) Verify the correct insertion via Colony PCR of up-fwd Primer / TM3685 (or 
resistance specific, see below) and TM3682 / down-rev. 
Table 4. Oligonucleotides for integration check PCR 
Primer Name Sequence (5’ to 3’) 
TM3682 GAACGCTCGGTTGCCGC 
TM3685 GGACAAATCCGCCGCCCT 
TM0057 (mls) CCTTAAAACATGCAGGAATTGACG 
TM0718 (cat) AATAGCGACGGAGAGTTAGG 
TM0498 (kan) GCCGGTATAAAGGGACCACC 
TM0058 (spec) GTTATCTTGGAGAGAATATTGAATGGAC 
TM5222 (tet) TGTTTTAGGTGGGCTTTCGTTC 
After performing your experiments & demonstrating functionality: 





 SUPPLEMENTAL DATA 
Some of the open questions presented in the publications and manuscript were 
addressed and the corresponding data is presented in this section. The corresponding 
strains are listed in Table 1 at the end of this section. 
7.6.1 PBCRC-RESPONSE DOES NOT DEPEND ON LIAIH 
PbcrC activity dependends on σM which is activated by CESR. The molecular cue is still 
unknown. LiaIH is activated upon cell envelope stress caused by bacitracin and it was 
shown to mediate resistance against its inducer in the absence of BceAB. This newly-
found feature raised the question, if the presence of LiaIH reduces the CESR caused 
 
Figure 6. Activity of the bcrC-promoter depending on LiaIH-levels in the presence and absence of 
BceAB. Target promoter activity of PbcrC -lux in strains expressing different levels of LiaIH in wild type 
(A) or bceAB-disruption background (B), as given by specific luciferase activity (RLU/OD600) one hour 
after addition of indicated amounts of bacitracin. Measurements were performed as described in 
Fig. 3 of publication II. Colors code for different expression levels of liaIH, as driven by the xylose-
inducible promoter PxylA: (red) No expression, via deletion of LiaIH; (orange) Low constitutive 
expression, via complementation of the deletion mutant with PxylA-liaIH in the absence of xylose; 
(light green) High constitutive expression, via complementation of the deletion mutant PxylA-liaIH in 
the presence of 0.2% xylose; (dark green) overexpression in W168 wild type background, via 
expression of PxylA-liaIH in the presence of 0.2% xylose. The corresponding strains are (A) TMB1620, 
TMB1662, TMB3684, TMB3685 and (B) TMB1620, TMB1624, TMB2195, TMB3686, and TMB3687, 





by bacitracin as detected by PbcrC. Consequently, the activity of PbcrC was measured as 
described in publication II, and the level of LiaIH was adjusted using the xylose-
inducible promoter PxylA. This was also performed in strains missing bceAB, to exclude 
that any measurable effect is covered by the presence of the main resistance 
determinant. Figure 6 shows PbcrC-activity 1 hour after addition of increasing amounts 
of bacitracin. PbcrC-activity shows a high basal activity and low dynamic range, from 
about 7 * 105 to 1.5 * 106 (A, with native bceAB) or 4 * 106 RLU/OD (B, without bceAB). 
In the absence and presence of bceAB, the amount of LiaIH did not significantly 
influence the promoter activity of PbcrC, suggesting that these proteins protect the cell 
envelope in a distinct manner, compared to the cell envelope stress sensed by σM. 
Since the dynamic range is so low, it is still conceivable that influencing patterns could 
not be detected. 
7.6.2 PBCEA-RESPONSE TO LOSS OF BCRC DOES NOT DEPEND ON PRODUCTION OF 
ANTIMICROBIAL PEPTIDES 
In publication II, it was found that PbceA is activated in the absence of BcrC, which was 
puzzling because PbceA was normally activated in response to the flux of bacitracin 
transport (publication I). It was suggested that in case of bcrC deletion, PbceA is 
activated by intrinsically produced AMPs under these experimental conditions. To 
address this question, PbceA-activity was measured as described in publication II in 
strains where the operons known to encode for toxin production of SdpC, SkfA, and 
YydF were disrupted by antibiotic cassettes, as described in (Höfler et al., 2016). 
Strains were measured as described in publication II. Figure 7 shows PbceA-activity of 
the wild type and AMP-defective strains 1 hour after bacitracin addition with (blue) 
and without presence of BcrC (red). Without bacitracin, PbceA-activity is low (104 
RFU/OD) and it gradually increases for all strains with increasing bacitracin 
concentrations, reaching a maximum of 2.5*106 RFU/OD, in line with previous 
descriptions (publications I, II). All strains missing BcrC (red) show an about 10-fold 
higher PbceA-activity than their counterparts with BcrC, if bacitracin is added. So, the 
presence or absence of all three AMPs investigated did not influence PbceA-activity, 







Figure 7. Influence of Cannibalism toxins SdpC, SkfA and YydF on PbceA-activity in the presence and 
absence of BcrC. Target promoter activity of PbceA-lux in wild type or strains missing the genes 
necessary for functional cannibalism toxin production in wildtype (red), or bcrC-disruption 
background (blue), as given by specific luciferase activity (RLU/OD600) one hour after addition of 
indicated amounts of bacitracin. Measurements were performed as described in Fig. 3 of 
publication II. Genotypes are given in the legend, corresponding to TMB1619, TMB1627, TMB1770, 
TMB 1773, TMB1775, TMB2015, and TMB3570-TMB3573 (Table 1). Error bars indicate the standard 
deviation between at least three biological replicates. 
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7.6.3 LIST OF ADDITIONAL STRAINS 
Table 1: B. subtilis strains used for additional data in this study 
 
Strain Description Source  
Strains used for Figure 6 
TMB1620 W168 sacA::pCHlux104 (PbcrC-lux) (Höfler et al., 2016) 
TMB1624 W168 bceAB::kan sacA::pCHlux104 (PbcrC-lux) publication II 
TMB1662 W168 ∆liaIH (clean deletion) sacA::pCHlux104 (PbcrC-lux) publication II 
TMB2159 W168 ΔliaIH bceAB::kan sacA::pCHlux104 (PbcrC-lux) This study 
TMB3684 W168 lacA::pJR2EF02 (pBS2E-PxylA-liaIH) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3685 W168 ∆liaIH lacA::pJR2EF02 (pBS2E-PxylA-liaIH) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3686 W168 bceAB::kan lacA::pJR2EF02 (pBS2E- PxylA-liaIH) sacA::pCHlux104 (PbcrC-lux) This study 
TMB3687 W168 ∆liaIH bceAB::kan lacA::pJR2EF02 (pBS2E- PxylA-liaIH) sacA::pCHlux104 (PbcrC-lux) This study 
Strains used for Figure 7 
TMB1619 W168 sacA::pCHlux103 (PbceA-lux) (Radeck et al., 2013) 
TMB1627 W168 bcrC::tet sacA::pCHlux103 (PbceA-lux) (Radeck et al., 2013) 
TMB1770 W168 sdpC::kan sacA::pCHlux103 (PbceA-lux) (Höfler et al., 2016) 
TMB1773 W168 skfA-H::spec sacA::pCHlux103 (PbceA-lux) (Höfler et al., 2016) 
TMB1775 W168 sacA::pCHlux103 (PbceA-lux)) yydFGHIJ::spec sacA::pCHlux103 (PbceA-lux) (Höfler et al., 2016) 
TMB2015 W168 sdpC::kan skfA-H::spec sacA::pCHlux103 (PbceA-lux) (Höfler et al., 2016) 
TMB3570 W168 bcrC::tet sdpC::kan sacA::pCHlux103 (PbceA-lux) This study 
TMB3571 W168 bcrC::tet skfA-H::spec sacA::pCHlux103 (PbceA-lux) This study 
TMB3572 W168 bcrC::tet yydFGHIJ::spec sacA::pCHlux103 (PbceA-lux) This study 
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